233-241.pdf
201-208.pdf
	American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington,  DC: the Association, 1987.  	NO_MATCH
	ANTHONY, J.C.; WARNER, L.A.; AND KESSLER, R.C. Comparative  epidemiology of dependence on tobacco, alcohol, controlled  substances, and inhalants: Basic findings from the National  Comorbidity Survey. Experimental and Clinical Psychopharmacology  2:244–268, 1994.  	NO_MATCH
	KESSLER, R.C.; MCGONAGLE, K.A.; ZHAO, S.; ET AL. Lifetime  and 12-month prevalence of DSM–III–R psychiatric disorders in  the United States. Results from the National Comorbidity Survey. Archives in General Psychiatry 51(1):8–19, 1994. 	8279933
	WARNER, L.A.; KESSLER, R.C.; HUGHES, M.; ANTHONY, J.C.;  AND NELSON, C.B. Prevalence and correlates of drug use and  dependence in the United States. Results from the National  Comorbidity Survey. Archives in General Psychiatry 52(3):  219–229, 1995. 	7872850
12249_2008_Article_1310.pdf
	1. Arneodo C, Benoit JP, Thies C. Etude  préliminaire de la microencapsulation d’huiles  essentielles par coacervation complexe. STP  Pharma Sciences. 1986; 2:303-306.  	NO_MATCH
	2. Benoit JP, Thies C. Microencapsulation  methods and industrial applications. In: Benita  S, ed. Drugs and the Pharmaceutical Sciences.  , Vol. 73. New York: Marcel Dekker;1996.  	NO_MATCH
	3. Benita S, Benoit JP, Puisieux F, Thies C.  Characterization of drug-loaded poly(d,l lactide) microspheres. J Pharm Sci.  1984;73:1721-1724.  	6527243
	4. Mathews BR, Nixon JR. Surface characteristics  of gelatin microcapsules by scanning electron  microscopy. J Pharm Pharmacol.  1974;26:383-384.  	4153096
	5. Bodmeier R, McGinity J. Polylactic acid  microspheres containing quinidine base and  quinidine sulphate prepared by the solvent  evaporation technique. I. Methods and  morphology. J Microencapsul. 1987;4:279 288.  	NO_MATCH
	6. Cutts LS, Hibberd S, Adler J, Davies MC,  Melia CD. Characterising drug release  processes within controlled release dosage  forms using the confocal laser-scanning  microscope. J Controlled Rel. 1996;42:115 124.  	NO_MATCH
	7. De Smedt SC, Meyvis TKL, Van Oostveldt P,  Demeester J. A new microphotolysis based  approach for mapping the mobility of drugs in  microscopic drug delivery devices. Pharm Res.  1999;16:1639-1642.  	10554110
	8. Bouillot P, Babak V, Dellacherie E. Novel  bioresorbable and bioeliminable surfactants for  microsphere preparation. Pharm Res.  1999;16:148-154.  	9950294
	9. Adler J, Jayan A, Melia CD. A method for  quantifying differential expansion within  hydrating hydrophilic matrixes by tracking  embedded fluorescent microspheres. J Pharm  Sci. 1999;88:371-377.  	10052997
	10. Rojas J, Pinto-Alphandary H, Leo E, Pecquet  S, Couvreur P, Gulik A, Fattal E. A  polysorbate-based non-ionic surfactant can  modulate loading and release of beta lactoglobulin entrapped in multiphase  poly(DL-lactide-co-glycolide) microspheres.  Pharm Res. 1999;16:255-260.  	10100311
	11. Caponetti G, Hrkach JS, Kriwet B, Poh M,  Lotan N, Colombo P, Langer R. Microparticles  of novel branched copolymers of lactic acid  and amino acids: preparation and  characterization. J Pharm. Sci 1999;88:136 141.  	9874715
	12. Lamprecht A, Schäfer UF, Lehr,  CM.  Characterisation of microcapsules by confocal  laser scanning microscopy: analysis of  structure, capsule wall composition and of  encapsulation rate. Eur J Pharm Biopharm.  2000;49:1-9.  	10613921
	13. Alex R, Bodmeier R. Encapsulation of water soluble drugs by a modified solvent  evaporation method. I. Effect of process and  formulation variables on drug entrapment. J  Microencapsul. 1989;7:347-355.  	2384837
	14. Iwata M, McGinity JW. Preparation of multi phase microspheres of poly(lactic acid) and  poly(lactic-co-glycolic acid) containing a W/O  emulsion by a multiple solvent evaporation  technique. J Microencapsul. 1992;9:201-214.  	1593404
	15. Schreiber AB, Haimovich J. Quantitative  fluorometric assay for detection and  characterization of Fc receptors. Meth Enzymol.  1983;93:147-155.  	6865782
	16. Luzzi LA, Gerraughty RJ. Effects of selected  variables on the extractability of oils from  coacervate capsules. J Pharm Sci.  1964;53:429-431.  	14189940
	17. Mussellwhite PR. The surface properties of an  oil-water emulsion stabilized by mixtures of  casein and gelatin. J Colloid and Interface  Science. 1966;21:99-102.  	5906905
	18. Boury F, Ivanova T, Panaiotov I, Proust JE.  Dilatational properties of adsorbed poly(D,L lactide) and bovine serum albumin monolayers  at the dichloromethane/water interface.  Langmuir. 1995;11:1636-1644.  	NO_MATCH
	19. Nihant N, Schugens C, Grandfils C, Jerome R,  Teyssie P. Polylactide microparticles prepared  by double emulsion/evaporation technique. I.  Effect of primary emulsion stability. Pharm  Res. 1994;11:1479-1484.  	7855056
	20. Sezer AD, Akbuga J. Release characteristics of  chitosan treated alginate beads: I. Sustained  release of a macromolecular drug from  chitosan treated alginate beads. J  Microencapsul. 1999;16:195-203.  	10080113
	21. Hari PR, Chandy T, Sharma  CP.  Chitosan/calcium alginate microcapsules for  intestinal delivery of nitrofurantoin. J  Microencapsul. 1996;13:319-329.  	8860687
	22. Murata Y, Toniwa S, Miyamoto E, Kawashima  S. Preparation of alginate gel beads containing  chitosan nicotinic acid salt and the functions.  Eur J Pharm Biopharm. 1999;48:49-52.  	10477328
12249_2008_Article_1255.pdf
	1. Yamashita F, Bando H, Koyama Y, Kitagawa S,  Takakura, Y, Hashida, M. In vivo and in vitro analysis of  skin penetration enhancement based on a two-layer model  with polar and non-polar routes in the stratum corneum.  Pharm Res. 1994;11:185-191.  	8165175
	2. Phillips CA, Michiniak BB. Transdermal delivery of  drugs with differing lipophilicities using azone analogs as  dermal penetration enhances. J Pharm Sci. 1995;84:1427 1437.  	8748324
	3. Flynn GL, Yalkowsky SH, Roseman TJ. Mass  transport phenomena and models: theoretical concepts. J  Pharm Sci. 1974;63:479-510.  	4828694
	4. Ozawa T, Takahashi M. Skin hydration: Recent  Advances. Acta Derm Venereol. Suppl. 1994;185:26-28.  	8091923
	5. Iazzo PA, Olsen RA, Seewald MJ, Powis G, Stier A,  Van Dyke RA. Transient increases of intracellular Ca++  induced by volatile anesthetics in rat hepatocytes. Cell  Calcium. 1990;11:515-524.  	2265428
	6. Reed PW, Lardy HA. A23187: Adivalent  Cationionophore. J Biol Chem. 1972;247:6970.  	NO_MATCH
	7. Wallace BA. Gramicidin channels and pores. Ann Rev  Biophysic Chem. 1990; 19:127  	1694667
	8. Araki M, Inaba H, Kon S, Imai M, Mizuguchi T.  Effects of volatile anesthetics on the calcium ionophore  A23187-mediated alterations in hepatic flow and  metabolism in the perfused liver in fasted rats. Acta  Anesthesiol Scan. 1997;41:55-61.  	9061115
	9. Plakas SM, James MO. Bioavailability, metabolism,  and renal excretion of benzoic acid in the channel catfish  (Ictalurus punctatus). Drug Metab Dispos.  1990;18(5):552-556.  	1981701
	10. French DL, Haglund BO, Himmelstein KJ, Mauger  JW: Controlled release of substituted benzoic and  naphthoic acids using Carbopol gels: measurement of  drug concentration profiles and correlation to release rate  kinetics. Pharm Res. 1995;12(10):1513-1520.  	8584491
	11. Miller GR, Smith CA, Stauber WT. Determination of  fibrosis from cryostat sections using high performance  liquid chromatography: skeletal muscle. Histochem J.  1999;31:89-94.  	10416680
	12. Bartlett GR. Phosphorous assay in column  chromatography. J Biol Chem. 1959;234:466-468.  	13641241
	13. Kabadi MB, Chien YW. Intravaginal controlled  administration of flurogestone acetate IV: in-vitro and in vivo correlation for intravaginal drug delivery from rate control vaginal pessary. Drug Develop Ind Pharm. 1985;  11:1313-1361.  	NO_MATCH
	14. Lee CH, Vyavahare N, Zand R, Kruth H, Schoen  FJ,Bianco R,. Levy RJ. Inhibition of aortic wall  calcification in bioprosthetic heart valves by ethanol  pretreatment: Biochemical and biophysical mechanisms. J  Biomed Mater Res. 1998;42(1):30-37.  	9740004
	15. Hu W, Cross TA. Tryptophan hydrogen bonding and  electric dipole moments: functional roles in the gramicidin  channel and implications for membrane proteins.  Biochemistry. 1995;34:14,147-14,155.  	7578012
	16. Heitz F, Gavach C. Ca+2 gramicidin A interactions  and blocking effects on the ionic channel. Biophysical  Chemistry. 1983; 18:153-163.  	6194829
	17. Mitchell DC, Litman BJ. Effect of hydration on  receptor conformation: decreased levels of bound water  promote metarhodopsin II formation.Biochemistry. 1999;  38: 7617-7623.  	10387000
	18. Kuruc M, Krupey J. Application of an insoluble  protein precipitation reagent. Am Biotechnol.  1992;10(3):12-14.  	1368383
	19. Hwang J, Tamm LK, Bohm C, Ramalingam TS,  Betzig E, Edidin M. Nanoscale complexity of  phospholipid monolayers investigated by near-field  scanning optical microscopy. Science. 1995; 270:610-614.  	7570018
	20. Carruthers A, Melchior DL. Human erythrocyte  hexose transporter activity is governed by bilayer  lipid composition in reconstituted vesicles.  Biochemistry. 1984;23(26):6901-6911.  	6543323
JVS001-02-03.pdf
	1. Bredt, D.S and Snyder, S.H. Nitric oxide, a novel neuronal  messenger. Neuron 1992, 8, 3-11.   	1370373
	2. Cooper, J. and Walker, R.D. Listeriosis. Vet. Clin. North.  Am. Food Anim. Pract. 1998, 14, 113-125.   	NO_MATCH
	3. Charlton, K.M. and Garcia, M.M. Spontaneous listeric  encephalitis and neuritis in sheep. Light microscopic studies.  Vet. Pathol. 1997, 14, 297-313.   	NO_MATCH
	4. Dramsi, S., Levi, S., Triller, A. and Cossart, P. Entry of  Listeria monocytogenes into neurons occurrs by cell-to-cell  spread: an in vitro study. Infect. Immun. 1998, 66, 4461 4468.  	9712801
	5. Greenberg, S.S., Ouyang, J., Zhao, X. and Giles, T.D.  Human and rat neutrophils constitutively express neuronal  nitric oxide synthase mRNA. Nitric Oxide 1998, 2, 203-212.  	9731638
	6. Hooper, D.C., Ohnishi, S.T., Kean, R., Numagami, Y.,  Dietzschold, B. and Koprowski, H. Local nitric oxide  production in viral and autoimmune disease of the central  nervous system. Proc. Natl. Acad. Sci. U.S.A. 1995, 92,  5312-5316.  	7539914
	7. Johnson, G.C., Fales, W.H., Maddox, C.W. and Ramos Vara, J.A. Evaluation of laboratory test for confirming the  diagnosis of encephalitic listeriosis in ruminants. J. Vet.  Diagn. Invest. 1995, 7, 223-228.  	7542480
	8. Jungi, T.W., Pfister, H., Sager, H., Fatzer, R., Vandevelde,  M. and Zurbriggen, A. Comparison of inducible nitric  oxide synthase expression in the brain of Listeria  monocytogenes-infected cattle, sheep and goats and in  macrophages stimulated in vitro. Infect. Immun. 1997, 65,  5279-5288.   	9393827
	9. Krueger, N., Low, C. and Donachie, W. Phenotypic  characterization of the cells of the inflammatory response in  ovine encephalitic listeriosis. J. Comp. Pathol. 1995, 113,  263-275.  	8592052
	10. Kim, S., Moon, C., Wie, M., Kim, H., Tanuma, N.,  Matsumoto, Y. and Shin, T. Enhanced expression of  constitutive and inducible forms of nitric oxide synthase in  autoimmune encephalomyelitis. J. Vet. Sci., 2000, 1, 11-17.  	NO_MATCH
	11. Moncada, S., Palmer, R.M.J. and Higgs, E.A. Nitric  oxide: physiology, pathophysiology, and pharmacology.  Pharmacol. Rev., 1991, 43, 109-134.   	1852778
	12. Murphy, S., Simmons, M.L., Agullo, L., Carcia, A.,  Feinstein, D.L., Galea, E., Reis, D.J., Minc-Golomb, D.  and Schwartz, J.P. Synthesis of nitric oxide in CNS glial  cells. T.I.N.S. 1993, 16, 323-328.  	7691008
	13. Nathan, C. and Xie, Q.-W. Nitric oxide synthases: Roles,  tolls and controls. Cell 1994, 78, 915-918.   	7522969
	14. Otter, A. and Blackmore, W.F. Observation on the  presence of Listeria monocytogenes in axons. Acta  Microbiol. Hung. 1989, 36, 125-131.   	2517159
	15. Reiling, N., Ulmer, A.J., Duchrow, M., Ernst, M., Flad,  H.D. and Hauschildt, S. Nitric oxide synthase: mRNA  expression of different isoforms in human monocytes/  macrophages. Eur. J. Immunol. 1994, 24, 1941-1944.  	7520003
	16. Reiling, N., Kroncke, R., Ulmer, A.J., Gerdes, J., Flad,  H.D. and Hauschildt, S. Nitric oxide synthase: expression  of the endothelial, Ca2+/calmodulin-dependent isoform in  human B and T lymphocytes. Eur. J. Immunol. 1996, 26,  511-516.  	8605914
	17. Rouquette, C. and Berche, P. The pathogenesis of infection  by Listeria monocytogenes. Microbiologia 1996, 12, 245 258.  	8767708
	18. Sinz, E.H., Kochanek, P.M., Dixon, C.E., Clark, R.S.,  Carcillo, J.A., Schiding, J.K., Chen, M., Wisniewski,  S.R., Carlos, T.M., William, D., DeKosky, S.T., Watkins,  S.C., Marion, D.W. and Billiar, T.R. Inducible nitric oxide  synthase is an endogenous neuroprotectant after traumatic  brain injury in rats and mice. J. Clin. Invest. 1999, 104, 647 656.   	10487779
	19. Wu, J., Lin, Q., Lu, Y., Willis, W.D. and Westlund, K.N.  Changes in nitric oxide synthase isoforms in the spinal cord  of rat following induction of chronic arthritis. Exp. Brain  Res. 1998, 118, 457-465  	9504841
Nucleic Acids Symp Ser-2000-Inoue-279-80.pdf
	1. Trawick, B. N., Daniher, A. T., and Bashkin, J. K.  (1998) Chem. Rev., 98,939-960.  	NO_MATCH
	2. Inoue, H., Furukawa, T., Shimizu, M., Tamura, T.,  Matsui, M., and Ohtsuka, E. (1999) Chem.  Commun., 45-46.  	NO_MATCH
	3. Tamura, T., Furukawa, T., Komatsu, Y., Ohtsuka,  E., and Inoue, H. (1999) Nucleic Acids Symp. Ser.  No. 42, 109-110.  	NO_MATCH
	4. Cuenoud, B., Casset, F., Hiisken, D., Natt, F.,  Wolf, R. M., Altmann, K.-H., Martin, P., and  Moser, H. E. (1998) Angew. Chem. Int. Ed. Engl.,  37, 1288-1291.  	NO_MATCH
20008720.pdf
20008706.pdf
53_979.pdf
	1) Horinouchi, S.: 7-Butyrolactones that control secondary  metabolism and cell differentiation  in Streptomyces, In  Cell-cell signaling in Bacteria. Ed., G. M. Dunny, et al,  pp. 193-207, American Society for Microbiology,  	NO_MATCH
	Washington,  D. C, 1999  	NO_MATCH
	2) Yamada, Y.: Autoregulatory factors and regulation of  antibiotic production in Streptomyces, In Microbial  	NO_MATCH
	signalling  and communication. Ed., R. England, et  al., pp. 177-196, Society for General Microbiology,  Cambridge University Press., Cambridge, 1999  	NO_MATCH
	3) Takano, E.; T. Nihira, Y Hara, I J. Jones, C. J.  Gershater, Y Yamada & M. Bibb: Purification and  structural determination of SCB1 , a 7-butyrolactone that  elicAit3s  (2). antJ.i bBiiool.t ic Chpemro. du2c75t:i on1 1i0n10- 11S01t6,r eptomyc2e00s0 coelicolor  	NO_MATCH
	4) Grafe, U; W. Schade, I. Eritt, W. F. Fleck & L.  Radics: A new inducer of the anthracycline biosynthesis  from Streptomyces viridochromogenes. J. Antibiotics 35 :  1208-1215, 1982  	6962795
	5) Grafe, U; G. Reinhardt, W. Schade, I. Eritt, W.  F. Fleck & L. Radics: Interspecific inducers of  cytodifferntiation and anthracycline  biosynthesis from  	NO_MATCH
	Streptomyces bikiniensis and S. cyanofuscatus. Biotech nol. Lett. 5: 591-596, 1983  	NO_MATCH
	6) Hara, O. & T. Beppu: Mutants blocked in streptomycin  production in Streptomyces griseus-the role of A factor. J. Antibiotics 35: 349-358, 1982  	6804428
53_954.pdf
	Fuhrmann, U; E. Bause, & P. Hidde: Inhibitiors oligo95s-a1c10h, aride 1985processing. Biochim. Biophys. Acta 825:	3159432
	Truscheit, E.; W. Frommer, B. Junge & W.  Wingender: Chemistry and biochemistry of microbial a-glucosidase inhibitors.  Angew. Chem. Int. Ed. Engl.  20: 744-761,  1981  	NO_MATCH
	Bischoft, H.: Pharmacology of a-glucosidases  inhibition. Eur. J. Clin. Invest. 24 (Suppl. 3): 3-10, 1994  	NO_MATCH
	Watanabe, I; J. Kawabata, H. Kurihara & R. Niki:  Isolation and identification of a-glucosidase inhibitors  from Tochu-ch2L(Eucommia ulmoides). Biosci. Biotech.  Biochem. 61:.177-178,"1997  	9028049
	Matsui, T.; C. Yoshimoto, K. Osajima, T. Oki & Y. Osajima: In vitro survey of a-glucosidase inhibitory  food components. Biosci. Biotech. Biochem. 60: 2019 2022, 1996  	NO_MATCH
	Nitecki, D. E. & B. Halpern: A simple route to  sterically  pure diketopiperazines.  J. Org. Chem. 33:  864-866, 1968  	NO_MATCH
	Lee, S.; T. Kanmera, H. Aoyagi & N. Izumiya: Cyclic  peptides. VI. Asymmetric hydrogenation of dehydro alanine or dehydroaminobutanoic acid residue in cyclic dipeptides. Int. J. Peptide Protein Res. 13: 207-217,  1979  	429097
	Pan, Y T.; J. Ghidoni & A. D. Elbein: The effects of  castanospermine and swainsonine on the activity and  synthesis of intestinal sucrase. Archi. of Biochem. and  Biophys. 303: 134-144, 1993  	8489256
	Bell, R.; S. Carmeli & N. Sar: Vibrindole A,  a metabolite of the marine bacterium, Vibrio  parahaemolyticus, isolated from the toxic mucus of the  box fish Ostracion cubicus. J. Nat. Prod. 57: 1587-1590,  1994	7853008  
	Fenouillet, E.; M. J. Papandreou & L. Jones:  Recombinant HIVenvelope expressed in an a-glucosi dase I-deficient CHOcell line and its parental cell line in the presence of 1-deoxynojirimycin   is functional. Virology 231: 89-95, 1997	7853008
53_903.pdf
	1) Cabib, E.; J. A. Shaw, P. C. Mol, B. Bower & W. J.  Choi: Chitin biosynthesis and morphogenetic process. In  The Mycota. Biochemistry and Molecular Biology. Vol.  III. Ed. R. Brambl & G. A. Marzluf, pp. 243-267, Springer-Verlag,  Berlin,  1 996  	NO_MATCH
	2) Bulawa, C. E.: CSD2, CSD3, and CSD4, genes required  for chitin synthesis in Saccharomyces cerevisiae: the  CSD2gene product is related to chitin synthases and to  developmentally regulated proteins in Rhizobium species  and Xenopus laevis. Mol. Cell. Biol. 12: 1764-1776, 1992	1532231
	3) Takita, M. A. & B. Castilho-Valavicius:  Absence of  cell wall chitin in Saccharomyces cerevisiae leads to  resistance to Kluyveromyces lactis killer toxin. Yeast 9:  589-598, 1993  	8346675
	Bulawa, C. E. & B. C. Osmond: Chitin synthase I and  chitin synthase II are not required for chitin synthesis in  vivo in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci.  U.S.A. 87: 7424-7428, 1990  	2217173
	Shaw, J. A.; P. C. Mol, B. Bowers, S. J. Silverman, M.  M. Valdivieso, A. Duran & E. Cabib: The function of  chitin synthases 2 and 3 in the Saccharomyces cerevisiae cell cycle. J. CellBiol. 114: 111-123,  1991  	2050738
	Cabib, E.; B. Sburlati, B. Bowers & S. J. Silverman:  Chitin synthase I, an auxiliary enzyme for chitin  synthesis in Saccharomyces cerevisiae. X Cell Biol. 108:  1665-1672, 1989  	2523889
	Cabib, E.; S. J. Silverman & J. A. Shaw: Chitinase and  chitin synthase I: counterbalancing activities in cell  separation of Saccharomyces cerevisiae. X Gen.  Microbiol. 138: 97-102,  1992  	1556560
	Silverman, S. X: Similar and different domains of chitin  synthases 1 and 2 of Saccharomyces cerevisiae: two  isozyme with distinct functions. Yeast 5: 459-467, 1989  Silverman, S. X; A. Sburlati, M. Slater & E. Cabib:  Chitin synthase 2 is essential function and cell division  in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U.S.A. 85: 4735-4739, 1988 	2533436
	Sburlati, A. & E. Cabib: Chitin synthethase 2, a  presumptive participant in septum formation in  Saccharomyces cerevisiae. X Biol. Chem. 261: 15147 15152, 1986  	2945823
	Gilbertson, R. L. & L. Ryvarden: North American Polypores. Vol. 2. pp. 541-623, Fungi flora, Oslo,  Norway, 1987  	NO_MATCH
	Choi, W. J. & E. Cabib: The use ofdivalent cations and  pH for the determination of specific yeast chitin  synthetases.  Anal. Biochem. 219: 368-372, 1994  	8080094
	Lowry, O. H.; N. I Rosebrough, A. L. Farr & R. X  Randall: Protein measurement with the folin phenol  reagent. X Biol. Chem. 193: 265-275, 1951  	14907713
	Stalpers, X A.: Studies in Mycology. No 16;  Identification of wood-inhibiting fungi in pure culture, p.  248, Centraalbureau voor Schimmelcultures, Baarn,  Netherlands,  1 978  	NO_MATCH
	Ryvarden, L. & R. L. Gilbertson: European Polypores.  Vol. 1-2. p. 743, Fungi flora, Oslo, Norway, 1993  	NO_MATCH
	Larsen, M. X & L. A. Cobb-Poulle: Synopsis  Fungorum 3: Phellinus  (Hymenochaetaecae)-A survey  of the world taxa. p. 206, Fungi flora, Oslo, Norway, 1990  	NO_MATCH
	Gilbertson, R. L. & L. Ryvarden: North American Polypores. Vol. 1-2. p. 885, Fungi flora, Oslo, Norway,  1987  	NO_MATCH
	Dai, Y. C. & M. Q. Xu: Studies on the medicinal  polypore, Phellinus baumil, and its kin, P. linteus.  Mycotaxon 62: 191-200, 1998  	NO_MATCH
	Cabib, E.: Differential inhibition of chitin synthases 1  and 2 from Saccharomyces cerevisiae by polyoxin D and  nikkomycin Z. Antimicrob. Agents Chemother. 35:  170-173, 1991  	2014972
	Georgopapadakou, N. H.: Antifungals targeted to the  cell wall. Exp. Opin. Invest. Drugs. 6: 147-150, 1997  	NO_MATCH
	Denning, D. W.: Echinocandins and pneumocandins- a  newantifungal class with a novel mode of action. X Antimicrob. Chemother. 40: 61 1-614, 1997 	9421307
	Sakurai, T.; N. Cheepthan, T. Mikawa, A. Yokota & F.  Tomita: A novel screen for the detection of chitin acting  antifungal compounds. X Antibiotics 52: 508-51 1, 1999  	10480577
	23) Naowarat, C; T. Higashiyama, N. Phay & F. Tomita:  Rapid and unique screening system for the discovery of  new antifungal antibiotics against chitin  synthesis in  fungal cell walls. Thai J. Biotechnol. 1(1): 31-36, 1999  	NO_MATCH
	24) Naowarat, C; N. Phay, T. Higashiyama, E. Fukushi, H.  Matsuura, T. Mikawa, A. Yokota, A. Ichihara & F.  Tomita: Studies on an antifungi antibiotic from  Ellisiodothis inguinans L1588-A8. Thai J. Biotechnol.  1(1): 37-45, 1999  	NO_MATCH
	25) Pfefferle, W.; H. Anke & M. Bross: Inhibition   solubilized chitin synthase by chlorinated aromatic  compounds isolated from mushroomcultures. Agric.  Biol. Chem. 54(6): 1381-1384, 1990  	NO_MATCH
	26) Hector, R. F. & P. C. Braun: Synergic action of  nikkomycin X and Z with papulacandin B on whole cells  and regenerating protoplasts of Candida albicans.  Antimicrob. Agents Chemother. 29: 389-394, 1986  	3521483
	27) Gaughram, J. P.; M. H. Lai, D. R. Kirsch & S. J.  Silverman: Nikkomycin Z is a specific inhibitor of  Saccharomyces cerevisiae chitin synthase isozyme chs3  in vitro and in vivo. J. Bacteriol. 176: 5857-5860, 1994  	8083179
	Cabib, E.; R. Roberts & B. Bowers: Synthesis of the  yeast cell wall and its regulation.  Ann. Rev. Biochem.  51: 763-793,  1982  	7051965
	Hwang, E. L; B. S. Yun, Y. K. Kim, B. M. Kwon, H. G.  Kim, H. B. Lee, K. S. Bae & S. U. Kim: Chaetoatrosin  A,  a novel ehitin synthase II inhibitor produced by  Chaetomium atrobrunneum F449. J. Antibiotics  53: 248-255, 2000 	10819295
	Kim, S. U; E. I. Hwang, J. Y. Nam, K. H. Son, S. H.  Bok, H. E. Kim & B. M. Kwon: Inhibition  of chitin synthase II by catechins from stem bark of Taxus  cuspidata. Planta Medica 65: 97-98, 1999  	10083852
	Jeong, T. S.; E. I. Hwang, H. B. Lee, E. S. Lee, Y K.  Kim, B. S. Min, K. H. Bae, S. H. Bok & S. U. Kim:  Chitin stnthase II Inhibitory activity of ursolic acid,  isolated from Crataegus pinnatifida. Planta Medica 65: 261-263, 1999  	10232075
262.pdf
241.pdf
207.pdf
196.pdf
J Neurophysiol-2000-Samson-1330-45.pdf
	ADRIA´N HO, LIFSCHITZ WM, TAVITAS RJ, AND GALLI FP. Activity of neural  units in medial geniculate body of cat and rabbit. J Neurophysiol 29:  1046–1060, 1966.  	5971661
	AITKIN LM. Medial geniculate body of the cat: responses to tonal stimuli of  neurons in medial division. J Neurophysiol 36: 275–283, 1973.  	4574714
	AITKIN LM AND DUNLOP CW. Interplay of excitation and inhibition in the cat  medial geniculate body. J Neurophysiol 31: 44–61, 1968.  	5640739
	AITKIN LM AND MARTIN RL. The representation of stimulus azimuth by high  best-frequency azimuth-selective neurons in the central nucleus of the  inferior colliculus of the cat. J Neurophysiol 57: 1185–1200, 1987.  	3585459
	AITKIN LM AND WEBSTER WR. Medial geniculate body of the cat: organization  and responses to tonal stimuli of neurons in ventral division. J Neurophysiol  35: 365–380, 1972.  	5029955
	ALTMAN JA, SYKA J, AND SHMIGIDINA GN. Neuronal activity in the medial  geniculate body of the cat during monaural and binaural stimulation. Exp  Brain Res 10: 81–93, 1970.  	5411976
	ANDERSEN RA, KNIGHT PL, AND MERZENICH MM. The thalamocortical and  corticothalamic connections of AI, AII, and the anterior auditory field  (AAF) in the cat: evidence for two largely segregated systems of connec tions. J Comp Neurol 194: 663–701, 1980.  	7451688
	BARONE P, CLAREY JC, IRONS WA, AND IMIG TJ. Cortical synthesis of azimuth sensitive single-unit responses with nonmonotonic level tuning: a thalamo cortical comparison in the cat. J Neurophysiol 75: 1206–1220, 1996.  	8867129
	CLAREY JC, BARONE P, AND IMIG, T.J. Physiology of thalamus and cortex. In:  The Mammalian Auditory Pathway: Neurophysiology, edited by Fay RR and  Popper A. New York: Springer-Verlag, 1992, chapt. 5, p. 232–334.  	NO_MATCH
	CLAREY JC, BARONE P, IRONS WA, SAMSON FK, AND IMIG TJ. Comparison of  noise and tone azimuth tuning of neurons in cat primary auditory cortex and  medial geniculate body. J Neurophysiol 74: 961–980, 1995.  	7500165
	DELGUTTE B, JORIS PX, LITOVSKY RY, AND YIN TCT. Receptive fields and  binaural interactions for virtual-space stimuli in the cat inferior colliculus.  J Neurophysiol 81: 2833–2851, 1999.  	10368401
	FUZESSERY ZM, WENSTRUP JJ, AND POLLAK GD. Determinants of horizontal  sound location selectivity of binaurally excited neurons in an isofrequency  region of the mustache bat inferior colliculus. J Neurophysiol 63: 1128–  1147, 1990.  	2358867
	HIRSCH JA, CHAN JC, AND YIN TC. Responses of neurons in the cat’s superior  colliculus to acoustic stimuli. I. Monaural and binaural response properties.  J Neurophysiol 53: 726–745, 1985.  	3981235
	IMIG TJ AND ADRIA´N HO. Binaural columns in the primary field (AI) of the cat  auditory cortex. Brain Res 138: 241–257, 1977.  	589474
	IMIG TJ, BIBIKOV NG, POIRIER P, AND SAMSON FK. Directionality derived from  pinna-cue spectral notches in the cat’s dorsal cochlear nucleus. J Neuro physiol 83: 907–925, 2000.  	10669504
	IMIG TJ, IRONS WA, AND SAMSON FR. Single-unit selectivity to azimuthal  direction and sound pressure level of noise bursts in cat high-frequency  primary auditory cortex. J Neurophysiol 63: 1448–1466, 1990.  	2358885
	IMIG TJ AND MOREL A. Tonotopic organization in the ventral nucleus of the  medial geniculate body in the cat. J Neurophysiol 53: 309–340, 1985a.  	3973661
	IMIG TJ AND MOREL A. Tonotopic organization of the lateral part of the  posterior group of thalamic nuclei in the cat. J Neurophysiol 53: 836–851,  1985b.  	3981239
	IMIG TJ, POIRIER P, IRONS WA, AND SAMSON FK. A monaural spectral contrast  mechanism for neural sensitivity to sound direction in the medial geniculate  body of the cat. J Neurophysiol 78: 2754–2771, 1997.  	9356424
	IVARSSON C, DE RIBAUPIERRE Y, AND DE RIBAUPIERRE F. Influence of auditory  localization cues on neuronal activity in the auditory thalamus of the cat.  J Neurophysiol 59: 586–606, 1988.  	3351575
	JORIS PX. Response classes in the dorsal cochlear nucleus and its output tract  in the chloralose-anesthetized cat. J Neurosci 18: 3955–3966, 1998.  	9570822
	KITZES LM, WREGE KS, AND CASSADY JM. Patterns of responses of cortical  cells to binaural stimulation. J Comp Neurol 192: 455–472, 1980.  	7419739
	KITZES LM AND DOHERTY D. Influence of callosal activity on units in the  auditory cortex of the ferret (Mustela putorius). J Neurophysiol 71: 1740–  1751, 1994.  	8064345
	MIDDLEBROOKS JC AND GREEN DM. Sound localization by human listeners.  Annu Rev Psychol 42: 135–159, 1991.  	2018391
	MOREL A AND IMIG TJ. Thalamic projections to fields A, AI, P, and VP in the  cat auditory cortex. J Comp Neurol 265: 119–144, 1987.  	2826552
	MUSICANT AD, CHAN JCK, AND HIND JE. Direction-dependent spectral prop erties of cat external ear: new data and cross-species comparisons. J Acoust  Soc Am 87: 757–781, 1990.  	2307774
	NELKEN I AND YOUNG ED. Two separate inhibitory mechanisms shape the  responses of dorsal cochlear nucleus type IV units to narrowband and  wideband noise. J Neurophysiol 71: 2446–2462, 1994.  	7931527
	POIRIER, P, SAMSON FK, AND IMIG TJ. Directional mechanisms and spatial  preferences of single units in the cat’s inferior colliculus. Soc Neurosci Abstr  22: 889, 1996.  	NO_MATCH
	RAJAN R, AITKIN LM, IRVINE DRF, AND MCKAY J. Azimuthal sensitivity of  neurons in primary auditory cortex of cats. I. Types of sensitivity and effects  of variations in stimulus parameters. J Neurophysiol 64: 872–887, 1990.  	2230931
	RICE JJ, MAY BJ, SPIROU GA, AND YOUNG ED. Pinna-based spectral cues for  sound localization in cat. Hear Res 58: 132–152, 1992.  	1568936
	SAMSON FK, BARONE P, CLAREY JC, AND IMIG TJ. Effects of ear plugging on  single-unit azimuth sensitivity in cat primary auditory cortex. II. Azimuth  tuning dependent upon binaural stimulation. J Neurophysiol 71: 2194–2216,  1994.  	7931511
	SAMSON FK, CLAREY JC, BARONE P, AND IMIG TJ. Effects of ear plugging on  single-unit azimuth sensitivity in cat primary auditory cortex. I. Evidence for  monaural directional cues. J Neurophysiol 70: 492–511, 1993.  	8410151
	SAMSON FK, POIRIER P, IRONS WA, AND IMIG TJ. Effects of ear plugging on  responses of azimuth sensitive neurons in medial geniculate body (MGB)  and primary auditory cortex (AI) of barbiturate anesthetized cats. Soc  Neurosci Abstr 22: 889, 1996.  	NO_MATCH
	SPIROU GA AND YOUNG ED. Organization of dorsal cochlear nucleus type IV  unit response maps and their relationship to activation by band-limited  noise. J Neurophysiol 66: 1750–1766, 1991.  	1765805
	WENSTRUP JJ, FUZESSERY ZM, AND POLLAK GD. Binaural neurons in the  mustache bat’s inferior colliculus. I. Responses of 60-kHz. EI units to  dichotic sound stimulation. J Neurophysiol 60: 1369–1383, 1988a.  	3193162
	WENSTRUP JJ, FUZESSERY ZM, AND POLLAK GD. Binaural neurons in the  mustache bat’s inferior colliculus. II. Determinants of spatial responses  among 60-kHz EI units. J Neurophysiol 60: 1384–1404, 1988b.  	3193163
	WISE LZ AND IRVINE DRF. Topographic organization of interaural intensity  difference sensitivity in deep layers of the cat superior colliculus: implica tions for auditory spatial representation. J Neurophysiol 54: 185–211, 1985.  	4031984
	YOUNG ED, SPIROU GA, AND RICE JJ. Representation of pinna-produced  spectral notches in dorsal cochlear nucleus (DCN). Soc Neurosci Abstr 18:  1037, 1992a.  	NO_MATCH
	YOUNG ED, SPIROU GA, RICE JJ, AND VOIGT HF. Neural organization and  responses to complex stimuli in the dorsal cochlear nucleus. Philos Trans R  Soc Lond B Biol Sci 336: 407–413, 1992b.  	1354382
J Neurophysiol-2000-Keller-1303-13.pdf
	AMADOR N, SCHLAG-REY M, AND SCHLAG J. Primate antisaccades. I. Behav ioral characteristics. J Neurophysiol 80: 1775–1786, 1998.  	9772238
	CHIMOTO S, IWAMOTO Y, SHIMAZU H, AND YOSHIDA K. Monosynaptic activa tion of medium-lead burst neurons from the superior colliculus in the alert  cat. J Neurophysiol 75: 2658–2661, 1996.  	8793771
	EDELMAN JA AND KELLER EL. Activity of visuomotor burst neurons in the  superior colliculus accompanying express saccades. J Neurophysiol 76:  908–926, 1996.  	NO_MATCH
	EDELMAN JA AND KELLER EL. Dependence on target configuration of express  saccade-related activity in the primate superior colliculus. J Neurophysiol  80: 1407–1426, 1998.  	9744949
	EVERLING S, DORRIS MC, KLEIN RM, AND MUNOZ DP. Role of primate superior  colliculus in preparation and execution of anti-saccades and pro-saccades.  J Neurosci 19: 2740–2754, 1999.  	10087086
	FRENS MA AND VAN OPSTAL AJ. Monkey superior colliculus activity during  short-term saccadic adaptation. Brain Res Bull 43: 473–483, 1997.  	9250621
	FUCHS AF, KANEKO CRS, AND SCUDDER CA. Brainstem control of saccadic eye  movements. Annu Rev Neurosci 8: 307–337, 1985.  	3920944
	FUCHS AF AND ROBINSON DA. A method for measuring horizontal and vertical  eye movement chronically in the monkey. J Appl Physiol 21: 1068–1070,  1966.  	4958032
	FUNAHASHI S, CHAFEE MV, AND GOLDMAN-RAKIC PS. Prefrontal neuronal  activity in Rhesus monkeys performing a delayed anti-saccade task. Nature  365: 753–756, 1993.  	8413653
	GRANTYN AA AND GRANTYN R. Synaptic actions of tectofugal pathways on  abducens motoneurons in the cat. Brain Res 105: 269–285, 1976.  	1260444
	GRAYBIEL AM. Direct and indirect preoculomotor pathways of the brainstem:  an autoradiographic study of the pontine reticular formation in the cat.  J Comp Neurol 175: 37–78, 1977.  	886026
	GUITTON D AND MUNOZ DP. Control of gaze shifts by the tectoreticulospinal  system in the head-free cat. I. Identification, localization and effects of  behavior on sensory responses. J Neurophysiol 66: 1605–1623, 1991.  	1765797
	HARTING JK. Descending pathways from the superior colliculus: an autoradio graphic analysis in the rhesus monkey (Macaca mulatta). J Comp Neurol  173: 583–612, 1977.  	404340
	HEPP K AND HENN H. Spatio-temporal recording of rapid eye movement  signals in the monkey paramedian pontine reticular formation (PPRF). Exp  Brain Res 52: 105–120, 1983.  	6628590
	HEPP K, HENN V, VILIS T, AND COHEN B. Brainstem regions related to  saccade generation. In: The Neurobiology of Saccadic Eye Movements,  edited by Wurtz RH and Goldberg ME. Amsterdam: Elsevier, 1989, p.  105–212.  	NO_MATCH
	JUDGE SJ, RICHMOND BJ, AND CHU FC. Implantation of magnetic search coils  for measurement of eye position: an improved method. Vision Res 20:  535–538, 1980.  	6776685
	KELLER EL. The brainstem. In: Eye Movements, edited by Carpenter RHS.  London: Macmillan, 1991, p. 200–223.  	NO_MATCH
	KELLER EL AND EDELMAN JA. Use of interrupted saccade paradigm to study  spatial and temporal dynamics of saccadic burst cells in superior colliculus  in monkey. J Neurophysiol 72: 2754–2770, 1994.  	7897487
	KELLER EL, GANDHI NJ, AND WEIR PT. Discharge of superior collicular  neurons during saccades made to moving targets. J Neurophysiol 76: 3573–  3577, 1996.  	8930297
	KELLER EL AND MCPEEK RM. State dependent activation of paramedian  pontine reticular formation (PPRF) burst neurons by superior collicular  stimulation in monkey. Soc Neurosci Abstr 25: 6, 1999.  	NO_MATCH
	LEICHNETZ G, SMITH DJ, AND SPENCER RF. Cortical projections to the para median tegmental and basilar pons in the monkey. J Comp Neurol 228:  388–408, 1984.  	6480918
	MIYASHITA N AND HIKOSAKA O. Minimal synaptic delay in the saccadic output  pathway of the superior colliculus studied in awake monkey. Exp Brain Res  112: 187–196, 1996.  	8951387
	MOSCHOVAKIS AK, KITAMA T, DALEZIOS Y, PETIT J, BRANDI AM, AND  GRANTYN A. An anatomical substrate for the spatiotemporal transformation.  J Neurosci 18: 10219–10229, 1998.  	9822775
	MOSCHOVAKIS AK, SCUDDER CA, AND HIGHSTEIN SM. The microscopic anat omy and physiology of the mammalian saccadic system. Prog Neurobiol 50:  133–254, 1996.  	8971981
	OLIVIER E, GRANTYN A, CHAT M, AND BERTHOZ A. The control of slow  orienting eye movements by tectoreticulospinal neurons in the cat—behav ior, discharge patterns and underlying connections. Exp Brain Res 93:  435–449, 1993.  	8519334
	PARE´ M AND GUITTON D. The fixation area of the cat superior colliculus:  effects of electrical stimulation and direct connection with brainstem om nipause neurons. Exp Brain Res 101: 109–122, 1994.  	7843290
	RAYBOURN MS AND KELLER EL. Colliculoreticular organization in primate  oculomotor system. J Neurophysiol 40: 861–878, 1977.  	407334
	SEGRAVES MA. Activity of monkey frontal eye field neurons projecting  to oculomotor regions of the pons. J Neurophysiol 68: 1967–1985,  1992.  	NO_MATCH
	STANFORD TR AND SPARKS DL. Systematic errors for saccades to remembered  targets: evidence for a dissociation between saccade metrics and activity in  the superior colliculus. Vision Res 34: 93–106, 1994.  	8116272
	STANTON GB, GOLDBERG ME, AND BRUCE C. Frontal eye field efferents in the  macaque monkey. I. Subcortical pathways and topography of striatal and  thalamic terminal fields. J Comp Neurol 271: 473–492, 1988.  	2454970
	STRASSMAN A, EVINGER C, MCCREA RA, BAKER RG, AND HIGHSTEIN SM.  Anatomy and physiology of intracellularly labelled omnipause neurons in  the cat and squirrel monkey. Exp Brain Res 67: 436–440, 1987.  	3622701
	STRASSMAN A, HIGHSTEIN SM, AND MCCREA RA. Anatomy and physiology of  saccadic burst neurons in the alert squirrel monkey. II. Inhibitory burst  neurons. J Comp Neurol 249: 358–380, 1986.  	3734161
1279.full.pdf
	ABRAHAM WC AND BEAR MF. Metaplasticity: the plasticity of synaptic plas ticity. Trends Neurosci 19: 126–130, 1996.  	8658594
	ANWYL R, WALSHE J, AND ROWAN M. Electroconvulsive treatment reduces  long-term potentiation in rat hippocampus. Brain Res 435: 377–379, 1987.  	3427466
	BARR DS, HOYT KL, MOORE SD, AND WILSON WA. Post-ictal depression  transiently inhibits induction of LTP in area CA1 of the rat hippocampal  slice. Epilepsy Res 27: 111–118, 1997.  	9192185
	BEAR MF. Mechanism for a sliding synaptic modification threshold. Neuron  15: 1–4, 1995.  	7619513
	BIENENSTOCK EL, COOPER LN, AND MUNRO PW. Theory for the development  of neuron selectivity: orientation specificity and binocular interaction in  visual cortex. J Neurosci 2: 32–48, 1982  	7054394
	BLISS TVP AND COLLINGRIDGE GL. A synaptic model of memory: Long-term  potentiation in the hippocampus. Nature 361: 31–39, 1993.  	8421494
	BLITZER RD, WONG T, NOURANIFAR R, IYENGAR R, AND LANDAU EM. Postsyn aptic cAMP pathway gates early LTP in hippocampal CA1 region. Neuron  15: 1403–1414, 1995.  	8845163
	BORTOLOTTO ZA AND COLLINGRIDGE GL. Involvement of calcium/calmodulin dependent protein kinases in the setting of a molecular switch involved in  hippocampal LTP. Neuropharmacology 37: 535–544, 1998.  	9704994
	CHRISTIE BR AND ABRAHAM WC. Priming of associative long-term depression  in the dentate gyrus by u frequency synaptic activity. Neuron 9: 79–84,  1992.  	1321647
	CLARK KA, RANDALL AD, AND COLLINGRIDGE GL. A comparison of paired pulse facilitation of AMPA and NMDA receptor-mediated excitatory  postsynaptic currents in the hippocampus. Exp Brain Res 101: 272–278,  1994.  	7843313
	COAN EJ AND COLLINGRIDGE GL. Magnesium ions block an N-methyl-D aspartate receptor-mediated component of synaptic transmission in rat hip pocampus. Neurosci Lett 53: 21–26, 1985.  	2859558
	COHEN AS AND ABRAHAM WC. Facilitation of long-term potentiation by prior  activation of metabotropic glutamate receptors. J Neurophysiol 76: 953–  962, 1996.  	NO_MATCH
	COUSSENS C, KERR DS, AND ABRAHAM WC. Glucocorticoid receptor activation  lowers the threshold for NMDA-receptor–dependent homosynaptic long term depression in the hippocampus through activation of voltage-dependent  calcium channels. J Neurophysiol 78: 1–9, 1997.  	9242254
	FREY U, HUANG YY, AND KANDEL ER. Effects of cAMP stimulates a late stage  of LTP in hippocampal CA1 neurons. Science 260: 1661–1664, 1993.  	8389057
	FUJII S, SAITO K, MIYAKAWA H, ITO K, AND KATO H. Reversal of long-term  potentiation (depotentiation) induced by tetanus stimulation of the input to  CA1 neurons of guinea pig hippocampal slices. Brain Res 555: 112–122,  1991.  	1681992
	GEAN PW. NMDA receptor-independent epileptiform activity induced by  magnesium-free solution in rat amygdala neurons is blocked by CNQX.  Neurosci Lett 119: 53–55, 1990.  	1982960
	GODA Y AND STEVENS CF. Synaptic plasticity: the basis of particular types of  learning. Curr Opin Neurobiol 6: 375–378, 1996.  	8723336
	GOLD JI AND BEAR MF. A model of dendritic spine Ca21 concentration  exploring possible bases for a sliding synaptic modification threshold. Proc  Natl Acad Sci USA 91: 3941–3945, 1994.  	8171016
	HALGREN E AND WILSON CL. Recall deficts produced by afterdischarges in the  human hippocampal formation and amygdala. Clin Neurophysiol 61: 375–  380, 1985.  	2412789
	HEBB DO. Organization of Behavior. New York: Wiley, 1949.  	NO_MATCH
	HERRON CE, WILLIAMSON R, AND COLLINGRIDGE GL. A selective N-methyl D-aspartate antagonist depresses epileptiform activity in rat hippocampal  slices. Neurosci Lett 61: 255–260, 1985.  	2867507
	HESSE GW AND TEYLER TJ. Reversible loss of hippocampal long-term poten tiation following electroconvulsive seizure. Nature 264: 562–564, 1976.  	1004596
	HOLLAND LL AND WAGNER JJ. Primed facilitation of homosynaptic long-term  depression and depotentiation in rat hippocampus. J Neurosci 18: 887–894,  1998.  	9437010
	HSU KS. Characterization of dopamine receptors mediating inhibition of  excitatory synaptic transmission in the rat hippocampal slices. J Neuro physiol 76: 1887–1895, 1996.  	8890301
	HSU KS AND HUANG CC. Characterization of the anoxia-induced long-term  synaptic potentiation in area CA1 of the rat hippocampus. Br J Pharmacol  122: 671–681, 1997.  	9375963
	HSU KS, HUANG CC, HO WC, AND TSAI JJ. Prior short-term synaptic disinhi bition by GABA-antagonist facilitates long-term potentiation and suppresses  long-term depression at CA1 hippocampal synapses. Eur J Neurosci 11:  4059–4069, 1999.  	10583494
	HUANG YY, COLINO A, SELIG DK, AND MALENKA RC. The influence of prior  synaptic activity on the induction of long-term potentiation. Science 255:  730–733, 1992.  	1346729
	HUANG YY AND KANDEL ER. Postsynaptic induction and PKA-dependent  expression of LTP in the lateral amygdala. Neuron 21: 169–178, 1998.  	9697861
	IZUMI Y, CLIFFORD DB, AND ZORUMSKI CF. Low concentrations of N-methyl D-aspartate inhibit the induction of long-term potentiation in rat hippocam pal slices. Neurosci Lett 137: 245–248, 1992.  	1350078
	JENSEN LH AND SHEARDOWN M. Lack of potent antiepileptic effect of specific  non-NMDA EAA receptor antagonist. In: Frontiers in Excitatory Amino Acid Research, edited by Cavalheiro EA, Lehmann L, and Turski L. New  York: Liss, 1988, p. 219–226.  	NO_MATCH
	LINDEN DJ AND CONNOR JA. Participation of postsynaptic PKC in cerebellar  long-term depression in culture. Neuron 15: 1393–1401, 1991.  	1721243
	MALINOW R, SCHULMAN H, AND TSIEN RW. Inhibition of postsynaptic PKC or  CaMKII blocks induction but not expression of LTP. Science 245: 862–866,  1989.  	2549638
	MALINOW R AND TSIEN RW. Presynaptic enhancement shown by whole-cell  recordings of long-term potentiation in hippocampal slices (Abstract). Na ture 346: 177, 1990.  	2164158
	MARTINEZ JLJ AND DERRICK BE. Long-term potentiation and learning. Annu  Rev Psychol 47: 173–203, 1996.  	8624136
	MAYFORD M, WANG J, KANDEL ER, AND O’DELL TJ. CaMKII regulates the  frequency-response function of hippocampal synapses for the production of  both LTD and LTP. Cell 81: 891–904, 1995.  	7781066
	MCNAMARA JO. Cellular and molecular basis of epilepsy. J Neurosci 14:  3413–3425, 1994.  	8207463
	MODY I, LAMBERT JDC, AND HEINEMANN U. Low extracellular magnesium  induces epileptiform activity and spreading depression in rat hippocampal  slices. J Neurophysiol 57: 869–888, 1987.  	3031235
	MOORE SD, BARR DS, AND WILSON WA. Seizure-like activity disrupts LTP in  vitro. Neurosci Lett 163: 117–119, 1993.  	8295725
	MOYER JR, THOMPSON LT, BLACK JP, AND DISTERHOFT JF. Nimodipine in creases excitability of rabbit CA1 pyramidal neurons in an age- and con centration-dependent manner. J Neurophysiol 68: 2100–2109, 1992.  	1491260
	MULLER D AND LYNCH G. Evidence that changes in presynaptic calcium  currents are not responsible for long-term potentiation in hippocampus.  Brain Res 479: 290–299, 1989.  	2924160
	PSARROPOULOU C AND KOSTOPOULOS G. Long-term enhancement of postsyn aptic excitability after brief exposure to Mg21-free medium in normal and  epileptic mice. Brain Res 508: 70–75, 1990.  	2337794
	RAYMOND CR, THOMPSON VL, TATE WP, AND ABRAHAM WC. Metabotropic  glutamate receptors trigger homosynaptic protein synthesis to prolong long term potentiation. J Neurosci 20: 969–976, 2000.  	10648701
	SANES JR AND LICHTMAN W. Can molecules explain long-term potentiation?  Nature Neurosci 2: 597–604, 1999.  	10404178
	SCHULZ PE, COOK EP, AND JOHNSTON D. Changes in paired-pulse facilitation  suggest presynaptic involvement in long-term potentiation. J Neurosci 14:  5327–5337, 1994.  	7916043
	SONENBURG N. mRNA 59 cap-binding protein eIF4E and control of cell  growth. In: Transcriptional Control, edited by Hershey JWB, Mathews MB,  and Sonenburg N. New York: Cold Spring Harbor Laboratory, 1996, p.  245–269.  	NO_MATCH
	SQUIRE LR AND SPANIS CW. Long gradient of retrograde amnesia in mice,  continuity with the findings in humans. Behav Neurosci 98: 345–348, 1984.  	6539119
	STANTON PK. Transient protein kinase C activation primes long-term depres sion and suppresses long-term potentiation of synaptic transmission in  hippocampus. Proc Natl Acad Sci USA 92: 1724–1728, 1995.  	7878048
	SUZUKI T. Messengers from the synapses to the nucleus (MSNs) that establish  late phase of long-term potentiation (LTP) and long-term memory. Neurosci  Res 25: 1–6, 1996.  	8808794
	THOMPSON PJ. Memory function in patients with epilepsy. Adv Neurol 55:  369–384, 1991.  	2003416
	TOMPA P AND FRIEDRICH P. Synaptic metaplasticity and the local charge effect  in postsynaptic dendrites. Trends Neurosci 21: 97–102, 1998.  	9530914
	WEXLER EM AND STANTON PK. Priming of homosynaptic long-term depres sion in hippocampus by previous synaptic activity. Neuroreport 4: 591–594,  1993.  	8390312
Blood-2000-Mudry-1926-32.pdf
	1. Goulden N, Langlands K, Steward C, et al. PCR  assessment of bone marrow status in “isolated”  extramedullary relapse of childhood B-precursor  acute lymphoblastic leukaemia. Br J Haematol. 1994;87:282-285.  	7947268
	2. Miniero R, Saracco P, Pastore G, et al. Relapse  after first cessation of therapy in childhood acute  lymphoblastic leukemia: a 10-year follow-up  study, Italian Association of Pediatric Hematol ogy-Oncology (AIEOP). Med Pediatr Oncol.  1995;24:71-76.  	7990766
	3. Miyake K, Medina K, Ishihara K, Kimoto M, Auer bach R, Kincade PW. A VCAM-like adhesion mol ecule on murine bone marrow stromal cells medi ates binding of lymphocyte precursors in culture.  J Cell Biol. 1991;114:557-565.  	1713592
	4. Ryan DH. Adherence of normal and neoplastic  human B cell precursors to the bone marrow mi croenvironment. Blood Cells. 1993;19:225-241.  	7906154
	5. Kinashi T, Springer TA. Adhesion molecules in  hematopoietic cells. Blood Cells. 1994;20:25-44.  	7527678
	6. Kincade PW. Cell interaction molecules and cyto kines which participate in B lymphopoiesis. Baillieres Clin Haematol. 1992;5:575-598.  	1281019
	7. Makrynikola V, Kabral A, Bradstock KF. Effects of  recombinant human cytokines on precursor-B  acute lymphoblastic leukemia cells. Exp Hematol.  1991;19:674-679.  	1893954
	8. Manabe A, Coustan-Smith E, Behm FG, Rai mondi SC, Campana D. Bone marrow-derived  stromal cells prevent apoptotic cell death in B lineage acute lymphoblastic leukemia. Blood.  1992;79:2370-2377.  	1373973
	9. Gibson LF, Fortney J, Landreth KS, Piktel D, Eric son SG, Lynch JP. Disruption of bone marrow  stromal cell function by etoposide. Biol Blood  Marrow Transplant. 1997;3:122-132.  	9310189
	10. Haskell CM, Berek JS. Cancer Treatment, 4th ed.  Philadelphia: WB Saunders; 1995.  	NO_MATCH
	11. Roberts RA, Spooncer E, Parkinson EK, Lord BI,  Allen TD, Dexter TM. Metabolically inactive 3T3  cells can substitute for marrow stromal cells to  promote the proliferation and development of  multipotent haemopoietic stem cells. J Cell  Physiol. 1987;132:203-214.  	3497927
	12. Hasslen SR, Burns AR, Simon SI, et al. Preservation of spatial organization and antigenicity of leu kocyte surface molecules by aldehyde fixation:  flow cytometry and high-resolution FESEM stud ies of CD62L, CD11b, and Thy-1. J Histochem  Cytochem. 1996;44:1115-1122.  	8813076
	13. Wilmanns C, Fan D, O’Brian CA, Bucana CD,  Fidler IJ. Orthotopic and ectopic organ environ ments differentially influence the sensitivity of mu rine colon carcinoma cells to doxorubicin and  5-fluorouracil. Int J Cancer. 1992;52:98-104.  	1500231
	14. Staroselsky AN, Fan D, O’Brian CA, Bucana CD,  Gupta KP, Fidler IJ. Site-dependent differences in  response of the UV-2237 murine fibrosarcoma to  systemic therapy with adriamycin. Cancer Res. 1990;50:7775-7780	2253220
	15. Murti KG, Brown PS, Kumagai M, Campana D.  Molecular interactions between human B-cell pro genitors and the bone marrow microenvironment.  Exp Cell Res. 1996;226:47-58.  	8660938
	16. Van d V, Smits AJ, Verdaasdonk MA, et al. b1 Integrins dominate cell traffic of leukemic cells in  human bone- marrow stroma. Int J Cancer. 1996;  66:225-233.  	8603816
	17. Bradstock K, Makrynikola V, Bianchi A, Byth K.  Analysis of the mechanism of adhesion of precur sor-B acute lymphoblastic leukemia cells to bone  marrow fibroblasts. Blood. 1993;82:3437-3444.  	7694686
	18. Ryan DH, Nuccie BL, Abboud CN, Winslow JM.  Vascular cell adhesion molecule-1 and the inte grin VLA-4 mediate adhesion of human B cell precursors to cultured bone marrow adherent  cells. J Clin Invest. 1991;88:995-1004.  	1715889
	19. Filshie R, Gottlieb D, Bradstock K. VLA-4 is involved  in the engraftment of the human pre-B acute lympho blastic leukaemia cell line NALM-6 in SCID mice.  Br J Haematol. 1998;102:1292-1300.  	9753059
	20. Brisco MJ, Condon J, Hughes E, et al. Outcome  prediction in childhood acute lymphoblastic leu kaemia by molecular quantification of residual disease at the end of induction [see comments].  Lancet. 1994;343:196-200.  	7904666
	21. Shah N, Oseth L, LeBien TW. Development of a  model for evaluating the interaction between hu man pre-B acute lymphoblastic leukemic cells and the bone marrow stromal cell microenviron ment. Blood. 1998;92:3817-3828.  	9808575
	22. Gibson LF, Piktel D, Narayanan R, Nunez G, Lan dreth KS. Stromal cells regulate bcl-2 and bax  	expression in pro-B cells. Exp Hematol. 1996;24:  628-637.  	8605968
	23. Miyashita T, Reed JC. Bcl-2 oncoprotein blocks  chemotherapy-induced apoptosis in a human leu kemia cell line. Blood. 1993;81:151-157.  	8417786
	24. Thomas A, El Rouby S, Reed JC, et al. Drug-in duced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene muta tion and bcl-2/bax proteins in drug resistance.  Oncogene. 1996;12:1055-1062.  	8649796
	25. McConkey DJ, Chandra J, Wright S, et al. Apop tosis sensitivity in chronic lymphocytic leukemia is  determined by endogenous endonuclease con tent and relative expression of BCL-2 and BAX.  J Immunol. 1996;156:2624-2630.  	8786328
	26. Taylor ST, Hickman JA, Dive C. Epigenetic deter minants of resistance to etoposide regulation of  Bcl- X(L. and Bax by tumor microenvironmental  factors [see comments]. J Natl Cancer Inst. 2000;  92:18-23.  	10620629
	27. Jiang H, Sugimoto K, Sawada H, et al. Mutual  education between hematopoietic cells and bone  marrow stromal cells through direct cell-to-cell contact: factors that determine the growth of bone  marrow stroma-dependent leukemic (HB-1) cells.  Blood. 1998;92:834-841.  	9680351
	28. Elices MJ, Osborn L, Takada Y, et al. VCAM-1  on activated endothelium interacts with the leu kocyte integrin VLA-4 at a site distinct from the  VLA-4/fibronectin binding site. Cell. 1990;60:577-584.  	1689216
	29. Menard S, Squicciarini P, Luini A, et al. Immuno detection of bone marrow micrometastases in  breast carcinoma patients and its correlation with  primary tumour prognostic features. Br J Cancer.  1994;69:1126-1129.  	7911032
	30. Mansi JL, Berger U, Wilson P, Shearer R,  Coombes RC. Detection of tumor cells in bone  marrow of patients with prostatic carcinoma by  immunocytochemical techniques. J Urol. 1988;  139:545-548.  	2449548
	31. Kamel-Reid S, Letarte M, Doedens M, et al. Bone  marrow from children in relapse with pre-B acute lym phoblastic leukemia proliferates and disseminates  rapidly in scid mice. Blood. 1991;78:2973-2981.  	1835412
1906.full.pdf
	1. Look AT. Oncogenic transcription factors in the  human acute leukemias. Science. 1997;278:  1059-1064.  	9353180
	2. Rauskolb C, Peifer M, Weischaus E. extraden ticle, a regulator of homeotic gene activity, is a  homolog of the homeobox-containing human proto-oncogene PBX1. Cell. 1993;74:1101-1112.  	8104703
	3. Chan SK, Jaffe L, Capovilla M, Botas J, Mann  RS. The DNA binding specificity of Ultrabithorax  is modulated by cooperative interactions with ex tradenticle, another homeoprotein. Cell. 1994;78:  603-615.  	7915199
	4. Chang C-P, Shen W-F, Rozenfeld S, Lawrence  HJ, Largman C, Cleary ML. Pbx proteins display  hexapeptide-dependent cooperative DNA binding  with a subset of Hox proteins. Genes Dev. 1995;  9:663-674.  	7729685
	5. Lu Q, Knoepfler PS, Scheele J, Wright DD,  Kamps MP. Both Pbx1 and E2A-Pbx1 bind the  DNA motif ATCAATCAA cooperatively with the  products of multiple murine Hox genes, some of  which are themselves oncogenes. Mol Cell Biol.  1995;15:3786-3795.  	7791786
	6. Mann RS, Chan S-K. Extra specificity from extra denticle: the partnership between HOX and PBX/  EXD homeodomain proteins. Trends Genet. 1996;12:258-262.  	8763497
	7. Van Dijk MA, Murre C. extradenticle raises the  DNA binding specificity of homeotic selector gene  products. Cell. 1994;78:617-624.  	7915200
	8. Maconochie MK, Nonchev S, Studer M, et al.  Cross-regulation in the mouse HoxB complex: the  expression of Hoxb2 in rhombomere 4 is regulated by Hoxb1. Genes Dev. 1997;11:1885-1895.  	9242495
	9. Po¨pperl H, Bienz M, Studer M, et al. Segmental  expression of Hoxb-1 is controlled by a highly  conserved autoregulatory loop dependent upon  exd/pbx. Cell. 1995;81:1031-1042.  	7600572
	10. Rauskolb C, Weischaus E. Coordinate regulation  of downstream genes by extradenticle and the  homeotic selector proteins. EMBO J. 1994;13:  3561-3569.  	7914871
	11. Kamps MP, Murre CM, Sun X-H, Baltimore D. A  new homeobox gene contributes the DNA binding  domain of the t(1;19) translocation protein in  pre-B ALL. Cell. 1990;60:547-555.  	1967983
	12. Nourse J, Mellentin JD, Galili N, et al. Chromo somal translocation t(1;19) results in synthesis of  a homeobox fusion mRNA that codes for a poten tial chimeric transcription factor. Cell. 1990;60:  535-545.  	1967982
	13. Bain G, Murre C. The role of E-proteins in B- and  T-lymphocyte development. Semin Immunol.  1998;10:143-153.  	NO_MATCH
	14. LeBrun DP, Cleary ML. Fusion with E2A alters the  transcriptional properties of the homeodomain  protein PBX1 in t(1;19) leukemias. Oncogene.  1994;9:1641-1647.  	8183558
	15. Lu Q, Wright DD, Kamps MP. Fusion with E2A  converts the Pbx1 homeodomain protein into a  constitutive transcriptional activator in human leu kemias carrying the t(1;19) translocation. Mol Cell  Biol. 1994;14:3938-3948.  	7910944
	16. Van Dijk MA, Voorhoeve PM, Murre C. Pbx1 is  converted into a transcriptional activator upon  acquiring the N-terminal region of E2A in pre-B  cell acute lymphoblastic leukemia. Proc Natl Acad  Sci U S A. 1993;90:6061-6065.  	8327485
	17. Chang C-P, De Vivo I, Cleary ML. The Hox coop erativity motif of chimeric oncoprotein E2a-Pbx1  is necessary and sufficient for oncogenesis. Mol  Cell Biol. 1997;17:81-88.  	8972188
	18. Kamps MP, Wright DD, Lu Q. DNA-binding by  oncoprotein E2A-Pbx1 is important for blocking  differentiation but dispensible for fibroblast trans formation. Oncogene. 1996;12:19-30.  	8552391
	19. Artavanis-Tsakonas S, Matsuro K, Fortini ME.  Notch signaling. Science. 1995;268:225-232.  	7716513
	20. Greenwald I. Structure/function studies of lin-12/  Notch proteins. Curr Opin Genet Dev. 1994;4:  556-562.  	7950324
	21. Weinmaster G. The ins and outs of Notch signal ing. Mol Cell Neurosci. 1997;9:91-102.  	9245493
	22. Kopan R, Schroeter E, Weintraub H, Nye JS. Sig nal transduction by activated mNotch: importance  of proteolytic processing and its regulation by the  extracellular domain. Proc Natl Acad Sci U S A.  	1996;93:1683-1688.	8643690
	23. Schroeter EH, Kisslinger JA, Kopan R. Notch-1  signalling requires ligand-induced proteolytic re lease of intracellular domain. Nature. 1998;393:  382-386.  	9620803
	24. Struhl G, Adachi A. Nuclear access and action of  notch in vivo. Cell. 1998;93:649-660.  	9604939
	25. Chitnis AB. The role of Notch in lateral inhibition  and cell fate specification. Mol Cell Neurosci.  1995;6:311-321.  	8846001
	26. Kopan R, Nye JS, Weintraub H. The intracellular  domain of mouse Notch: a constitutively activated  repressor of myogenesis directed at the basic  helix-loop-helix region of MyoD. Development.  1994;120:2385-2396.  	7956819
	27. Lieber T, Kidd S, Alcamo E, Corbin V, Young MW.  Antineurogenic phenotypes induced by truncated  Notch proteins indicate a role in signal transduc tion and may point to a novel function for Notch in  nuclei. Genes Dev. 1993;7:1949-1965.  	8406001
	28. Robey E, Chang D, Itano A, et al. An activated  form of Notch influences the choice between CD4  and CD8 T cell lineages. Cell. 1996;87:483-492.  	8898201
	29. Ellisen LW, Bird J, West DC, et al. TAN-1, the hu man homologue of the Drosophila Notch gene, is  broken by chromosomal translocations in T lymphoblastic neoplasms. Cell. 1991;66:649-661.  	1831692
	30. Aster J, Pear W, Hasserjian R, et al. Functional  analysis of the TAN-1 gene, a human homolog of  Drosophila notch. Cold Spring Harbor Symp  Quant Biol. 1994;59:125-136.  	7587062
	31. Capobianco AJ, Zagouras P, Blaumueller CM,  Artavanis-Tsakonas S, Bishop JM. Neoplastic  transformation by truncated alleles of human  NOTCH1/TAN1 and NOTCH2. Mol Cell Biol.  1997;17:6265-6273.  	9343387
	32. Pear WS, Aster JC, Scott ML, et al. Exclusive de velopment of T cell neoplasms in mice trans planted with bone marrow expressing activated  Notch alleles. J Exp Med. 1996;183:2283-2291.  	8642337
	33. Dedera DA, Waller EK, LeBrun DP, et al. Chi meric homeobox gene E2A-PBX1 induces prolif eration, apoptosis, and malignant lymphomas in  transgenic mice. Cell. 1993;74:833-843.  	8104101
	34. Hogan B, Constantini F, Lacy E. Manipulating the  Mouse Embryo: A Laboratory Manual. Cold  Spring Harbor, NY: Cold Spring Harbor Labora tory Press; 1986.  	NO_MATCH
	35. Abraham KM, Levin SD, Martin JD, Forbush KA,  Perlmutter RM. Thymic tumorigenesis induced by  overexpression of p56lck. Proc Natl Acad Sci  U S A. 1991;88:3977-3981.  	1708890
	36. Sambrook J, Fritsch EF, Maniatis T. Molecular  Cloning: A Laboratory Manual, 2nd ed. Cold  Spring Harbor, NY: Cold Spring Harbor Labora tory Press; 1989:18.53-18.73.  	NO_MATCH
	37. Natarajan D, BoultenA. Isolation of genomic se quences flanking a retroviral insertion site using a  novel PCR-based method. Gene. 1995;161:195-196.  	7665078
	38. Haupt Y, Alexander WS, Barri G, Klinken SP,  Adams JM. Novel zinc finger gene implicated as  myc collaborator by retrovirally accelerated lym phomagenesis in Em-myc transgenic mice. Cell.  1991;65:753-763.  	1904009
	39. Van Lohuizen M, Verbeek S, Scheijen B,  Wientjens E, van der Gulden H, Berns A. Identifi cation of cooperating oncogenes in Em-myc  transgenic mice by provirus tagging. Cell. 1991;  65:737-752.  	1904008
	40. Cuypers HT, Selten G, Quint W, et al. Murine leu kemia virus-induced T-cell lymphomagenesis:  integration of proviruses in a distinct chromo somal region. Cell. 1984;37:141-150.  	6327049
	41. Girard L, Hanna Z, Beaulieu N, et al. Frequent  provirus insertional mutagenesis of Notch1 in thy momas of MMTVD/myc transgenic mice suggests  collaboration of c-myc and Notch1 for oncogenesis. Genes Dev. 1996;10:1930-1944.  	8756350
	42. Kurooka H, Kuroda K, Honjo T. Roles of the  ankyrin repeats and C-terminal region of the  mouse notch1 intracellular region. Nucl Acids  Res. 1998;26:5448-5455.  	9826771
	43. Feldman BJ, Reid TR, Cleary ML. Pim1 cooper ates with E2a-Pbx1 to facilitate the progression of  thymic lymphomas in transgenic mice. Onco gene. 1997;15:2735-2742.  	9401000
	44. Fortini ME, Artavanis-Tsakonas S. The suppres sor of hairless protein participates in notch recep tor signaling. Cell. 1994;79:273-282.  	7954795
	45. Nofziger D, Miyamoto A, Lyons KM, Weinmaster  G. Notch signaling imposes two distinct blocks in  the differentiation of C2C12 myoblasts. Develop ment. 1999;126:1689-1702.  	10079231
	46. Shawber C, Nofziger D, Hsieh JJ, et al. Notch  signaling inhibits muscle cell differentiation  through a CBF1-independent pathway. Develop ment. 1996;122:3765-3773.  	9012498
	47. Ordentlich P, Lin A, Shen C-P, et al. Notch inhibition  of E47 supports the existence of a novel signaling  pathway. Mol Cell Biol. 1998;18:2230-2239.  	9528794
	48. Aplan PD, Lombardi DP, Ginsberg AM, Cossman  J, Bertness VI, Kirsch IR. Disruption of the human  SCL locus by “illegitimate” V-(D)-J recombinase activity. Science. 1991;250:1426-1429.  	2255914
	49. Begley CG, Aplan PD, Davey MP, et al. Chromo somal translocation in a human leukemic stem cell line disrupts the T-cell antigen receptor delta chain diversity region and results in a previously  unreported fusion transcript. Proc Natl Acad Sci  U S A. 1989;86:2031-2035.  	2467296
	50. Brown L, Cheng JT, Chen Q, et al. Site-specific  recombination of the tal-1 gene is a common oc currence in human T cell leuekmia. EMBO J.  1990;9:3343-3351.  	2209547
	51. Chen Q, Cheng JT, Tasi LH, et al. The tal gene  undergoes chromosome translocation in T cell  leukemia and potentially encodes a helix-loop helix protein. EMBO J. 1990;9:415-424.  	2303035
	52. Finger LR, Kagan J, Christopher G, et al. Involve ment of the TCL5 gene on human chromosome 1  in T-cell leukemia and melanoma. Proc Natl Acad  Sci U S A. 1989;86:5039-5043.  	2740341
	53. Hsu HL, Wadman I, Baer R. Formation of in vivo  complexes between the TAL1 and E2A polypep tides of leukemic T cells. Proc Natl Acad Sci U S A. 1994;91:3181-3185.  	8159721
	54. Park ST, Sun XH. The Tal1 oncoprotein inhibits  E47-mediated transcription: mechanisms of inhi bition. J Biol Chem. 1998;273:7030-7037.  	9507011
	55. Bain G, Engel I, Robanus Maandag EC, et al.  E2A deficiency leads to abnormalities in a/b T-cell  development and to rapid development of T-cell  lymphomas. Mol Cell Biol. 1997;17:4782-4791.  	9234734
	56. Yan W, Young AZ, Soares VC, Kelley R, Benezra  R, Zhuang Y. High incidence of T-cell tumors in  E2A-null mice and E2A/Id1 double knockout  mice. Mol Cell Biol. 1997;17:7317-7327.  	9372963
	57. Sawada S, Littman DR. A heterodimer of Heb and  an E12-related protein interacts with the CD4 en hancer and regulates its activity in T-cell lines. Cell Biol. 1993;13:5620-5628.  	8355705
	58. Hasserjian RP, Aster JC, Davi F, Weinberg DS,  Sklar J. Modulated expression of Notch1 during  thymocyte development. Blood. 1996;88:970 976.  	8704256
	59. Washington T, Schweighoffer E, Gridley T, et al.  Notch activity influences the ab versus gD T cell  lineage decision. Cell. 1997;88:833-843.  	NO_MATCH
	60. Jehn BM, Bielke W, Pear WS, Osborne BA. Cut ting edge: protective effects of Notch-1 on TCR induced apoptosis. J Immunol. 1999;162:635 	9916679
	61. Smith KS, Jacobs Y, Chang C-P, Cleary ML. Chi meric oncoprotein E2a-Pbx1 induces apoptosis  of hematopoietic cells by a p53-independent mechanism that is suppressed by Bcl-2. Onco gene. 1997;14:2917-2926.  	9205098
	62. Nazarov V, Wolff L. Novel integration site at the  distal 39 end of the c-myb locus in retrovirus-in duced promonocytic leukemias. J Virol. 1995;69:  3885-3888.  	7745739
	63. Ceci JD, Patriotis CP, Tsatsanis C, et al. Tpl-2 is  an oncogenic kinase that is activated by carboxy terminal truncation. Genes Dev. 1997;11:688 700.  	9087424
	64. Sakura H, Kanei-Ishii C, Nagase T, Nakagoshi H,  Gonda TJ, Ishii S. Delineation of three functional  domains of the transcriptional activator encoded  by the c-myc proto-oncogene. Proc Natl Acad Sci  U S A. 1989;86:5758-5762.  	2668947
	65. Rogers S, Wells R, Rechsteiner M. Amino acids  common to rapidly degraded proteins: the PEST  hypothesis. Science. 1986;234:364-368.  	2876518
	66. Mango SE, Maine EM, Kimble J. Carboxyl-termi nal truncation activates glp-1 protein to specify  vulval fates in Caenorhabditis elegans. Nature.  1991;352:811-815.  	1881436
	67. Rebay I, Fehon RG, Artavanis-Tsakonas S. Spe cific truncations of Drosophila Notch define domi nant activated and dominant negative forms of  the receptor. Cell. 1993;74:319-329.  	8343959
	68. Axelrod JD, Matsuno K, Artavanis-Tsakonas S,  Perrimon N. Interaction between Wingless and  Notch signaling pathways mediated by Dishev elled. Science. 1996;271:1826-1832.  	8596950
	69. Guo M, Jan LY, Jan YN. Control of daughter cell  fates during asymmetric division: Interaction of  Numb and Notch. Neuron. 1996;17:27-41.  	8755476
	70. Zhong W, Feder JN, Jiang MM, Jan LY, Jan YN.  Asymmetric localization of a mammalian numb  homolog during mouse cortical neurogenesis.  Neuron. 1996;17:43-53.  	8755477
	71. Lyman D, Young MW. Further evidence for func tion of the Drosophila Notch protein as a trans membrane receptor. Proc Natl Acad Sci U S A.  1993;90:10395-10399.  	8234305
	72. Luo B, Aster JC, Hasserjian RP, Kuo F, Sklar J.  Isolation and functional analysis of a cDNA for  human Jagged2, a gene encoding a ligand for the  Notch1 receptor. Mol Cell Biol. 1997;17:6057 6067.  	9315665
	73. Varnum-Finney B, Purton LE, Yu M, et al. The  Notch ligand, Jagged-1, influences the develop ment of primitive hematopoietic precursor cells.  Blood. 1998;91:4084-4091.  	9596653
	74. Bash J, Zong W-X, Banga S, et al. Rel/NF-kB can  trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch re ceptors. EMBO J. 1999;18:2803-2811.  	10329626
Blood-2000-Anagnostopoulos-1889-99.pdf
	1. Lukes RJ, Craver LF, Hall TC, Rappaport H,  Ruben P. Report of the nomenclature committee.  Cancer Res. 1966;26:1311.  	NO_MATCH
	2. Jackson H. Classification and prognosis of  Hodgkin’s disease and allied disorders. Surg Gy necol Obstet. 1937;64:465.  	NO_MATCH
	3. Jackson H, Parker F. Hodgkin’s disease. I. Gen eral considerations. N Engl J Med. 1944;230:1.  	NO_MATCH
	4. Rappaport H, Winter WJ, Hicks EB. Follicular  lymphoma: a re-evaluation of its position in the  scheme of malignant lymphoma, based on a sur vey of 253 cases. Cancer. 1956;4:792.  	13356265
	5. Lukes RJ, Butler JJ. The pathology and nomen clature of Hodgkin’s disease. Cancer Res. 1966;  26:1063.  	NO_MATCH
	6. Lukes RJ, Butler JJ, Hicks EB. Natural history of  Hodgkin’s disease as related to its pathologic pic ture. Cancer. 1966;19:317.  	NO_MATCH
	7. Hansmann M-L, Wacker HH, Radzun HJ. Para granuloma is a variant of Hodgkin’s disease with  predominance of B cells. Virchows Arch (Pathol  Anat). 1986;409:171.  	3087053
	8. Hansmann M-L, Zwingers T, Bo¨ske A, Lo¨ffler H,  Lennert K. Clinical features of nodular paragranu loma (Hodgkin’s disease, lymphocyte predomi nance type, nodular). J Cancer Res Clin Oncol.  1984;108:321.  	6511805
	9. Pinkus GS, Said JW. Hodgkin’s disease, lympho cyte predominance type, nodular—a distinct en tity? Unique staining profile for L&H variants of  Reed -Sternberg cells defined by monoclonal an tibodies to leucocyte common antigen, granulo cyte specific antigen, and B cell specific antigen.  Am J Pathol. 1985;118:1-6.  	3155594
	10. Poppema S, Kaiserling E, Lennert K. Epidemiol ogy of nodular paragranuloma (Hodgkin’s disease with lymphocyte predominance, nodular). J  Cancer Res Clin Oncol. 1979;95:57.  	500769
	11. Poppema S, Kaiserling E, Lennert K. Nodular  paragranuloma and progressively transformed  germinal centers: ultrastructural and immunohis tological findings. Virchows Arch (Cell Pathol).  1979;31:211.  	43015
	12. Stein H, Hansmann M-L, Lennert K, Brandtzaeg  P, Gatter KC, Mason DY. Reed-Sternberg and  Hodgkin cells in lymphocyte-predominant  Hodgkin’s disease of nodular subtype contain J  chain. Am J Clin Pathol. 1986;86:292.  	3529924
	13. Timens W, Visser L, Poppema S. Nodular lym phocyte predominance type of Hodgkin’s disease  is a germinal center lymphoma. Lab Invest. 1986;  54:457.  	3083157
	14. Coles FB, Cartun RW, Pastuszak WT. Hodgkin’s  disease, lymphocyte predominant type: immuno reactivity with B cell antibodies. Mod Pathol. 	3266337
	15. Chittal SM, Caveriviere P, Schwarting R, et al.  Monoclonal antibodies in the diagnosis of  Hodgkin’s disease: the search for a rational  panel. Am J Surg Pathol. 1988;12:9.  	2827535
	16. Pinkus GS, Said JW. Hodgkin’s disease, lympho cyte predominance type, nodular-further evi dence for a B cell derivation: L&H variants of  Reed-Sternberg cells express L26, a pan B cell  marker. Am J Pathol. 1988;133:211.  	3263805
	17. Nicholas DS, Harris S, Wright DH. Lymphocyte  predominance Hodgkin’s disease—an immuno histochemical study. Histopathol. 1990;16:157.  	2323737
	18. Chittal SM, Alard C, Rossi J-F, et al. Further phe notypic evidence that nodular, lymphocyte-pre dominant Hodgkin’s disease is a large B-cell lym phoma in evolution. Am J Surg Pathol. 1990;14:  1024.  	2240355
	19. Pileri S, Sabattini E, Tazzari PL, et al. Hodgkin’s  disease: update of findings. Haematologica.  1991;76:175.  	1660436
	20. Harris NL, Jaffe ES, Stein H, et al. A revised Eu ropean-American classification of lymphoid neo plasms: a proposal from the International Lym phoma Study Group. Blood. 1994;84:1361.	8068936
	21. Mason DY, Banks PM, Chan J, et al. Nodular lym phocyte predominance Hodgkin’s disease: a dis tinct clinicopathological entity. Am J Surg Pathol.  1994;18:526.  	8172327
	22. Regula DP, Hoppe RT, Weiss LM. Nodular and  diffuse types of lymphocyte predominance  Hodgkin’s disease. N Engl J Med. 1988;318:214.  	3336412
	23. Borg-Grech A, Radford JA, Crowther D, Swindell  R, Harris M. A comparative study of the nodular  and diffuse variants of lymphocyte-predominant  Hodgkin’s disease. J Clin Oncol. 1989;7:1303.  	2769329
	24. Tefferi A, Zellers RA, Banks PM, Therneau TM,  Colgan JP. Clinical correlates of distinct immuno phenotypic and histologic subcategories of lymphocyte-predominance Hodgkin’s disease. J Clin  Oncol. 1990;8:1959.  	2230888
	25. Hansmann M-L, Stein H, Dallenbach F, Fellbaum  C. Diffuse lymphocyte-predominant Hodgkin’s  disease (diffuse paragranuloma): a variant of the  B-cell derived nodular type. Am J Pathol. 1991;  138:29.  	1987769
	26. Jaffe ES, Longo DL, Cossman J, Hsu S-M, Arnold  A, Kosrmeyer SJ. Diffuse B-cell lymphomas with  T-cell predominance in patients with follicular lym phoma or “pseudo T-cell lymphoma” [abstract].  Lab Invest. 1984;50:27a.  	NO_MATCH
	27. Chittal SM, Brousset P, Voigt JJ, Delsol G. Large  B-cell lymphoma rich in T-cells and simulating Hodgkin’s disease. Histopathology. 1991;19:211.  	1655614
	28. Macon WR, Williams NE, Greer JP, Stein RS,  Collins RD, Cousar JB. T-cell rich B-cell lympho mas: a clinicopathologic study of 19 cases. Am J  Surg Pathol. 1992;16:351.  	NO_MATCH
	29. Ng CS, Chan JKC, Hui PK, Lau WH. Large B-cell  lymphomas with high content of reactive T cells.  Hum Pathol. 1989;20:1145.  	2591944
	30. Osborne BM, Butler JJ, Pugh WC. The value of  immunophenotyping on paraffin sections in the  identification of T-cell rich B-cell large-cell lym phomas: lineage confirmed by JH rearrangement.  Am J Surg Pathol. 1990;14:933.  	2169708
	31. Ramsay AD, Smith WJ, Isaacson PG. T-cell rich  B-cell lymphoma. Am J Surg Pathol. 1988;12:  433.  	NO_MATCH
	32. Krishnan J, Wallberg K, Frizzera G. T-cell rich  large B-cell lymphoma. Am J Surg Pathol. 1994;  18:455.  	NO_MATCH
	33. Rodriguez J, Pugh WC, Cabanillas F. T-cell rich  B-cell lymphoma. Blood. 1993;82:1586.  	NO_MATCH
	34. de Wolf Peeters C, Pittaluga S. T-cell rich B-cell  lymphoma: a morphological variant of non  Hodgkin’s lymphomas or a clinico-pathological  entity? Histopathology. 1995;26:383.  	7541773
	35. de Jong D, van Gorp J, Sie-Go D, van Heerde P.  T-cell rich B-cell non Hodgkin’s lymphoma: a pro gressed form of follicle centre cell lymphoma and  lymphocyte predominance Hodgkin’s disease. Histopathology. 1996;28:15. 	8838116
	36. Ashton-Key M, Thorpe PA, Allen JP, Isaacson  PG. Follicular Hodgkin’s disease. Am J Surg  Pathol. 1995;19:1294.  	7573692
	37. Diehl V, Sextro M, Franklin J, et al. Clinical pre sentation, course and prognostic factors in lym phocyte predominant Hodgkin’s disease and lym phocyte-rich classical Hodgkin’s disease: report  from the European Task Force on Lymphoma  Project on lymphocyte-predominant Hodgkin’s  disease. J Clin Oncol. 1999;117:776.  	10071266
	38. Norton AJ, Jordan S, Yeomans P. Brief, high-tem perature heat denaturation (pressure cooking): a  simple and effective method of antigen retrieval for routinely processed tissues. J Pathol. 1994;  173:371. 	7965396
	39. Hummel M, Anagnostopoulos I, Dallenbach F,  Korbjuhn P, Dimmler C, Stein H. EBV infection  patterns in Hodgkin’s disease and normal lym phoid tissue: expression and cellular localization  of EBV gene products. Br J Haematol. 1992;83:  689.  	1336392
	40. Georgii A, Fischer R, Hu¨bner K, Schwarze EW,  Bernhards J. Classification of Hodgkin’s disease  biopsies by a panel of four histopathologists: re port of 1140 patients from the German national  trial. Leuk Lymphoma. 1993;9:365.	8348072
	41. von Wasielewski R, Werner M, Fischer R, et al.  Lymphocyte-predominant Hodgkin’s disease: an  immunohistochemical analysis of 208 reviewed  Hodgkin’s disease cases from the German Hodgkin Study Group. Am J Pathol. 1997;150:  793. 	9060817
	42. Kadin ME, Glatstein E, Dorfman RF. Clinico pathological studies of 117 untreated patients  subjected to laparotomy for the staging of  Hodgkin’s disease. Cancer. 1971;27:1277.  	5088206
	43. Lukes RJ. Criteria for involvement of lymph node,  bone marrow, spleen and liver in Hodgkin’s dis ease. Cancer Res. 1971;31:1755.  	4941351
	44. Poppema S, Kaiserling E, Lennert K. Hodgkin’s  disease with lymphocytic predominance, nodular  type (nodular paragranuloma) and progressively  transformed germinal centers: a cytohistological  study. Histopathology. 1979;3:295.  	468131
	45. Korkolopoulou P, Cordell J, Jones M, et al. The  expression of the B-cell marker mb-1 (CD79a) in  Hodgkin’s disease. Histopathology. 1994;24:511.  	NO_MATCH
	46. Hall PA, D’ Ardenne AJ. Value of CD15 immuno staining in diagnosing Hodgkin’s disease: a review of published literature. J Clin Pathol. 1987;  40:1298.  	3320093
	47. Angel CA, Warford A, Campbell AC, Pringle JH,  Lauder I. The immunohistology of Hodgkin’s dis ease: Reed-Sternberg cells and their variants. J Pathol. 1987;153:21. 	3499498
	48. Algara P, Martinez P, Sachez L, et al. Lymphocyte  predominance Hodgkin’s disease (nodular para granuloma)-a bcl-2 negative germinal centre lym phoma. Histopathology. 1991;19:69.  	1916688
	49. Fellbaum C, Hansmann M-L, Niedermeyer H, et  al. Influence of Epstein-Barr virus genomes on  patient survival in Hodgkin’s disease. Am J Clin  Pathol. 1992;98:319.  	1326892
	50. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young  LS. Expression of Epstein-Barr virus latent gene  products in tumor cells of Hodgkin’s disease. Lan cet. 1991;337:320.  	1671232
	51. Delsol G, Brousset P, Chittal S, Rigal Huguet F.  Correlation of the expression of Epstein-Barr vi rus latent membrane protein and in situ hybridiza tion with biotinylated BamHI-W probes in  Hodgkin’s disease. Am J Pathol. 1992;140:247.  	1310829
	52. Murray PG, Young LS, Rowe M, Crocker J. Im munohistochemical demonstration of the Epstein Barr virus encoded latent membrane protein in  paraffin sections of Hodgkin’s disease. J Pathol.  1992;166:1.  	1311374
	53. Weiss LM, Chen YY, Liu XF, Shibata D. Epstein Barr virus and Hodgkin’s disease: a correlation in  situ hybridization and polymerase chain reaction  study. Am J Pathol. 1991;139:1259.  	1661073
	54. Coates PJ, Slavin G, d’Ardenne AJ. Persistence  of Epstein-Barr virus in Reed-Sternberg cells  throughout the course of Hodgkin’s disease.  J Pathol. 1991;164:291.  	1656004
	55. Alkan S, Ross CW, Hanson CA, Schnitzer B. Ep stein-Barr virus and bcl-2 protein overexpression  are not detected in neoplastic cells of nodular lymphocyte predominance Hodgkin’s disease.  Mod Pathol. 1995;8:544.  	7675775
Blood-2000-Merad-1865-72.pdf
	1. Banchereau J, Steinman RM. Dendritic cells and  the control of immunity. Nature. 1998;392:245 252.  	9521319
	2. Larsen CP, Steinman RM, Witmer-Pack M,  Hankins DF, Morris PJ, Austyn JM. Migration and  maturation of Langerhans cells in skin transplants  and explants. J Exp Med. 1990;172:1483-1493.  	2230654
	3. Bujdoso R, Hopkins J, Dutia BM, Young P, Mc Connell I. Characterization of sheep afferent  lymph dendritic cells and their role in antigen car riage. J Exp Med. 1989;170:1285-1301.  	2794860
	4. Macatonia SE, Knight SC, Edwards AJ, Griffiths  S, Fryer P. Localization of antigen on lymph node  dendritic cells after exposure to the contact sensi tizer fluorescein isothiocyanate: functional and  morphological studies. J Exp Med. 1987;166:  1654-1667.  	3119761
	5. Vremec D, Zorbas M, Scollay R, et al. The sur face phenotype of dendritic cells purified from  mouse thymus and spleen: investigation of the  CD8 expression by a subpopulation of dendritic  cells. J Exp Med. 1992;176:47-58.  	1613465
	6. Maurer D, Stingl G. Dendritic cells in the context  of skin immunity. In: Lotze MT, Thomson AW, eds.  Dendritic Cells: Biology and Clinical Implications.  San Diego: Academic Press; 1999.  	NO_MATCH
	7. Geissmann F, Prost C, Monnet JP, Dy M, Brousse  N, Hermine O. Transforming growth factor beta1,  in the presence of granulocyte/macrophage  colony-stimulating factor and interleukin 4, in duces differentiation of human peripheral blood  monocytes into dendritic Langerhans cells. J Exp  Med. 1998;187:961-966.  	9500798
	8. Zhang Y, Zhang YY, Ogata M, et al. Transforming growth factor-b1 polarizes murine hematopoietic  progenitor cells to generate Langherans cell-like  dendritic cells through a monocyte/macrophage  differentiation pathway. Blood. 1999;93:1208 1220.  	9949163
	9. Sprent J, Webb SR. Intrathymic and extrathymic  clonal deletion of T cells. Curr Opin Immunol.  1995;7:196-205.  	7546379
	10. Ardavin C, Wu L, Li CL, Shortman K. Thymic den dritic cells and T cells develop simultaneously in  the thymus from a common precursor population.  Nature. 1993;362:761-763.  	8469288
	11. Vestweber D, Kemler R. Rabbit antiserum against  a purified surface glycoprotein decompacts  mouse preimplantation embryos and reacts with  specific adult tissues. Exp Cell Res. 1984;152:  169-178.  	6370707
	12. Schuler G, Steinman RM. Murine epidermal  Langerhans cells mature into potent immuno stimulatory dendritic cells in vitro. J Exp Med.  1985;161:526-546.  	3871837
	13. Metlay JP, Witmer-Pack MD, Agger R, Crowley  MT, Lawless D, Steinman RM. The distinct leuko cyte integrins of mouse spleen dendritic cells as  identified with new hamster monoclonal antibod ies. J Exp Med. 1990;171:1753-1771.  	2185332
	14. Kraal G, Breel M, Janse M, Bruin G. Langerhans’  cells, veiled cells, and interdigitating cells in the  mouse recognized by a monoclonal antibody. J  Exp Med. 1986;163:981-997.  	3950549
	15. Borkowski TA, Van Dyke BJ, Schwarzenberger K,  McFarland VW, Farr A, Udey MC. Expression of  E-cadherin by murine dendritic cells: E-cadherin  as a dendritic cell differentiation antigen charac teristic of epidermal Langerhans cells and related  cells. Eur J Immunol. 1994;24:2767-2774.  	7957569
	16. Wu L, Li C, Shortman K. Thymic dendritic cell  precursors: relationship to the T lymphocyte lin eage and phenotype of the dendritic cell progeny.  J Exp Med. 1996;184:903-911.  	9064350
	17. Wu L, Vremec D, Ardavin C, et al. Mouse thymus  dendritic cells: kinetics of development and  changes in surface markers during maturation.  Eur J Immunol. 1995;25:418-425.  	7875203
	18. Brocker T, Riedinger M, Karjalainen K. Targeted  expression of major histocompatibility complex  (MHC) class II molecules demonstrates that den dritic cells can induce negative but not positive selection of thymocytes in vivo. J Exp Med. 1997;  185:541-550. 	9053454
	19. Pulendran B, Smith JL, Caspary G, et al. Distinct  dendritic cell subsets differentially regulate the  class of immune response in vivo. Proc Natl Acad  Sci U S A. 1999;96:1036-1041.  	9927689
	20. Maldonado-Lopez R, De Smedt T, Michel P, et al.  CD8a1 and CD8a- subclasses of dendritic cells  direct the development of distinct T helper cells in  vivo. J Exp Med. 1999;189:587-592.  	9927520
	21. Fung-Leung WP, Schilham MW, Rahemtulla A, et  al. CD8 is needed for development of cytotoxic T  cells but not helper T cells. Cell. 1991;65:443 	1673361
	22. Power CA, Church DJ, Meyer A, et al. Cloning  and characterization of a specific receptor for the  novel CC chemokine MIP-3alpha from lung den dritic cells. J Exp Med. 1997;186:825-835.  	9294137
	23. Greaves DR, Wang W, Dairaghi DJ, et al. CCR6, a CC chemokine receptor that interacts with mac rophage inflammatory protein 3alpha and is  highly expressed in human dendritic cells. J Exp  Med. 1997;186:837-844.  	9294138
	24. Rossi DL, Vicari AP, Franz-Bacon K, McClanahan  TK, Zlotnik A. Identification through bioinformatics  of two new macrophage proinflammatory human chemokines: MIP-3alpha and MIP-3beta. J Im munol. 1997;158:1033-1036.  	9013939
	25. Dieu MC, Vanbervliet B, Vicari A, et al. Selective  recruitment of immature and mature dendritic cells by distinct chemokines expressed in differ ent anatomic sites. J Exp Med. 1998;188:373 386.  	9670049
	26. Yang D, Chertov O, Bykovskaia SN, et al. beta Defensins: linking innate and adaptive immunity  through dendritic and T cell CCR6. Science. 1999;286:525-528. 	10521347
	27. Schweickart VL, Raport CJ, Godiska R, et al.  Cloning of human and mouse EBI1, a lymphoid specific G-protein-coupled receptor encoded on  human chromosome 17q12–q21.2. Genomics. 1994;23:643-650.	7851893
	28. Hedrick JA, Zlotnik A. Identification and charac terization of a novel beta chemokine containing  six conserved cysteines. J Immunol. 1997;159:  1589-1593.  	9257816
	29. Gunn MD, Tangemann K, Tam C, Cyster JG, Rosen SD, Williams LT. A chemokine expressed  in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lympho cytes. Proc Natl Acad Sci U S A. 1998;95:258 263.  	9419363
	30. Chan VW, Kothakota S, Rohan MC, et al. Sec ondary lymphoid-tissue chemokine (SLC) is che motactic for mature dendritic cells. Blood. 1999;  93:3610-3616.  	10339465
	31. Gunn MD, Kyuwa S, Tam C, et al. Mice lacking  expression of secondary lymphoid organ chemo kine have defects in lymphocyte homing and den dritic cell localization [see comments]. J Exp Med.  1999;189:451-460.  	9927507
	32. Saeki H, Moore AM, Brown MJ, Hwang ST. Cut ting edge: secondary lymphoid-tissue chemokine  (SLC) and CC chemokine receptor 7 (CCR7) par ticipate in the emigration pathway of mature den dritic cells from the skin to regional lymph nodes.  J Immunol. 1999;162:2472-2475.  	10072485
	33. Godiska R, Chantry D, Raport CJ, et al. Human  macrophage-derived chemokine (MDC), a novel  chemoattractant for monocytes, monocyte derived dendritic cells, and natural killer cells. J  Exp Med. 1997;185:1595-1604.  	9151897
	34. Tang HL, Cyster JG. Chemokine up-regulation  and activated T cell attraction by maturing den dritic cells. Science. 1996;284:819-822.  	NO_MATCH
	35. Imai T, Yoshida T, Baba M, Nishimura M, Kakizaki  M, Yoshie O. Molecular cloning of a novel T cell directed CC chemokine expressed in thymus by  signal sequence trap using Epstein-Barr virus vector. J Biol Chem. 1996;271:21514-21521.	8702936
	36. De St Groth B. The evolution of self-tolerance: a  new cell arises to meet the challenge of self-reac tivity. Immunol Today. 1998;19:448-454.  	9785668
	37. Reis e Sousa C, Germain R. Analysis of adjuvant  function by direct visualization of accumulation of  antigen-bearing dendritic cells in the T cell area of  lymphoid tissue. J Immunol. 1999;162:6552 	10352271
	38. Inaba K, Pack M, Inaba M, Sakuta H, Isdell F,  Steinman RM. High levels of a major histocom patibility complex II–self-peptide complex on den dritic cells from the T cell areas of lymph nodes. J  Exp Med. 1997;186:665-672.  	9271582
	39. Reis e Sousa C, Hieny S, Scharton-Kersten T, et  al. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleu kin 12 by dendritic cells and their redistribution to  T cell areas [see comments]. J Exp Med. 1997; 186:1819-1829.  	9382881
	40. Ohteki T, Fukao T, Suzue K, et al. Interleukin 12 dependent interferon gamma production by  CD8alpha1 lymphoid dendritic cells. J Exp Med.  1999;189:1981-1986.  	10377194
v017p00286.pdf
Am J Clin Nutr-2000-Borchers-339-47.pdf
	1. Scimone A, Scimone A. US sees the green in herbal supplements.  Chem Market Rep 1998;254:FR3–4.  	NO_MATCH
	2. Thomson WAR. Medicines from the earth: a guide to healing plants.  New York: Harper & Row, 1983.  	NO_MATCH
	3. Foster S, Duke JA. A field guide to medicinal plants: eastern and  central North America. Boston: Houghton Mifflin Company, 1990.  	NO_MATCH
	4. Tierra M. The way of herbs. New York: Pocket Books, 1990.  	NO_MATCH
	5. Duke JA. The green pharmacy. Emmaus, PA: Rodale Press, 1997.  	NO_MATCH
	6. Blumenthal M. New world plants; new world drugs. Allergy Proc  1992;13:345–52.  	1283381
	7. Schacter L. Etoposide phosphate: what, why, where, and how?  Semin Oncol 1996;23:1–7.  	8996569
	8. Moerman DE. An analysis of the food plants and drug plants of  native North America. J Ethnopharmacol 1996;52:1–22.  	8733114
	9. Moerman DE. Medicinal plants of North America. Ann Arbor, MI:  Museum of Anthropology, University of Michigan, 1986.  	NO_MATCH
	10. Johnson Gottesfeld LM, Anderson B. Gitksan traditional medicine:  herbs and healing. J Ethnobiol 1988;8:13–33.  	NO_MATCH
	11. Turner NJ, Hebda RJ. Contemporary use of bark for medicine by  two Salishan native elders of Southeast Vancouver Island, Canada.  J Ethnopharmacol 1990;29:59–72.  	2345461
	12. Johnson Gottesfeld LM. Wet’suwet’en ethnobotany: traditional  plant uses. J Ethnobiol 1994;14:185–200.  	NO_MATCH
	13. Ritch-Krc EM, Thomas S, Turner NJ, Towers GHN. Carrier herbal  medicine: traditional and contemporary plant use. J Ethnopharma col 1996;52:85–94.  	8735452
	14. Moerman DE. The medicinal flora of native North America: an  analysis. J Ethnopharmacol 1991;31:1–42.  	2030588
	15. Reichard GA. Navaho religion: a study of symbolism. Princeton,  NJ: Princeton University Press, 1990.  	NO_MATCH
	16. Vogel VJ. American Indian medicine: University of Oklahoma  Press, 1970.  	NO_MATCH
	17. Arnason T. Use of plants for food and medicine by native peoples of  eastern Canada. Can J Bot 1981;59:2189–325.  	NO_MATCH
	18. Herrick JW. Iroquois medical botany. Syracuse, NY: Syracuse Uni versity Press, 1995.  	NO_MATCH
	19. Hobbs C. Echinacea: a literature review. Botany, history, chemistry,  pharmacology, toxicology, and clinical uses. Herbalgram 1994;33:  35–48.  	NO_MATCH
	20. Schwarz H-D. 100 Jahre Lobelin. Z Phytother 1990;11:159–60.  	NO_MATCH
	21. Orvis KS, Goldman IL. Relationship between antiplatelet activity  and sulfur fertility in hydroponic and field-grown onions (Allium  cepa). Hort Sci 1997;32:523 (abstr).  	NO_MATCH
	22. Weber ND, Andersen DO, North JA, Murray BK, Lawson LD,  Hughes BG. In vitro virucidal effects of Allium sativum (garlic)  extract and compounds. Planta Med 1992;58:417–23.  	1470664
	23. Goldman IL. Strength of onion-induced human antiplatelet activity  is associated with plant development. Hort Sci 1997;32:523 (abstr).  	NO_MATCH
	24. McCutcheon AR, Ellis SM, Hancock REW, Towers GHN. Antibi otic screening of medicinal plants of the British Columbian native  peoples. J Ethnopharmacol 1992;37:213–23.  	1453710
	25. McCutcheon AR, Roberts TE, Gibbons E, et al. Antiviral screening  of British Columbian medicinal plants. J Ethnopharmacol 1995;49:  101–10.  	8847882
	26. Tunón H, Olavsdotter C, Bohlin L. Evaluation of anti-inflammatory  activity of some Swedish medicinal plants. Inhibition of prostaglandin  biosynthesis and PAF-induced exocytosis. J Ethnopharmacol 1995;  48:61–76.  	8583796
	27. Yesilada E, Sezik E. Screening of some Turkish medicinal plants used  in the treatment of rheumatoid arthritis and inflammatory diseases for  their anti-inflammatory activities. Planta Med 1990;56:659.  	NO_MATCH
	28. Wagner H. Search for new plant constituents with potential  antiphlogistic and antiallergic activity. Planta Med 1989;55:235–41.  	2662231
	29. Müller-Jakic B, Breu W, Pröbstle A, Redl K, Greger H, Bauer R. In  vitro inhibition of cyclooxygenase and 5-lipoxygenase by alkamides  from Echinacea and Achillea species. Planta Med 1994;60:37–40.  	8134414
	30. Wagner H, Breu W, Willer F, Wierer M, Remiger P, Schwenker G.  In vitro inhibition of arachidonate metabolism by some alkamides  and prenylated phenols. Planta Med 1989;55:566–7.  	NO_MATCH
	31. Hartisch C, Kolodziej H, von Bruchhausen F. Dual inhibitory activ ities of tannins from Hamamelis virginiana and related polyphenols  on 5-lipoxygenase and lyso-PAF:acetyl-CoA acetyltransferase.  Planta Med 1997;63:106–10.  	9140221
	32. Vavrecková C, Gawlik I, Müller K. Benzophenanthridine alkaloids  of Chelidonium majus; I. Inhibition of 5- and 12-lipoxygenase by a  non-redox mechanism. Planta Med 1996;62:397–401.   	9005450
	33. Sumner H, Salan U, Knight DW, Hoult JRS. Inhibition of 5-lipoxy genase and cyclo-oxygenase in leukocytes by feverfew. Involvement  of sesquiterpene lactones and other components. Biochem Pharma col 1992;43:2313–20.  	1319159
	34. Obertreis B, Giller K, Teucher T, Behnke B, Schmitz H. Antiphlo gistische Effekte von Extractum Urticae dioicae foliorum im Ver gleich zu kaffeoyläpfelsäure. (Antiphlogistic effects of Urtica  dioica leaf extract compared to caffeic malic acid.) Arzneimit telforschung 1996;46:52–6.  	NO_MATCH
	35. Agarwal S, Reynolds MA, Pou S, Peterson DE, Charon JA, Suzuki  JB. The effect of sanguinarine on human peripheral blood neutrophil  viability and functions. Oral Microbiol Immunol 1991;6:51–61.  	1945482
	36. Chaturvedi MM, Kumar A, Darnay BG, Chainy GBN, Agarwal S,  Aggarwal BB. Sanguinarine (pseudochelerythrine) is a potent  inhibitor of NF-B activation, IB phosphorylation, and degrada tion. J Biol Chem 1997;272:30129–34.  	9374492
	37. Erdelmeier CAJ, Cinatl J Jr, Rabenau H, Doerr HW, Biber A, Koch  E. Antiviral and antiphlogistic activities of Hamamelis virginiana  bark. Planta Med 1996;62:241–5.  	8693037
	38. Duwiejua M, Zeitlin IJ, Waterman PG, Gray AI. Anti-inflammatory  activity of Polygonum bistorta, Guaiacum officinale and Hamamelis  virginiana in rats. J Pharm Pharmacol 1994;46:286–90.  	8051612
	39. Hughes-Formella BJ, Bohnsack K, Rippke F, et al. Anti-inflamma tory effect of hamamelis lotion in a UVB erythema test. Dermatol ogy 1998;196:316–22.  	9621139
	40. Korting HC, Schafer-Korting M, Hart H, Laux P, Schmid M. Anti inflammatory activity of hamamelis distillate applied topically to  the skin. Influence of vehicle and dose. Eur J Clin Pharmacol  1993;44:315–8.  	8513841
	41. Korting HC, Schafer-Korting M, Klovekorn W, Klovekorn G, Martin  C, Laux P. Comparative efficacy of hamamelis distillate and hydrocor tisone cream in atopic eczema. Eur J Clin Pharmacol 1995;48:461–5.  	8582464
	42. Yesilada E, Üstün O, Sezik E, Takaishi Y, Ono Y, Honda G.  Inhibitory effects of Turkish folk remedies on inflammatory  cytokines: interleukin-1, interleukin-1 and tumor necrosis factor  . J Ethnopharmacol 1997;58:59–73.  	9324006
	43. Zakay-Rones Z, Varsano N, Zlotnik M, et al. Inhibition of several  strains of influenza virus in vitro and reduction of symptoms by an  elderberry extract (Sambucus nigra L.) during an outbreak of  influenza B Panama. J Altern Complement Med 1995;1:361–9.  	NO_MATCH
	44. Bauer R, Remiger P, Jurcic K, Wagner H. Beeinflussung der Phagozy tose-aktivität durch Echinacea-Extrakte. (Effects of Echinacea  extracts on phagocytic activity.) Z Phytotherapie 1989;10:43–8 (in  German).  	NO_MATCH
	45. Bauer R, Remiger P. TLC and HPLC analysis of alkamides in Echi nacea drugs. Planta Med 1989;55:367–71.  	NO_MATCH
	46. Perry NB, van Klink JW, Burgess EJ, Parmenter GA. Alkamide lev els in Echinacea purpurea: a rapid analytical method revealing dif ferences among roots, rhizomes, stems, leaves and flowers. Planta  Med 1997;63:58–62.  	NO_MATCH
	47. Bauer R, Jurcic K, Puhlmann J, Wagner H. Immunologische In-vivo und In-vitro-Untersuchungen mit Echinacea-Extrakten. (Immuno logical in vivo and in vitro examinations of Echinacea extracts.)  Arzneimittelforschung 1988;38:276–81 (in German).  	3370076
	48. O’Hara MA, Kiefer D, Farrell K, Kemper K. A review of 12 com monly used medicinal herbs. Arch Fam Med 1998;7:523–36.  	9821826
	49. Tympner K-D. Der immunbiologische Wirkungsnachweis von  Pflanzenextrakten. (The demonstration of immunobiological effec tiveness of plant extracts.). Z Angewandte Phytother 1981;5:181–4  (in German).  	NO_MATCH
	50. Gaisbauer M, Schleich T, Stickl HA, Wilczek I. Untersuchungen  zum Einfluß von Echinacea purpurea Moench auf die Phagozytose  von Granulozyten mittels Messung der Chemilumineszenz. (The  effect of Echinacea purpurea Moench on the phagocytosis in gran ulocytes measured by chemiluminescence.) Arzneim-Forsch/Drug  Res 1990;40:594–8 (in German).  	2383303
	51. Jurcic K, Melchart D, Holzmann M, et al. Zwei Probandenstudien  zur Stimulierung der Granulozyten-Phagozytose durch Echinacea extrakt-haltige präparate. (Two clinical studies on the stimulation of  granulocyte phagocytosis by preparations containing Echinacea.)  Z Phytother 1989;10:67–70.  	NO_MATCH
	52. Burger RA, Torres AR, Warren RP, Caldwell VD, Hughes BG. Echi nacea-induced cytokine production by human macrophages. Int J  Immunopharmacol 1997;19:371–9.  	9568541
	53. Wagner H, Proksch A, Vollmar A, Kreutzkamp B, Bauer J. In-vitro Phagozytose-Stimulierung durch isolierte Pflanzenstoffe gemessen  im Phagozytose-Chemilumineszenz-(CL)-Modell. (In vitro phagocy tosis stimulation by isolated plant materials in a chemoluminescence phagocytosis model.) Planta Med 1985;2:139–44 (in German).  	4034729
	54. Roesler J, Emmendörffer A, Steinmüller C, Luettig B, Wagner H,  Lohmann-Matthes M-L. Application of purified polysaccharides  from cell cultures of the plant Echinacea purpurea to test subjects  mediates activation of the phagocytic system. Int J Immunopharma col 1991;13:931–41.  	1761359
	55. See DM, Broumand N, Sahl L, Tilles JG. In vitro effects of echi nacea and ginseng on natural killer and antibody-dependent cell  cytotoxicity in healthy subjects and chronic fatigue syndrome or  acquired immunodeficiency syndrome patients. Immunopharmacol ogy 1997;35:229–35.  	9043936
	56. Steinmüller C, Roesler J, Gröttrup E, Franke G, Wagner H, Lohmann Matthes M-L. Polysaccharides isolated from plant cell cultures of  Echinacea purpurea enhance the resistance of immunosuppressed  mice against systemic infections with Candida albicans and Listeria  monocytogenes. Int J Immunopharmacol 1993;15:605–14.  	8375943
	57. Roesler J, Steinmüller C, Kinderlein A, Emmendörffer A, Wagner  H, Lohmann-Matthes M-L. Application of purified polysaccharides  from cell cultures of the plant Echinacea purpurea to mice mediates  protection against systemic infections with Listeria monocytogenes  and Candida albicans. Int J Immunopharmacol 1991;13:27–37.  	2026472
	58. Möse JR. Zur Wirkung von Echinacin auf Phagozytoseaktivität und  natural killer cells. (On the effect of Echinacin on phagocytic activity  and natural killer cells.) Medwelt 1983;51/52:1463–7 (in German).  	6366434
	59. Melchart D, Linde K, Worku F, et al. Results of five randomized  studies on the immunomodulatory activity of preparations of Echi nacea. J Altern Complement Med 1995;1:145–60.  	NO_MATCH
	60. Elsässer-Beile U, Willenbacher W, Bartsch HH, Gallati H, Schulte  Mönting J, von Kleist S. Cytokine production in leukocyte cultures  during therapy with Echinacea extract. J Clin Lab Anal 1996;10:  441–5.  	8951617
	61. Bräunig B, Dorn M, Knick E. Echinaceae purpureae radix: zur  Stärkung der körpereigenen Abwehr bei grippalen Infekten.  (Echinacea purpurea radix: for strengthening host immunity in res piratory infections.) Z Phytother 1992;13:7–13 (in German).  	NO_MATCH
	62. Schmidt U, Albrecht M, Schenk N. Pflanzliches Immunstimulans  senkt Häufigkeit grippaler Infekte. (A plant-derived immunostimu lant reduces the frequency of upper respiratory infections.) Natur  Ganzheits Medizin 1990;3:277–81 (in German).  	NO_MATCH
	63. Melchart D, Walther E, Linde K, Brandmaier R, Lersch C. Echi nacea root extracts for the prevention of upper respiratory tract  infections. Arch Fam Med 1998;7:541–5.  	NO_MATCH
	64. Mengs U, Clare CB, Poiley JA. Toxicity of Echinacea purpurea.  Arzneimittelforschung 1991;41:1076–81.  	NO_MATCH
	65. Schimmer O, Abel G, Behninger C. Untersuchungen zur Gentoxi schen Potenz eines neutralen Polysaccharids aus Echinacea-Gewe bekulturen in menschlichen Lymphozytenkulturen. (Investigations  of the genotoxic potential of a neutral polysaccharide from Echi nacea tissue cultures in cultures of human lymphocytes.) Z Phy tother 1989;10:39–42.  	NO_MATCH
	66. Mullins RJ. Echinacea-associated anaphylaxis. Med J Aust 1998;  168:170–1.  	9507713
	67. Myers SP, Wohlmuth H. Echinacea-associated anaphylaxis. Med J  Aust 1998;168:583–4.  	9640313
	68. Bauer R, Khan IA, Wagner H. Neue Möglichkeiten zur Standar disierung von Echinacea-Extrakten. (New possibilities for stan dardization of Echinacea extracts.) Sci Pharm 1986;54:145 (abstr)  (in German).  	NO_MATCH
	69. Obertreis B, Ruttkowski T, Teucher T, Behnke B, Schmitz H. Ex vivo in-vitro inhibition of lipopolysaccharide stimulated tumor  necrosis factor- and interleukin-1 secretion in human whole blood  by extractum Urticae dioicae foliorum. Arzneimittelforschung  1996;46:389–94.  	8740085
	70. Riehemann K, Behnke B, Schulze-Osthoff K. Plant extracts from  stinging nettle (Urtica dioica), an antirheumatic remedy, inhibit the  proinflammatory transcription factor NF-B. FEBS Lett 1999;442:  89–94.  	9923611
	71. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell  1996;85:307–10.  	NO_MATCH
	72. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheuma toid arthritis. Annu Rev Immunol 1996;14:397–440.  	8717520
	73. Marok R, Winyard PG, Coumbe A, et al. Activation of the tran scription factor nuclear factor-B in human inflamed synovial tis sue. Arthritis Rheum 1996;39:583–91.  	8630106
	74. Shiozawa S, Shimizu K, Tanaka K, Hino K. Studies on the contri bution of c-fos/AP-1 to arthritic joint destruction. J Clin Invest  1997;99:1210–6.  	9077528
	75. Miyazawa K, Mori A, Yamamoto K, Okudaira H. Constitutive tran scription of the human interleukin-6 gene by rheumatoid synovio cytes. Spontaneous activation of NF-B and CBF1. Am J Pathol  1998;152:793–803.  	9502421
	76. Teucher T, Obertreis B, Ruttkowski T, Schmitz H. Zytokin-Sekre tion im Vollblut gesunder Probanden nach oraler Einnahme eines  Urtica dioica L.-Blattextraktes. (Cytokine secretion in whole blood  of healthy volunteers after oral ingestion of an Urtica dioica L. leaf  extract.) Arzneimittelforschung 1996;46:906–10.  	NO_MATCH
	77. Le Moal MA, Truffa-Bachi P. Urtica dioica agglutinin, a new mito gen for murine T lymphocytes: unaltered interleukin-1 production  but late interleukin 2-mediated proliferation. Cell Immunol 1988;  115:24–35.  	3261205
	78. Le Moal MA, Colle J-H, Galelli A, Truffa-Bachi P. Mouse T-lym phocyte activation by Urtica dioica agglutinin. II. Original pattern  of cell activation and cytokine production induced by UDA. Res  Immunol 1992;143:701–9.  	1439142
	79. Galelli A, Truffa-Bachi P. Urtica dioica agglutinin. A superanti genic lectin from stinging nettle rhizome. J Immunol 1993;151:  1821–31.  	8345184
	80. Musette P, Galelli A, Truffa-Bachi P, Peumans W, Kourilsky P,  Gachelin G. The J segment of the T cell receptor contributes to the  V-specific T cell expansion caused by staphylococcal enterotoxin  B and Urtica dioica superantigens. Eur J Immunol 1996;26:618–22.  	8605929
	81. Galelli A, Delcourt M, Wagner M-C, Peumans W, Truffa-Bachi P.  Selective expansion followed by profound deletion of mature  V8.3+ T cells in vivo after exposure to the superantigenic lectin  Urtica dioica agglutinin. J Immunol 1995;154:2600–11.  	7876535
	82. Delcourt M, Peumans WJ, Wagner M-C, Truffa-Bachi P. V-spe cific deletion of mature thymocytes induced by plant superantigen  Urtica dioica agglutinin. Cell Immunol 1996;168:158–64.  	8640861
	83. Thompson SD, Murray KJ, Grom AA, Passo MH, Choi E, Glass  DN. Comparative sequence analysis of the human T cell receptor   chain in juvenile rheumatoid arthritis and juvenile spondy larthropathies. Arthritis Rheum 1998;41:482–97.  	NO_MATCH
	84. Robinson CP, Cornelius J, Bounous DE, Yamamoto H, Humphreys Beher MG, Peck AB. Characterization of the changing lymphocyte  populations and cytokine expression in the exocrine tissues of  autoimmune NOD mice. Autoimmunity 1998;27:29–44.  	9482205
	85. Suzuki M, Cheng KC, Krug MS, Yoo TJ. Successful prevention of  retrocochlear hearing loss in murine experimental allergic encephalo myelitis with T cell receptor V8-specific antibody. Ann Otol Rhi nol Laryngol 1998;107:917–27.  	9823840
	86. Goldman-Brezinski S, Brezinski K, Zhang X-M, et al. Effects of  oral tolerance induction by myelin basic protein on V8+ Lewis rat  T cells. J Neurosci Res 1998;51:67–75.  	9452310
	87. Musette P, Pannetier C, Gachelin G, Kourilsky P. The expansion of  a CD4+ T cell population bearing a distinctive  chain in MRL  lpr/lpr mice suggests a role for the fas protein in peripheral T cell  selection. Eur J Immunol 1994;24:2761–6.  	7525303
	88. Musette P, Galelli A, Chabre H, et al. Urtica dioica agglutinin, a  V8.3-specific superantigen, prevents the development of the sys temic lupus erythematosus-like pathology of MRL lpr/lpr mice. Eur  J Immunol 1996;26:1707–11.  	8765010
Am J Clin Nutr-2000-Scott-333-4.pdf
	1. McCully KS. Vascular pathology of homocysteinemia: implications  for the pathogenesis of arteriosclerosis. Am J Pathol 1969;56:  111–28.  	5792556
	2. Brattström L, Wilcken DEL. Homocysteine and cardiovascular dis ease: cause or effect? Am J Clin Nutr 2000;72:315–23.  	10919920
	3. Mudd SH, Skovby F, Levy HL, et al. The natural history of homo cystinuria due to cystathionine beta-synthase deficiency. Am J Hum  Genet 1985;37:1–31.  	3872065
	4. Nygard O, Vollset SE, Refsum H, et al. Total plasma homocysteine  and cardiovascular risk profile. The Hordaland Homosycteine  Study. JAMA 1995;274:1526–33.  	7474221
	5. Bostom A, Brosnan JT, Hall B, Nadeau MR, Selhub J. Net uptake of  plasma homocysteine by the rat kidney in vivo. Atherosclerosis  1995;116:59–62.  	7488333
	6. Guttormsen AB, Ueland PM, Svarstad E, Refsum H. Kinetic basis  of hyperhomocysteinemia in patients with chronic renal failure.  Kidney Int 1997;52:495–502.  	9264008
	7. Ueland PM, Refsum H, Beresford SAA, Vollset SE. The contro versy over homocysteine and cardiovascular risk. Am J Clin Nutr  2000;72:324–32.  	10919921
j.1432-1327.2000.01418.x.pdf
	1. Wolff, I.A. (1966) Seed lipids. Seed triglyceride oils are chemically  diverse, scientifically interesting, and versatile in utility. Science 154,  1140±1149.  	NO_MATCH
	2. Shanklin, J. & Cahoon, E.B. (1998) Desaturation and related modifi cations of fatty acids. Annu. Rev. Plant Physiol. Plant Mol. Biol.  49, 611±641.  	NO_MATCH
	3. Girke, T., Sperling, P. & Heinz, E. (1998) Cloning of desaturases with  new specificities. In Advances in Plant Lipid Research (SaÂnchez, J.,  CerdaÂ-Olmedo, E. & MartÂõnez-Force, E., eds), pp. 103±109.  Secretariado de Publicaciones de la Universidad de Sevilla, Seville,  Spain.  	NO_MATCH
	4. van de Loo, F.J., Broun, P., Turner, S. & Somerville, C. (1995) An  oleate 12-hydroxylase from Ricinus communis L. is a fatty acyl  desaturase homologue. Proc. Natl Acad. Sci. USA 92, 6743±6747.  	7624314
	5. Broun, P., Boddupalli, S. & Somerville, C. (1998) A bifunctional oleate  12-hydroxylase: desaturase from Lesquerella fendleri. Plant J. 13,  201±210.  	9680976
	6. Broun, P., Shanklin, J., Whittle, E. & Somerville, C. (1998) Catalytic  plasticity of fatty acid modification enzymes underlying chemical  diversity of plant lipids. Science 282, 1315±1317.  	9812895
	7. Haigh, W.G., Morris, L.J. & James, A.T. (1968) Acetylenic acid  biosynthesis in Crepis rubra. Lipids 3, 307±312.  	NO_MATCH
	8. Lee, M., Lenman, M., Banaú, A., Bafor, M., Singh, S., Schweizer, M.,  Nilsson, R., Liljenberg, C., Dahlqvist, A., Gummeson, P.-O., SjoÈdahl, S., Green, A. & Stymne, S. (1998) Identification of non-heme diiron  proteins that catalyze triple bond and epoxy group formation. Science  280, 915±918.  	9572738
	9. Kohn, G., Hartman, E., Stymne, S. & Beutelmannn, J. (1994) Biosyn thesis of acetylenic fatty acids in the moss Ceratodon purpureus  (Hedw.) Brid.*. J. Plant Physiol. 144, 265±271.  	NO_MATCH
	10. Cahoon, E.B., Carlson, T.J., Ripp, K.G., Schweiger, B.J., Cook, G.A.,  Hall, S.E. & Kinney, A.J. (1999) Biosynthetic origin of conjugated  double bonds: Production of fatty acid components of high-value  drying oils in transgenic soybean embryos. Proc. Natl Acad. Sci. USA  96, 12935±12940.  	10536026
	11. Fritsche, K., Hornung, E., Peitzsch, N., Renz, A. & Feussner, I. (1999)  Isolation and characterization of a calendic producing (8,11) linoleoyl desaturase. FEBS Lett 462, 249±253.  	10622705
	12. Wallis, J.G. & Browse, J. (1999) The D8-desaturase of Euglena  gracilis: an alternative pathway for synthesis of 20-carbon poly unsaturated fatty acids. Arch. Biochem. Biophys. 365, 307±316.  	10328826
	13. Napier, J., Sayanova, O., Sperling, P. & Heinz, E. (1999) A growing  family of cytochrome b5-domain fusion proteins. Trends Plant Sci. 4,  2±4.  	NO_MATCH
	14. Pasentsis, K., Paulo, N., Algarra, P., Dittrich, P. & ThuÈmmler, F. (1998)  Characterization and expression of the phytochrome gene family in  the moss Ceratodon purpureus. Plant J. 13, 51±61.  	9680964
	15. Riggs, M.G. & McLachlan, A. (1986) A simplified screening procedure  for large numbers of plasmid minipreparations. Biotechniques 4,  310±313.  	NO_MATCH
	16. Dohmen, R.J., Strasser, A.W.M., HoÈner, C.B. & Hollenberg, C.P.  (1991) An efficient transformation procedure enabling long-term  storage of competent cells of various yeast genera. Yeast 7, 691±692.  	1776359
	17. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G.,  Smith, J.A., Struhl, K., Albright, L.M., Coen, D.M. & Varki, A.  (1995). Current Protocols in Molecular Biology. John Wiley & Sons.  New York, USA.  	NO_MATCH
	18. Avery, S.V., Howlett, N.G. & Radice, S. (1996) Copper toxicity towards  S. cerevisiae: dependence on plasma membrane fatty acid composi tion. Appl. Environ. Microbiol. 62, 3960±3966.  	8899983
	19. Girke, T., Schmidt, H., ZaÈhringer, U., Reski, R. & Heinz, E. (1998)  Identification of a novel D6-acyl-group desaturase by targeted gene  disruption in Physcomitrella patens. Plant J. 15, 39±48.  	9744093
	20. Christie, W.W. (1998) Mass spectrometry of fatty acids with methylene interrupted ene-yne systems. Chem. Phys. Lipids 94, 35±41.  	NO_MATCH
	21. Huang, Y.S., Chaudhary, S., Thurmond, J.M., Bobik, E.G. Jr, Yuan, L.,  Chan, G.M., Kirchner, S.J., Mukerji, P. & Knutzon, D.S. (1999)  Cloning of D12- and D6-desaturases from Mortierella alpina and  recombinant production of g-linolenic acid in S. cerevisiae. Lipids  34, 649±659.  	NO_MATCH
	22. Sayanova, O., Smith, M.A., Lapinskas, P., Stobart, A.K., Dobson, G.,  Christie, W.W., Shewry, P.R. & Napier, J.A. (1997) Expression of a  borage desaturase cDNA containing an N-terminal cytochrome b5  domain results in the accumulation of high levels of D6-desaturated  fatty acids in transgenic tobacco. Proc. Natl Acad. Sci. USA 94,  4211±4216.  	9108131
	23. Napier, J.A., Hey, S.J., Lacey, D.J. & Shewry, P.R. (1998) Identification  of a Caenorhabditis elegans D6-fatty-acid-desaturase by heterlogous  expression in S. cerevisiae. Biochem. J. 330, 611±614.  	9480865
	24. Cho, H.P., Nakamura, M.T. & Clarke, S.D. (1999) Cloning, expression,  and nutritional regulation of the mammalian D-6-desaturase. J. Biol.  Chem. 274, 471±477.  	9867867
	25. Reddy, A.S., Nuccio, M.L., Gross, L.M. & Thomas, T.L. (1993)  Isolation of a D6-desaturase gene from the cyanobacterium  Synechocystis sp. strain PCC 6803 by gain-of-function expression  in Anabaena sp. strain PCC 7120. Plant Mol. Biol. 27, 293±300.  	8389613
	26. Murata, N., Deshnium, P. & Tasaka, Y. (1996) Biosynthesis of  g-linolenic acid in the cyanobacterium Spirulina platensis. In  g-Linolenic Acid, Metabolism and its Roles in Nutrition and  Medicine (Huang, Y. & Milles, D.E., eds), pp. 22±32. AOC Press,  Champaign, IL, USA.  	NO_MATCH
	27. Lederer, F. (1994) The cytochrome b5-fold: an adaptable module.  Biochimie 76, 674±692.  	7893819
	28. Sperling, P., Schmidt, H. & Heinz, E. (1995) A cytochrome b5 containing fusion protein similar to acyl lipid desaturases. Eur. J.  Biochem. 232, 798±805.  	7588718
	29. Kohn, G., Vierengel, A., Vandekerkhove, O. & Hartmann, E. (1987)  9-Octadecen-6-ynoic acid from Riccia fluitans. Phytochemistry 26,  2101±2102.  	NO_MATCH
	30. Fay, L. & Richli, U. (1991) Location of double bonds in polyunsatu rated fatty acids by gas chromatography-mass spectrometry after  4,4-dimethyloxazoline derivatization. J. Chromatogr. 541, 89±98.  	NO_MATCH
	31. AÊ ndersson, B., Anderson, W.H., Chipault, J.R., Ellison, E.C., Fenton,  S.W., Gellerman, J.L., Hawkins, J.M. & Schlenk, H. (1974) 9,12,15 Octadecatrien-6-ynoic acid, a new acetylenic acid from mosses.  Lipids 9, 506±511.  	1160525
	32. Mitchell, A.G. & Martin, C.E. (1995) A novel cytochrome b5-like  domain is linked to the carboxyl terminus of the S. cerevisiae D9 fatty  acid desaturase. J. Biol. Chem. 270, 29766±29772.  	8530368
	33. Sayanova, O., Shewry, P.R. & Napier, J.A. (1999) Histidine-41 of the  cytochrome b5 domain of the borage D 6 fatty acid desaturase is  essential for enzyme activity. Plant Physiol. 121, 641±646.  	10517856
	34. Heinz, E. (1993) Biosynthesis of polyunsaturated fatty acids. In Lipid  Metabolism in Plants (Moore, T.S. Jr, ed.), pp. 33±89. CRC Press,  Boca Raton, FL.  	NO_MATCH
	35. Sperling, P., ZaÈhringer, U. & Heinz, E. (1998) A sphingolipid  desaturase from higher plants. Identification of a new cytochrome  b5 fusion protein. J. Biol. Chem. 273, 28590±28596.  	9786850
	36. Meckenstock, R.U., Krieger, R., Ensign, S., Kroneck, P.M.H. & Schink,  B. (1999) Acetylene hydratase of Pelobacter acetylenicus. Molecular  and spectroscopic properties of the tungsten iron-sulfur enzyme.  Eur. J. Biochem. 264, 176±182.  	10447686
j.1432-1327.2000.01408.x.pdf
	1. Mauro, A. (1961) Satellite cell of skeletal muscle fibers. J. Biophys.  Biochem. Cytol. 9, 493±498.  	13768451
	2. Plaghki, L. (1985) Regeneration and myogenesis of striated muscle.  J. Physiol. (Paris) 80, 51±110.  	2933512
	3. Zomzely-Neurath, C.E. (1983) Enolase. Enzymes in the Nervous  System. Handbook Neurochem. 4, 403±433.  	NO_MATCH
	4. Lucas, M., Goblet, C., Keller, A., LamandeÂ, N., Gros, F., Whalen, R.G.  & Lazar, M. (1992) Modulation of embryonic and muscle-specific  enolase gene products in the developing mouse hindlimb.  Differentiation 51, 1±7.  	1280607
	5. Keller, A., Ott, M.O., LamandeÂ, N., Lucas, M., Gros, F., Buckingham,  M. & Lazar, M. (1992) Activation of the gene encoding the glycolytic  enzyme beta-enolase during early myogenesis precedes an  increased expression during fetal muscle development. Mech.  Dev. 38, 41±54.  	1525038
	6. Kato, K., Shimizu, A., Semba, R. & Satoh, T. (1985) Tissue  distribution, developmental profiles and effect of denervation on  enolase isozymes in rat muscles. Biochim. Biophys. Acta 841, 50±58.  	3893549
	7. Merkulova, T., Thornell, L.E., Butler-Browne, G., Oberlin, C., Lucas,  M., LamandeÂ, N., Lazar, M. & Keller, A. (1999) The beta enolase  subunit displays three different patterns of microheterogeneity in  human striated muscle. J. Muscle Res. Cell. Motil. 20, 55±63.  	10360234
	8. Keller, A., Rouzeau, J.D., Farhadian, F., Wisnewsky, C., Marotte, F.,  LamandeÂ, N., Samuel, J.L., Schwartz, K., Lazar, M. & Lucas, M.  (1995) Differential expression of alpha and beta-enolase genes during  rat heart development and hypertrophy. Am. J. Physiol. Heart Circ.  Physiol. 38, H1843±H1851.  	8594891
	9. Nozais, M., Merkulova, T., Keller, A., Janmot, C., LompreÂ, A.M.,  d'Albis, A. & Lucas, M. (1999) Denervation of rabbit gastrocnemius  and soleus muscles ± effect on muscle-specific enolase. Eur. J.  Biochem. 263, 195±201.  	10429204
	10. Merkulova, T., Keller, A., Oliviero, P., Marotte, F., Samuel, J.-L.,  Rappaport, L., LamandeÂ, N. & Lucas, M. (2000) Thyroid hormones  modulate differentially isozymic enolase gene expressions during  rat skeletal and cardiac muscle development. Am. J. Physiol. 278,  E330±E339.  	NO_MATCH
	11. Discher, D., Bishopric, N., Wu, X., Peterson, C. & Webster, K. (1998)  Hypoxia regulates b-enolase and pyruvate kinase-M promoters by  modulating Sp1/Sp3 binding to a conserved GC element. J. Biol.  Chem. 273, 26087±26093.  	9748288
	12. Semenza, G., Jiang, B.-H., Leung, S., Passantino, R., Concordet, J.-P.,  Maire, P. & Giallongo, A. (1996) Hypoxia response elements in the  aldolase A, enolase 1, and lactate dehydrogenase A gene promoters  contain essential binding sites for hypoxia-inducible factor 1. J. Biol.  Chem. 271, 32529±32537.  	8955077
	13. Merkulova, T., Lucas, M., Jabet, C., LamandeÂ, N., Rouzeau, J.D.,  Gros, F., Lazar, M. & Keller, A. (1997) Biochemical characterization  of the mouse muscle-specific enolase: Developmental changes in  electrophoretic variants and selective binding to other proteins.  Biochem. J. 323, 791±800.  	9169614
	14. Knull, H. & Minton, A. (1996) Structure within eukaryotic cytoplasm  and its relationship to glycolytic metabolism. Cell Biochem. Funct.  14, 237±248.  	8952042
	15. Wojtas, K., Slepecky, N., von Kalm, L. & Sullivan, D. (1997) Flight  muscle function in Drosophila requires colocalization of glycolytic  enzymes. Mol. Biol. Cell 8, 1665±1675.  	9307964
	16. Foucault, G., Vacher, M., Cribier, S. & Arrio-Dupont, M. (2000)  Interactions between b-enolase and creatine kinase in the cytosol of  skeletal muscle cells. Biochem. J. 346, 127±131.  	10657248
	17. Foucault, G., Vacher, M., Merkulova, T., Keller, A. & Arrio-Dupont, M.  (1999) Presence of enolase in the M-band of skeletal muscle and  possible indirect interaction with the cytosolic muscle isoform of  creatine kinase. Biochem. J. 338, 115±121.  	9931306
	18. Angelov, D.N., Neiss, W.F., Gunkel, A., Guntinaslichius, O. &  Stennert, E. (1994) Axotomy induces intranuclear immuno localization of neuron-specific enolase in facial and hypoglossal  neurons of the rat. J. Neurocytol. 23, 218±233.  	8035205
	19. Kherif, S., Lafuma, C., Dehaupas, M., Lachkar, S., Fournier, J.,  VerdieÁre-Sahuque, M., Fardeau, M. & Alameddine, H. (1999)  Expression of matrix metalloproteinases 2 and 9 in regenerating  skeletal muscle: a study in experimentally injured and mdx muscles.  Dev. Biol. 205, 158±170.  	9882504
	20. Bradford, M.M. (1976) A rapid and sensitive method for the  quantitation of microgram quantities of proteins utilizing the  principle of protein-dye binding. Anal. Biochem. 72, 248±254.  	942051
	21. Keller, A., Scarna, H., Mermet, A. & Pujol, J.F. (1981) Biochemical  and immunological properties of the mouse brain enolases purified by  a simple method. J. Neurochem. 36, 1389±1397.  	7264635
	22. CreÂminon, C., Pilard, F., Grassi, J., Perly, B. & Pradelles, P. (1994) A  sensitive and specific enzyme immunoassay for cyclomaltoheptaose  and some derivatives. Carbohydr. Res. 258, 179±186.  	8039174
	23. McLaughlin, L., Wei, V., Stockman, P., Leahy, K., Needleman, P.,  Grassi, J. & Pradelles, P. (1987) Development, validation and  application of an enzyme immunoassay (EIA) of atriopeptin.  Biochem. Biophys. Res. Commun. 144, 469±476.  	2953338
	24. Pradelles, P., Grassi, J., Chabardes, D. & Guiso, N. (1989) Enzyme  immunoassays of adenosine cyclic 3 0,5 0-monophosphate and guano sine cyclic 3 0,5 0-monophosphate using acetylcholinesterase. Anal.  Chem. 61, 447±453.  	2541635
	25. Ellman, G., Courtney, K., Andres, V. & Featherstone, R. (1961) A new  and rapid colorimetric determination of acetylcholine esterase  activity. Biochem. Pharmacol. 7, 88±95.  	13726518
	26. d'Albis, A., Couteaux, R., Janmot, C., Roulet, A. & Mira, J.-C. (1988)  Regeneration after cardiotoxin injury of innervated and denervated  slow and fast muscles of mammals. Myosin isoform analysis. Eur.  J. Biochem. 174, 103±110.  	3371354
	27. Ovadi, J. & Srere, P. (1996) Metabolic consequences of enzyme  interactions. Cell Biochem. Funct. 14, 249±258.  	8952043
	28. DoÈlken, G., Leisner, E. & Pette, D. (1975) Immunofluorescent  localization of glycogenolytic and glycolytic enzyme proteins and  of malate dehydrogenase isozymes in cross-striated skeletal muscle  and heart of the rabbit. Histochemistry 43, 113±121.  	124716
	29. Dechesne, C. & Keller, A. (1996) Differential a enolase immuno reactivity in the two neuron types of the rat spiral ganglion during  postnatal development. Comparison with neurofilament protein  immunoreactivity. Auditory Neurosci. 2, 33±46.  	NO_MATCH
	30. Popanda, O., Fox, G. & Thielmann, H. (1998) Modulation of DNA  polymerase a, d and : by lactate dehydrogenase and 3-phos phoglycerate kinase. Biochim. Byophys. Acta 1397, 102±117.  	9545551
	31. Green, G., Girardot, R., Baldacini, O., Ledig, M. & Monteil, H. (1993)  Characterization of enolase from Clostridium difficile. Curr.  Microbiol. 26, 53±56.  	NO_MATCH
	32. al Giery, A. & Brewer, J.M. (1992) Characterization of the interaction  of yeast enolase with polynucleotides. Biochim. Biophys. Acta 1159,  134±140.  	1382613
	33. Babbitt, P.C., Hasson, M.S., Wedekind, J.E., Palmer, D.R., Barrett,  W.C., Reed, G.H., Rayment, I., Ringe, D., Kenyon, G.L. & Gerlt, J.A.  (1996) The enolase superfamily: a general strategy for enzyme catalyzed abstraction of the alpha-protons of carboxylic acids.  Biochemistry 35, 16489±16501.  	8987982
	34. Gorsich, S.W., Barrows, V., Halbert, J. & Farrar, W.W. (1999)  Purification and properties of gg-enolase from pig brain. J. Protein  Chem. 18, 103±115.  	10071935
	35. Hattori, T., Takei, N., Mizuno, Y., Kato, K. & Kohsaka, S. (1995)  Neurotrophic and neuroprotective effects of neuron-specific enolase  on cultured neurons from embryonic rat brain. Neurosci. Res. 21,  191±198.  	7753500
	36. Piatigorsky, J. & Wistow, G. (1989) Enzyme/crystallins: gene sharing  as an evolutionary strategy. Cell 57, 197±199.  	2649248
	37. Redlitz, A., Fowler, B., Plow, E. & Miles, L. (1995) The role of an  enolase-related molecule in plasminogen binding to cells. Eur. J.  Biochem. 227, 407±415.  	7851415
	38. Haimoto, H., Takahashi, Y., Koshikawa, T., Nagura, H. & Kato, K.  (1985) Immunohistochemical localization of gamma-enolase in  normal human tissues other than nervous and neuroendocrine tissues.  Lab. Invest. 52, 257±263.  	3974199
	39. Couteaux, R., Mira, J.C. & d'Albis, A. (1988) Regeneration of  muscles after cardiotoxin injury. I. Cytological aspects. Biol. Cell  62, 171±182.  	3390626
j.1432-1327.2000.01405.x.pdf
	1. Matthews, D.M. (1991) Protein Absorption. Development and Present  State of the Subject. Wiley-Liss, New York.  	NO_MATCH
	2. Ganapathy, V., Brandsch, M. & Leibach, F.H. (1994) Physiology of the  Gastro-Intestinal Tract (Johnson, L.R., ed.), 3rd edn, pp. 1773±1794.  Raven Press, New York.  	NO_MATCH
	3. Temple, C.S., Stewart, A.K., Meredith, D., Lister, N.A., Morgan, K.M.,  Collier, I.D., Vaughan-Jones, R.D., Boyd, C.A.R., Bailey, P.D. &  Bronk, J.R. (1998) Peptide mimics as substrates for the intestinal  peptide transporter. J. Biol. Chem. 273, 20±22.  	9417040
	4. Borner, V., Fei, Y.J., Hartrodt, B., Ganapathy, V., Leibach, F.H.,  Neubert, K. & Brandsch, M. (1998) Transport of amino acid aryl  amides by the intestinal H1/peptide cotransport system, PEPT1.  Eur. J. Biochem. 255, 698±702.  	9738910
	5. Doring, F., Will, J., Amasheh, S., Clauss, W., Ahlbrecht, H. & Daniel,  H. (1998) Minimal molecular determinants of substrates for  recognition by the intestinal peptide transporter. J. Biol. Chem. 273,  23211±23218.  	9722551
	6. Lister, N.A., Sykes, A.P., Bailey, P.D., Boyd, C.A.R. & Bronk,  J.R. (1994) Dipeptide transport and hydrolysis in isolated loops  of rat small intestine. Effects of stereospecificity. J. Physiol. 484,  173±182.  	7602518
	7. Guha, N., Boyd, C.A.R. & Meredith, D. (1999) Modified amino  acids and peptides as inhibitors of the rabbit peptide transporter  PepT1 expressed in Xenopus laevis oocytes. J. Physiol. 517P,  27P.  	NO_MATCH
	8. Fei, Y.J., Kanai, Y., Nussberger, S., Ganapathy, V., Leibach, F.H.,  Romero, M.F., Singh, S.M., Boron, M.F. & Hediger, M.A. (1994)  Expression cloning of a mammalian proton-coupled oligopeptide  transporter. Nature 368, 563±566.  	8139693
	9. Meredith, D. & Boyd, C.A.R. (1996) His57 is an essential  residue for the transport of the anionic dipeptide d-Phe-l-Glu  by PepT1 expressed in Xenopus laevis oocytes. J. Physiol.  497, 89P±90P.  	NO_MATCH
	10. Deves, R., Chavez, P. & Boyd, C.A.R. (1992) Identification of a new  transport system (y1L) in human erythrocytes that recognises lysine  and leucine with high affinity. J. Physiol. 454, 491±501.  	1474499
	11. Daniel, H., Morse, E.L. & Adibi, S.A. (1992) Determinants of substrate  affinity for the oligopeptide/H1 symporter in the renal brush border  membrane. J. Biol. Chem. 267, 9565±9573.  	1577796
	12. Ganapathy, M.E., Huang, W., Wang, H., Ganapathy, V. & Leibach, F.H.  (1998) Valacyclovir: a substrate for the intestinal and renal peptide  transporters PEPT1 and PEPT2. Biochem. Biophys. Res. Commun.  246, 470±475.  	9610386
	13. Miyamoto, Y., Ganapathy, V. & Leibach, F.H. (1986) Identification of  histidyl and thiol groups at the active site of rabbit renal dipeptide  transporter. J. Biol. Chem. 261, 16133±16140.  	3023343
	14. Temple, C.S., Bronk, J.R., Bailey, P.D. & Boyd, C.A.R. (1995)  Substrate-charge dependence of stoichiometry shows membrane  potential is the driving force for proton±peptide cotransport in rat  renal cortex. Eur. J. Physiol. 430, 825±829.  	7478939
	15. Terada, T., Saito, H., Mukai, M. & Inui, K.I. (1996) Identification  of the histidine residues involved in substrate recognition by a rat  H1/peptide cotransporter, PEPT1. FEBS Lett. 394, 196±200.  	8843163
	16. Fei, Y.J., Lui, W., Prasad, P.D., Kekuda, R., Oblak, T.G., Ganapathy, V.  & Leibach, F.H. (1997) Identification of the histidyl residue  obligatory for the catalytic activity of the human H1/peptide  cotransporters PEPT1 and PEPT2. Biochemistry 36, 452±460.  	9003198
	17. Meredith, D. & Boyd, C.A.R. (1995) Oligopeptide transport by  epithelial cells. J. Memb. Biol. 145, 1±12.  	7636881
	18. Terada, T., Saito, H. & Inui, K.I. (1998) Interaction of beta-lactam  antibiotics with histidine residue of rat H1/peptide cotransporters,  PEPT1 and PEPT2. J. Biol. Chem. 273, 5582±5585.  	9488685
	19. Bolger, M.B., Haworth, I.S., Yeung, A.K., Ann., D., von Grafenstein,  H., Hamm-Alvarez, S., Okamoto, C.T., Kim, K.J., Basu, S.K., Wu, S. & Lee, V.H. (1998) Structure, function, and molecular modeling  approaches to the study of the intestinal dipeptide transporter PepT1.  J. Pharmac. Sci. 87, 1286±1291.  	9811478
	20. Temple, C.S., Collier, I.D., Bronk, J.R., Bailey, P.D. & Boyd, C.A.R.  (1998) Structural requirements for non-peptide substrate binding to  the epithelial proton-coupled oligopeptide transporter. J. Physiol.  511P, 26P±27P.  	NO_MATCH
	21. Doring, F., Walter, J., Will, J., Focking, M., Boll, M., Amasheh, S.,  Clauss, W. & Daniel, H. (1998) Delta-aminolevulinic acid transport  by intestinal and renal peptide transporters and its physiological and  clinical implications. J. Clin. Invest. 101, 2761±2767.  	9637710
j.1432-1327.2000.01399.x.pdf
	1. Peck, H.D. & Gest, H. (1957) Formic dehydrogenase and the hydro genlyase enzyme complex in coli-aerogenes bacteria. J. Bacteriol. 73,  706±721.  	13449036
	2. BoÈhm, R., Sauter, M. & BoÈck, A. (1990) Nucleotide sequence and  expression of an operon in Escherichia coli coding for formate  hydrogenlyase components. Mol. Microbiol. 4, 231±243.  	2187144
	3. Lutz, S., Jacobi, A., Schlensog, V., BoÈhm, R., Sawers, G. & BoÈck, A.  (1991) Molecular characterization of an operon (hyp) necessary for  the activity of the three hydrogenase isoenzymes in Escherichia coli.  Mol. Microbiol. 5, 123±135.  	1849603
	4. Pecher, A., Zinoni, F. & BoÈck, A. (1985) The seleno-polypeptide of  formic dehydrogenase (formate hydrogen-lyase linked) from  Escherichia coli: genetic analysis. Arch. Microbiol. 141, 359±363.  	3160320
	5. Maier, T., Binder, U. & BoÈck, A. (1996) Analysis of the hydA locus of  Escherichia coli: two genes (hydN and hypF ) involved in formate and  hydrogen metabolism. Arch. Microbiol. 165, 333±341.  	8661925
	6. Sankar, P., Lee, J.H. & Shanmugam, K.T. (1988) Gene-product  relationships of fhlA and fdv genes of Escherichia coli. J. Bacteriol.  170, 5440±5445.  	3056900
	7. Schlensog, V. & BoÈck, A. (1990) Identification and sequence analysis  of the gene encoding the transcriptional activator of the formate  hydrogenlyase system of Escherichia coli. Mol. Microbiol. 4,  1319±1327.  	2280686
	8. Sauter, M., BoÈhm, R. & BoÈck, A. (1992) Mutational analysis of the  operon (hyc) determining hydrogenase 3 formation in Escherichia  coli. Mol. Microbiol. 6, 1523±1532.  	1625581
	9. Birkmann, A. & BoÈck, A. (1989) Characterization of a cis regulatory  DNA element necessary for formate induction of the formate  dehydrogenase gene ( fdhF ) of Escherichia coli. Mol. Microbiol. 3,  187±195.  	2668685
	10. Birkmann, A., Sawers, R.G. & BoÈck, A. (1987) Involvement of the  ntrA gene product in the anaerobic metabolism of Escherichia coli.  Mol. Gen. Genet. 210, 535±542.  	3323848
	11. Lutz, S., BoÈhm, A., Beier, A. & BoÈck, A. (1990) Characterisation of  divergent NtrA-dependend promotors in the anaerobically expressed  gene cluster coding for hydrogenase 3 components of Escherichia  coli. Mol. Microbiol. 4, 13±20.  	2181234
	12. Schlensog, V., Lutz, S. & BoÈck, A. (1994) Purification and DNA binding properties of FHLA, the transcriptional activator of the  formate hydrogenlyase system from Escherichia coli. J. Biol. Chem.  269, 19590±19596.  	8034727
	13. Hopper, S. & BoÈck, A. (1995) Effector-mediated stimulation of ATPase  activity by the s54-dependent transcriptional activator FHLA from  Escherichia coli. J. Bacteriol. 177, 2798±2803.  	7751289
	14. Hopper, S., Korsa, I. & BoÈck, A. (1996) The nucleotide concentration  determines the specificity of in vitro transcription activation by the  s54-dependent activator FhlA. J. Bacteriol. 178, 199±203.  	8550417
	15. Morett, E. & Segovia, L. (1993) The s54 bacterial enhancer-binding  protein family: mechanism of action and phylogenetic relationship of  their funcional domains. J. Bacteriol. 175, 6067±6074.  	8407777
	16. Shingler, V. (1996) Signal sensing by s54-dependent regulators:  derepression as a control mechanism. Mol. Microbiology 19,  409±416.  	8830233
	17. Weiss, V. & Magasanik, B. (1988) Phosphorylation of nitrogen  regulator I (NRI) of Escherichia coli. Proc. Natl Acad. Sci. USA  85, 8919±8923.  	2848245
	18. Henderson, N., Austin, S.A. & Dixon, R.A. (1989) Role of metal ions  in negative regulation of nitrogen fixation by the nifL gene product  from Klebsiella pneumoniae. Mol. Gen. Genet. 216, 484±491.  	NO_MATCH
	19. Pavel, H., Forsman, M. & Shingler, V. (1994) An aromatic effector  specificity mutant of the transcriptional regulator DmpR overcomes  the growth constraints of Pseudomonas sp. strain CF600 on para substituted methylphenols. J. Bacteriol. 176, 7550±7557.  	8002579
	20. Abril, M.A., Michan, C., Timmis, K.N. & Ramos, J.L. (1989)  Regulator and enzyme specificities of the TOL plasmid-encoded  upper pathway for degradation of aromatic hydrocarbons and  expansion of the substrate range of the pathway. J. Bacteriol. 171,  6782±6790.  	2687253
	21. Shingler, V. & Moore, T. (1994) Sensing of aromatic compounds by the  DmpR transcriptional activator of phenol-catabolizing Pseudomonas  sp. strain CF600. J. Bacteriol. 176, 1555±1560.  	8132448
	22. Weiss, D.S., Batut, J., Klose, K.E., Keener, J. & Kustu, S. (1991) The  phosphorylated form of the enhancer-binding protein NTRC has an  ATPase acivity that is essential for activation of transcription. Cell 67,  155±167.  	1833069
	23. Cornish, E.C., Argyropoulos, V.P., Pittard, J. & Davidson, B.E. (1986)  Structure of the Escherichia coli K12 regulatory gene tyrR.  Nucleotide sequence and sites of initiation of transcription and  translation. J. Biol. Chem. 261, 403±410.  	3001057
	24. North, A.K., Klose, K.E., Stedman, K.M. & Kustu, S. (1993)  Prokaryotic enhancer-binding proteins reflect eukaryote-like mod ularity: the puzzle of nitrogen regulatory protein C. J. Bacteriol. 175,  4267±4273.  	8331061
	25. Pelton, J.G., Kustu, S. & Wemmer, D.E. (1999) Solution structure  of the DNA-binding domain of NtrC with three alanine  substitutions. J. Mol. Biol. 292, 1095±1110.  	10512705
	26. PeÂrez-MartÂõn, J. & Lorenzo, V. (1996) In vitro activities of an  N-terminal truncated form of XylR, a s54-dependent transcriptional  activator of Pseudomonas putida. J. Mol. Biol. 258, 575±587.  	8636993
	27. Shingler, V. & Pavel, H. (1995) Direct regulation of the ATPase activity  of the transcriptional activator DmpR by aromatic compounds. Mol.  Microbiol. 17, 505±513.  	8559069
	28. FernaÂndez, S., Lorenzo, V. & PeÂrez-MartÂõn, J. (1995) Activation of the  transcriptional regulator XylR of Pseudomonas putida by  release of repression between functional domains. Mol. Microbiol.  16, 205±213.  	7565083
	29. Lee, J.H., Scholl, D., Nixon, B.T. & Hoover, T.R. (1994) Constitutive  ATP hydrolysis and transcription activation by a stable, truncated  form of Rhizobium meliloti DctD, a sigma 54-dependent transcrip tional activator. J. Biol. Chem. 269, 20401±20409.  	8051135
	30. Delgado, A., Salto, R., MarqueÂs, S. & Ramos, J.L. (1995) Single amino  acid changes in the signal reception domain of XylR result in  mutations that stimulate transcription in the absence of effectors.  J. Biol. Chem. 270, 5144±5150.  	7890623
	31. PeÂrez-MartÂõn, J. & Lorenzo, V. (1995) The amino-terminal  domain of the procaryotic enhancer-binding protein XylR is a  specific intramolecular repressor. Proc. Natl Acad. Sci. USA  92, 9392±9396.  	7568139
	32. Korsa, I. & BoÈck, A. (1997) Characterization of fhlA mutations  resulting in ligand ± independent transcriptional activation and ATP  hydrolysis. J. Bacteriol. 179, 41±45.  	8981978
	33. Begg, Y.A., Whyte, J.A. & Haddock, B.Y. (1977) The identifica tion of mutants of Escherichia coli deficient in formate  dehydrogenase and nitrate reductase activities using dye indicator  plates. FEMS Microbiol. Lett. 2, 47±50.  	NO_MATCH
	34. Balch, W.E. & Wolfe, R.S. (1976) New approach to the  cultivation of methanogenic bacteria: 2-mercaptoethanesulfonic  acid (HS-CoM)-dependent growth of Methanobacterium ruminan tium in a pressurized atmosphere. Appl. Environ. Microbiol. 32,  781±791.  	827241
	35. Miller, J.H. (1972) Experiments in Molecular Genetics. Cold Spring  Harbor Laboratory Press, Cold Spring Harbor, New York.  	NO_MATCH
	36. Sambrook, J., Fritsch, E.F. & Maniatis, T. (1989) Molecular Cloning: a  Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold  Spring Harbor, New York.  	NO_MATCH
	37. Fiedler, S. & Wirth, R. (1988) Transformation of bacteria with plasmid  DNA by electroporation. Anal. Biochem. 170, 38±44.  	3133958
	38. Dixon, W.J., Hayes, J.J., Levin, J.R., Weidner, M.F., Dombroski, B.A.  & Tullius, T.D. (1991) Hydroxyl radical footprinting. Methods  Enzymol. 208, 380±413.  	1664026
	39. Schickor, P. & Heumann, H. (1994) Hydroxyl radical footprinting. In  DNA±Protein Interactions: Principles and Protocols (Kneanle, G.G.,  ed.), pp. 21±32. Humana Press Inc, Totowa.  	8004196
	40. Maxam, A.M. & Gilbert, W. (1977) A new method for sequencing  DNA. Proc. Natl Acad. Sci. USA 74, 560±564.  	265521
	41. Whitaker, J.R. & Granum, P.E. (1980) An absolute method for protein  determination based on difference in absorbance at 235 and 280 nm.  Anal. Biochem. 109, 156±159.  	7469012
	42. Laemmli, U.K. (1970) Cleavage of structural proteins during  the assembly of the head of bacteriophage T4. Nature 227,  680±685.  	5432063
	43. Fiedler, G., Pajatsch, M. & BoÈck, A. (1996) Genetics of a novel starch  utilisation pathway present in Klebsiella oxytoca. J. Mol. Biol. 256,  279±291.  	8594196
	44. Mills, D.M., Bajaj, V. & Lee, C.A. (1995) A 40 kb chromosomal  fragment encoding Salmonella typhimurium invasion genes is absent  from the corresponding region of the Escherichia coli K-12  chromosome. Mol. Microbiol. 15, 749±759.  	7783645
	45. Hopper, S. (1995) Das Formiat-Regulon von Escherichia coli: Unter suchungen zur FhlA-abhaÈngigen Regulation. PhD Thesis, Ludwig Maximilians-UniversitaÈt, MuÈnchen.  	NO_MATCH
	46. Bantscheff, M., Weiss, V. & Glocker, M.O. (1999) Identification  of linker regions and domain borders of the transcription  activator protein NtrC from Escherichia coli by limited  proteolysis, in-gel digestion, and mass spectrometry. Biochemistry  38, 11012±11020.  	10460156
	47. Flashner, Y., Weiss, D.S., Keener, J. & Kustu, S. (1995) Constitutive  forms of the enhancer-binding protein NtrC: evidence that  essential oligomerization determinants lie in the central activation  domain. J. Mol. Biol. 249, 700±713.  	7602583
	48. PeÂrez-MartÂõn, J. & Lorenzo, V. (1996) Physical and functional analysis  of the prokaryotic enhancer of the s54-promotors of the TOL plasmid  of Pseudomonas putida. J. Mol. Biol. 258, 562±574.  	8636992
	49. Csonka, L.N. (1981) Proline over-production results in enhanced  osmotolerance in Salmonella typhimurium. Mol. Gen. Genet. 182,  82±86.  	7022140
	50. Bender, H. (1977) Cyclodextrin glucanotransferase from Klebsiella  pneumoniae. 2. Significance of the enzyme for the metabolism of  cyclodextrins by Klebsiella pneumoniae M 5 al. Arch. Microbiol. 113,  49±56.  	329783
	51. Casadaban, M.J. & Cohen, S.N. (1979) Lactose genes fused to  exogenous promoters in one step using a Mu-lac bacteriophage: in  vivo probe for transcriptional control sequences. Proc. Natl Acad.  Sci. USA 76, 4530±4533.  	159458
	52. Hopper, S., Babst, M., Schlensog, V., Fischer, H.M., Hennecke, H. &  BoÈck, A. (1994) Regulated expression in vitro of genes coding for  formate hydrogenlyase components of Escherichia coli. J. Biol.  Chem. 269, 19597±19604.  	8034728
	53. Schlensog, V. (1993) Genetische Analyse, Struktur und Funktion des  Formiat-Hydrogen-Lyase-Aktivatorproteins (FhlA) von Escherichia  coli. PhD Thesis, Ludwig-Maximilians-UniversitaÈt, MuÈnchen.  	NO_MATCH
	54. Sawers, G. & Suppmann, B. (1992) Anaerobic induction of pyruvate  formate-lyase gene expression is mediated by the ArcA and FNR  proteins. J. Bacteriol. 174, 3474±3478.  	1592804
	55. Yanisch-Perron, C., Vieira, J. & Messing, J. (1985) Improved M13  phage cloning vectors and host strains: nucleotide sequences of the  M13mp18 and pUC19 vectors. Gene 33, 103±109.  	2985470
	56. Studier, F.W. & Moffatt, B.A. (1986) Use of bacteriophage T7 RNA  polymerase to direct selective high-level expression of cloned genes.  J. Mol. Biol. 189, 113±130.  	3537305
	57. Bolivar, F., Rodriguez, R.L., Greene, P.J., Betlach, M.C., Heynecker,  H.L. & Boyer, H.W. (1977) Construction and characterization of  new cloning vehicles. II. A multipurpose cloning system. Gene 2,  95±113.  	344137
	58. Tabor, S. & Richardson, C.C. (1985) A bacteriophage T7 RNA  polymerase/promoter system for controlled exclusive expression of  specific genes. Proc. Natl Acad. Sci. USA 82, 1074±1078.  	3156376
	59. Martinez, E., Bartolome, B. & de la Cruz, F. (1988) pACYC184 derived cloning vectors containing the multiple cloning site and lacZ  alpha reporter gene of pUC8/9 and pUC18/19 plasmids. Gene (Amst.)  68, 159±162.  	2851489
2_ftp.pdf
J Immunol-2000-Baurain-6057-66.pdf
	1. Van den Eynde, B., and P. van der Bruggen. 1997. T cell-defined tumor antigens.  Curr. Opin. Immunol. 9:684.  	9368778
	2. van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen,  B. Van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen  recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643.  	1840703
	3. De Plaen, E., K. Arden, C. Traversari, J. J. Gaforio, J.-P. Szikora, C. De Smet,  F. Brasseur, P. van der Bruggen, B. Lethe´, C. Lurquin, et al. 1994. Structure,  chromosomal localization and expression of twelve genes of the MAGE family.  Immunogenetics 40:360.  	7927540
	4. Boe¨l, P., C. Wildmann, M.-L. Sensi, R. Brasseur, J.-C. Renauld, P. Coulie,  T. Boon, and P. van der Bruggen. 1995. BAGE, a new gene encoding an antigen  recognized on human melanomas by cytolytic T lymphocytes. Immunity 2:167.  	7895173
	5. Van den Eynde, B., O. Peeters, O. De Backer, B. Gaugler, S. Lucas, and T. Boon.  1995. A new family of genes coding for an antigen recognized by autologous  cytolytic T lymphocytes on a human melanoma. J. Exp. Med. 182:689.  	7544395
	6. Wo¨lfel, T., M. Hauer, J. Schneider, M. Serrano, C. Wo¨lfel, E. Klehmann-Hieb,  E. De Plaen, T. Hankeln, K.-H. Meyer zum Bu¨schenfelde, and D. Beach. 1995.  A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a  human melanoma. Science 269:1281.  	7652577
	7. Mandruzzato, S., F. Brasseur, G. Andry, T. Boon, and P. van der Bruggen. 1997.  A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and  neck carcinoma. J. Exp. Med. 186:785.  	9271594
	8. Robbins, P. F., M. El-Gamil, Y. F. Li, Y. Kawakami, D. Loftus, E. Appella, and  S. A. Rosenberg. 1996. A mutated b-catenin gene encodes a melanoma-specific  antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med. 183:1185.  	8642260
	9. Rubinfeld, B., P. Robbins, M. El-Gamil, I. Albert, E. Porfiri, and P. Polakis. 1997.  Stabilization of b-catenin by genetic defects in melanoma cell lines. Science  275:1790.  	9065403
	10. Coulie, P. G., H. Ikeda, J.-F. Baurain, and R. Chiari. 1999. Anti-tumor immunity  at work in a melanoma patient. Adv. Cancer Res. 76:213.  	10218103
	11. Lehmann, F., M. Marchand, P. Hainaut, P. Pouillart, X. Sastre, H. Ikeda, T. Boon,  and P. G. Coulie. 1995. Differences in the antigens recognized by cytolytic T cells  on two successive metastases of a melanoma patient are consistent with immune  selection. Eur. J. Immunol. 25:340.  	7875194
	12. Chiari, R., F. Foury, E. De Plaen, J.-F. Baurain, J. Thonnard, and P. G. Coulie.  1999. Two antigens recognized by autologous CTL on a melanoma result from a  single point mutation in an essential housekeeping gene. Cancer Res. 59:5785.  	10582700
	13. Coulie, P. G., F. Lehmann, B. Lethe´, J. Herman, C. Lurquin, M. Andrawiss, and  T. Boon. 1995. A mutated intron sequence codes for an antigenic peptide rec ognized by cytolytic T lymphocytes on a human melanoma. Proc. Natl. Acad.  Sci. USA 92:7976.  	7644523
	14. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WEHI 164  clone 13, for measuring cytotoxic factor/tumor necrosis factor from human  monocytes. J. Immunol. Methods 95:99.  	3782828
	15. Davis, L. G., M. D. Dibner, and J. F. Battey. 1986. Guanidine isothiocyanate  preparation of total RNA. In Basic Methods in Molecular Biology. L. G. Davis et  al., eds. Elsevier, New York, p. 130.  	NO_MATCH
	16. Hansen, M. B., S. E. Nielsen, and K. Berg. 1989. Re-examination and further  development of a precise and rapid dye method for measuring cell growth/cell  kill. J. Immunol. Methods 119:203.  	2470825
	17. Atherton, E., C. J. Logan, and R. C. Sheppard. 1981. Peptide synthesis. II. Pro cedures for solid phase synthesis using Na-fluorenylmethysoxycarbamylamino acid on polymide supports: synthesis of substance P and of acyl carrier protein  65–74 decapeptide. J. Chem. Soc. London Perkin Trans. 1:538.  	NO_MATCH
	18. Schutze, K., and G. Lahr. 1998. Identification of expressed genes by laser-me diated manipulation of single cells. Nat. Biotechnol. 16:737.  	9702771
	19. Altman, J. D., P. A. H. Moss, P. J. R. Goulder, D. H. Barouch,  M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996.  Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94.  	8810254
	20. Van Snick, J., A. Vink, S. Cayphas, and C. Uyttenhove. 1987. Interleukin-HP1,  a T cell-derived hybridoma growth factor that supports the in vitro growth of  murine plasmocytomas. J. Exp. Med. 165:641.  	3493321
	21. Geneve´e, C., A. Diu, J. Nierat, A. Caignard, P. Y. Dietrich, L. Ferradini,  S. Roman-Roman, F. Triebel, and T. Hercend. 1992. An experimentally validated  panel of subfamily-specific oligonucleotide primers (Va1-w29/Vb1-w24) for the  study of human T cell receptor variable V gene segment usage by polymerase  chain reaction. Eur. J. Immunol. 22:1261.  	1533591
	22. Manfras, B. J., W. A. Rudert, M. Trucco, and B. O. Boehm. 1997. Analysis of the  a/b T-cell receptor repertoire by competitive and quantitative family-specific  PCR with exogenous standards and high resolution fluorescence based CDR3 size  imaging. J. Immunol. Methods 210:235.  	9520306
	23. Lauber, J., P. Fabrizio, S. Teigelkamp, W. S. Lane, E. Hartmann, and  R. Luhrmann. 1996. The HeLa 200 kDa U5 snRNP-specific protein and its ho mologue in Saccharomyces cerevisiae are members of the DEXH-box protein  family of putative RNA helicases. EMBO J. 15:4001.  	8670905
	24. Parker, K. C., M. A. Bednarek, and J. E. Coligan. 1994. Scheme for ranking  potential HLA-A2 binding peptides based on independent binding of individual  peptide side-chains. J. Immunol. 152:163.  	8254189
	25. Rammensee, H.-G., T. Friede, and S. Stevanovic. 1995. MHC ligands and peptide  motifs: first listing. Immunogenetics 41:178.  	7890324
	26. Brash, D. E., J. A. Rudolph, J. A. Simon, A. Lin, G. J. McKenna, H. P. Baden,  A. J. Halperin, and J. Ponten. 1991. A role for sunlight in skin cancer: UV induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA  88:10124.  	1946433
	27. Goldstein, A. M., N. C. Dracopoli, M. Engelstein, M. C. Fraser, W. H. J. Clark,  and M. A. Tucker. 1994. Linkage of cutaneous malignant melanoma/dysplastic  nevi to chromosome 9p, and evidence for genetic heterogeneity. Am. J. Hum.  Genet. 54:489.  	8116618
	28. Puig, S., A. Ruiz, C. Lazaro, T. Castel, M. Lynch, J. Palou, A. Vilalta,  J. Weissenbach, J. M. Mascaro, and X. Estivill. 1995. Chromosome 9p deletions  in cutaneous malignant melanoma tumors: the minimal deleted region involves  markers outside the p16 (CDKN2) gene. Am. J. Hum. Genet. 57:395.  	7668266
	29. Healy, E., C. E. Belgaid, M. Takata, A. Vahlquist, I. Rehman, H. Rigby, and  J. L. Rees. 1996. Allelotypes of primary cutaneous melanoma and benign mela nocytic nevi. Cancer Res. 56:589.  	8564976
	30. McMichael, A. J., and C. A. O’Callaghan. 1998. A new look at T cells. J. Exp.  Med. 187:1367.  	NO_MATCH
	31. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. D. Sourdive, A. J. Zajac,  J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T  cells: a reevaluation of bystander activation during viral infection. Immunity  8:177.  	9491999
	32. Bieganowska, K., P. Ho¨llsberg, G. J. Buckle, D.-G. Lim, T. F. Greten, J. Schneck,  J. D. Altman, S. Jacobson, S. L. Ledis, B. Hanchard, et al. 1999. Direct analysis  of viral-specific CD81 T cells with soluble HLA-A2/Tax11–19 tetramer com plexes in patients with human T cell lymphotropic virus-associated myelopathy.  J. Immunol. 162:1765.  	9973440
	33. Nagata, S., and P. Goldstein. 1995. The Fas death factor. Science 267:1449.  	7533326
	34. Subramanya, H. S., L. E. Bird, J. A. Brannigan, and D. B. Wigley. 1996. Crystal  structure of a DExx box DNA helicase. Nature 384:379.  	8934527
	35. Linder, P., P. F. Lasko, M. Ashburner, P. Leroy, P. J. Nielsen, K. Nishi,  J. Schnier, and P. P. Slonimski. 1989. Birth of the D-E-A-D box. Nature 337:121.  	NO_MATCH
	36. Gorbalenya, A. E., and E. V. Koonin. 1993. Helicases: amino acid sequence  comparisons and structure-function relationships. Curr. Opin. Strut. Biol. 3:419.  	NO_MATCH
	37. Dubey, P., R. C. Hendrickson, S. C. Meredith, C. T. Siegel, J. Shabanowitz,  J. C. A. Skipper, V. H. Engelhard, D. F. Hunt, and H. Schreiber. 1997. The  immunodominant antigen of an ultraviolet-induced regressor tumor is generated  by a somatic point mutation in the DEAD box helicase p68. J. Exp. Med. 185:  695.  	9034148
	38. Friedberg, E. C. 1992. Xeroderma pigmentosum, Cockayne’s syndrome, heli cases, and DNA repair: what’s the relationship? Cell 71:887.  	1458537
	39. Coin, F., E. Bergmann, A. Tremeau-Bravard, and J. M. Egly. 1999. Mutations in  XPB and XPD helicases found in xeroderma pigmentosum patients impair the  transcription function of TFIIH. EMBO J. 18:1357.  	10064601
	40. Ellis, N. A., J. Groden, T. Z. Ye, J. Straughen, D. J. Lennon, S. Ciocci,  M. Proytcheva, and J. German. 1995. The Bloom’s syndrome gene product is  homologous to RecQ helicases. Cell 83:655.  	7585968
	41. Yu, C. E., J. Oshima, Y. H. Fu, E. M. Wijsman, F. Hisama, R. Alisch,  S. Matthews, J. Nakura, T. Miki, S. Ouais, et al. 1996. Positional cloning of the  Werner’s syndrome gene. Science 272:258.  	8602509
	42. Oshima, J., C. E. Yu, C. Piussan, G. Klein, J. Jabkowski, S. Balci, T. Miki,  J. Nakura, T. Ogihara, J. Ells, et al. 1996. Homozygous and compound heterozy gous mutations at the Werner syndrome locus. Hum. Mol. Genet. 5:1909.  	8968742
	43. Gibbons, R., D. J. Picketts, L. Villard, and D. R. Higgs. 1995. Mutations in a  putative global transcriptional regulator cause X-linked mental retardation with  alpha-thalassemia (ATR-X syndrome). Cell 80:837.  	7697714
	44. Troelstra, C., A. van Gool, J. de Wit, W. Vermeulen, D. Bootsma, and  J. H. Hoeijmakers. 1992. ERCC6, a member of a subfamily of putative helicases,  is involved in Cockayne’s syndrome and preferential repair of active genes. Cell  71:939.  	1339317
	45. Trepel, F. 1974. Number and distribution of lymphocytes in man: a critical anal ysis. Klin. Wochenschr. 52:511.  	4853392
	46. Tan, L. C., N. Gudgeon, N. E. Annels, P. Hansasuta, C. A. O’Callaghan,  S. Rowland-Jones, A. J. McMichael, A. B. Rickinson, and M. F. C. Callan. 1999.  A re-evaluation of the frequency of CD81 T cells specific for EBV in healthy  virus carriers. J. Immunol. 162:1827.  	9973448
	47. Gray, C. M., J. Lawrence, J. M. Schapiro, J. D. Altman, M. A. Winters,  M. Crompton, M. Loi, S. K. Kundu, M. M. Davis, and T. C. Merigan. 1999.  Frequency of class I HLA-restricted anti-HV CD81 T cells in individuals receiv ing highly active antiretroviral therapy (HAART). J. Immunol. 162:1780.  	9973442
	48. Lee, P. P., C. Yee, P. A. Savage, L. Fong, D. Brockstedt, J. S. Weber, D. Johnson,  S. Swetter, J. Thompson, P. D. Greenberg, et al. 1999. Characterization of cir culating T cells specific for tumor-associated antigens in melanoma patients. Nat.  Med. 5:677.  	10371507
	49. Ogg, G. S., P. R. Dunbar, P. Romero, J.-L. Chen, and V. Cerundolo. 1998. High  frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in auto immune vitiligo. J. Exp. Med. 188:1203.  	9743539
	50. Pittet, M. J., D. Valmori, P. R. Dunbar, D. E. Speiser, D. Lie´nard, F. Lejeune,  K. Fleischhauer, V. Cerunodolo, J.-C. Cerottini, and P. Romero. 1999. High  frequencies of naive Melan-A/MART-1-specific CD81 T cells in a large propor tion of human histocompatibility leukocyte antigen (HLA)-A2 individuals.  J. Exp. Med. 190:705.  	10477554
	51. Dunbar, P. R., J.-L. Chen, D. Chao, N. Rust, H. Teisserenc, G. S. Ogg,  P. Romero, P. Weynants, and V. Cerundolo. 1999. Cutting edge: rapid cloning of  tumor-specific CTL suitable for adoptive immunotherapy of melanoma. J. Im munol. 162:6959.  	10358133
	52. Brichard, V. G., G. Warnier, A. Van Pel, G. Morlighem, S. Lucas, and T. Boon.  1995. Individual differences in the orientation of the cytolytic T cell response  against mouse tumor P815. Eur. J. Immunol. 25:664.  	7705394
	53. Marchand, M., N. van Baren, P. Weynants, V. Brichard, B. Dre´no, M.-H. Tessier,  E. Rankin, G. Parmiani, F. Arienti, Y. Humblet, et al. 1999. Tumor regressions  observed in patients with metastatic melanoma treated with an antigenic peptide  encoded by gene MAGE-3 and presented by HLA-A1. Int. J. Cancer 80:219.  	9935203
	54. Rosenberg, S. A., J. C. Yang, D. J. Schwartzentruber, P. Hwu, F. M. Marincola,  S. L. Topalian, N. P. Restifo, M. E. Dudley, S. L. Schwarz, P. J. Spiess, et al.  1998. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for  the treatment of patients with metastatic melanoma. Nat. Med. 4:321.  	9500606
	55. Nestle, F. O., S. Alijagic, M. Gilliet, Y. Sun, S. Grabbe, R. Dummer, G. Burg, and  D. Schadendorf. 1998. Vaccination of melanoma patients with peptide- or tumor  lysate-pulsed dendritic cells. Nat. Med. 4:328.  	9500607
J Immunol-2000-Watarai-6027-33.pdf
	1. Isobe, M., H. Yagita, K. Okumura, and A. Ihara. 1992. Specific acceptance of  cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science  255:1125.  	1347662
	2. Isobe, M., J. Suzuki, H. Yagita, K. Okumura, S. Yamazaki, R. Nagai, Y. Yazaki,  and M. Sekiguchi. 1994. Immunosuppression to cardiac allografts and soluble  antigens by anti-vascular cell adhesion moleucle-1 and anti-very late antigen-4  monoclonal antibodies. J. Immunol. 153:5810.  	7527450
	3. Bergese, S. D., E. H. Huang, R. P. Pelletier, M. B. Widmer, R. M. Ferguson, and  C. G. Orosz. 1995. Regulation of endothelial VCAM-1 expression in murine  cardiac grafts. Am. J. Pathol. 147:166.  	7536398
	4. Schowengerdt, K. O., J. Y. Zhu, S. M. Stepkowski, Y. Tu, M. L. Entman, and  C. M. Ballantyne. 1995. Cardiac allograft survival in mice deficient in intercel lular adhesion molecule-1. Circulation 92:82.  	7788921
	5. Taub, D. D., and J. J. Oppenheim. 1994. Chemokines, inflammation, and immu nity. Ther. Immunol. 1:229.  	NO_MATCH
	6. Rollins, B. J. 1997. Chemokines. Blood 90:909.  	9242519
	7. Baggiolini, M., A. Walz, and S. L. Kunkel. 1989. Neutrophil-activating peptide 1/interleukin-8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84:  1045.  	2677047
	8. Watanabe, K., K. Konishi, M. Fugioka, S. Kinoshita, and H. Nakagawa. 1989.  The neutrophil chemoattractant produced by the rat kidney epitheliod cell line  NRK-52E is a protein related to the KC/gro protein. J. Biol. Chem. 264:19559.  	2684956
	9. Luster, A. D., and J. V. Ravetch. 1987. Biochemical characterization of a g  interferon-inducible cytokine (IP-10). J. Exp. Med. 166:1084.  	2443596
	10. Liao, F., R. L. Rabin, J. R. Yannelli, L. G. Koniaris, P. Vanguri, and J. M. Farber.  1995. Human Mig chemokine: biochemical and functional characterization.  J. Exp. Med. 182:1301.  	7595201
	11. Schall, T. J., M. Lewis, K. J. Koller, A. Lee, G. C. Rice, G. H. Wong,  T. Gatanaga, G. A. Granger, R. Lentz, H. Raab, et al. 1990. Molecular cloning  and expression of a receptor for human tumor necrosis factor. Cell 61:361.  	2158863
	12. Sherry, B., P. Tekamp-Olson, C. Gallegos, D. Bauer, G. Davatelis, S. D. Wolpe,  F. Masiarz, D. Coit, and A. Cerami. 1988. Resolution of the two components of  macrophage inflammatory protein 1, and cloning and characterization of one of  those components, macrophage inflammatory protein-1b. J. Exp. Med. 168:2251.  	3058856
	13. Matsushima, K., C. G. Larsen, G. C. DuBois, and J. J. Oppenheim. 1989. Puri fication and characterization of a novel monocyte chemotactic and activating  factor produced by a human myelomonocytic cell line. J. Exp. Med. 169:1485.  	2926331
	14. Rollins, B. J., E. D. Morrison, and C. D. Stiles. 1988. Cloning and expression of  JE, a gene inducible by platelet-derived growth factor and whose product has  cytokine like properties. Proc. Natl. Acad. Sci. USA 85:3738.  	3287374
	15. Vaddi, K., and R. C. Newton. 1994. Regulation of monocyte integrin expression  by b-family chemokines. J. Immunol. 153:4721.  	7525713
	16. Tanaka, Y., D. H. Adams, S. Hubscher, H. Hirano, U. Siebenlist, and S. Shaw.  1993. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1b.  Nature 361:79.  	7678446
	17. Djeu, J. Y., K. Matsushima, J. J. Oppenheim, K. Shiotsuki, and D. K. Blanchard.  1990. Functional activation of human neutrophils by recombinant monocyte-de rived neutrophil chemotactic factor/IL-8. J. Immunol. 144:2205.  	2155963
	18. Taub, D. D., M. Anver, J. J. Oppenheim, D. L. Longo, and W. J. Murphy. 1996.  T lymphocyte recruitment by interleukin-8 (IL-8): IL-8-induced degranulation of  neutrophils releases potent chemoattractants for human T lymphocytes both in  vitro and in vivo. J. Clin. Invest. 97:1931.  	8621778
	19. Fahey, T. J. I., K. J. Tracey, P. Tekamp-Olson, L. S. Cousens, W. G. Jones,  G. T. Shires, A. Cerami, and B. Sherry. 1992. Macrophage inflammatory protein  1 modulates macrophage function. J. Immunol. 148:2764.  	1573267
	20. Russell, M. E., D. H. Adams, L. R. Wyner, Y. Yamashita, N. J. Halnon, and  M. J. Karnovsky. 1993. Early and persistent induction of monocyte chemoattrac tant protein 1 in rat cardiac allografts. Proc. Natl. Acad. Sci. USA 90:6086.  	8327487
	21. Wieder, K. J., W. W. Hancock, G. Schmidbauer, C. L. Corpier, I. Wieder,  L. Kobzik, T. B. Strom, and J. W. Kupiec-Weglinski. 1993. Rapamycin treatment  depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-g in rat re cipients of cardiac allografts. J. Immunol. 151:1158.  	8335897
	22. Schmouder, R. L., R. M. Strieter, A. Walz, and S. L. Kunkel. 1995. Epithelial derived neutrophil-activating factor-78 production in human renal tubule epithe lial cells and in renal allograft rejection. Transplantation 59:118.  	7839412
	23. Pattison, J., P. J. Nelson, P. Huie, I. von Leuttichau, G. Farshid, R. K. Sibley, and  A. M. Krensky. 1994. RANTES chemokine expression in cell-mediated trans plant rejection of the kidney. Lancet 343:209.  	7507196
	24. Nadeau, K. C., H. Azuma, and N. L. Tilney. 1995. Sequential cytokine dynamics  in chronic rejection of rat renal allografts: roles for cytokines RANTES and  MCP-1. Proc. Natl. Acad. Sci. USA 92:8729.  	7568006
	25. Nagano, H., K. C. Nadeau, M. Takada, M. Kusaka, and N. L. Tilney. 1997.  Sequential cellular and molecular kinetics in acutely rejecting renal allografts in  rats. Transplantation 63:1101.  	9133471
	26. Kondo, T., A. C. Novick, H. Toma, and R. L. Fairchild. 1996. Induction of  chemokine gene expression during allogeneic skin graft rejection. Transplanta tion 61:1750.  	8685955
	27. Ichikawa, T., M. Kawai, A. Uenaka, H. Yamamoto, M. Gotoh, M. Monden,  T. Mori, H. Shiku, and E. Nakayama. 1989. The role of CD81 and CD41 cells  in rejection of multiple minor H-disparate skin grafts. Transplantation 47:909.  	2497573
	28. Qin, S., M. Wise, S. P. Cobbold, L. Leong, Y.-C. M. Kong, J. R. Parnes, and  H. Waldmann. 1990. Induction of tolerance in peripheral T cells with monoclonal  antibodies. Eur. J. Immunol. 20:2737.  	1702726
	29. Cobbold, S. P., A. Jayasuriya, A. Nash, T. D. Prospero, and H. Waldmann. 1984.  Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo.  Nature 312:548.  	6150440
	30. Tannenbaum, C. S., R. Tubbs, D. Armstrong, J. H. Finke, R. M. Bukowski, and  T. A. Hamilton. 1998. The CXC chemokines IP-10 and Mig are necessary for  IL-12 mediated regression of the mouse RENCA tumor. J. Immunol. 161:927.  	9670971
	31. Billingham, R. E., and P. B. Medawar. 1951. The technique of free skin grafting  in mammals. J. Exp. Biol. 28:385.  	NO_MATCH
	32. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979.  Isolation of biologically active ribonucleic acid from sources enriched in ribo nucleases. Biochemistry 18:5294.  	518835
	33. Fort, P., L. Marty, M. Piechaczyk, S. El Sabrouty, C. Dani, P. Jeanteur, and  J. M. Blanchard. 1985. Various rat adult tissues express only one major mRNA  species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family.  Nucleic Acids Res. 13:1431.  	2987824
	34. DiPietro, L. A., M. D. Burdick, Q. E. Low, S. L. Kunkel, and R. M. Strieter. 1998.  MIP-1a as a critical macrophage chemoattractant in murine wound repair.  J. Clin. Invest. 101:1693.  	9541500
	35. Englehardt, E., A. Toksoy, M. Goebeler, S. Debus, E.-B. Brocker, and  R. Gillitzer. 1998. Chemokines IL-8, GROa, MCP-1, IP-10, and Mig are sequen tially and differentially expressed during phase-specific infiltration of leukocyte  subsets in human wound healing. Am. J. Pathol. 153:1849.  	9846975
	36. Kondo, T., K. Morita, Y. Watarai, M. B. Auerbach, D. D. Taub, A. C. Novick,  H. Toma, and R. L. Fairchild. 2000. Early increased chemokine expression and  production in murine allogeneic skin grafts is mediated by natural killer cells.  Transplantation 69:969.  	10755559
	37. Hoglund, P., J. Sundback, M. Y. Olsson-Alheim, M. Johansson, M. Salcedo,  C. Ohlen, H.-G. Ljunggren, C. L. Sentman, and K. Karre. 1997. Host MHC class  I gene control of NK-cell specificity in the mouse. Immunol. Rev. 155:11.  	9059879
	38. Koga, S., H. Toma, A. C. Novick, and R. L. Fairchild. 1999. CD81 T cells  produce RANTES during acute rejection of murine allogeneic skin grafts. Trans plantation 67:854.  	10199734
	39. Farber, J. M. 1997. Mig and IP-10: CXC chemokines that target lymphocytes.  J. Leukocyte Biol. 61:246.  	9060447
	40. Borson, N. D., M. A. Strausbauch, R. B. Kennedy, R. P. Oda, J. P. Landers, and  P. J. Wettstein. 1999. Temporal sequence of transcription of perforin, Fas ligand,  and tumor necrosis factor-a genes in rejecting skin allografts. Transplantation  67:672.  	10096521
	41. Koga, S., M. D. Auerbach, T. M. Engeman, A. C. Novick, H. Toma, and  R. L. Fairchild. 1999. T cell infiltration into class II MHC-disparate allografts and  acute rejection is dependent on the IFN-g-induced chemokine Mig. J. Immunol.  163:4878.  	10528189
	42. Kapoor, A., K. Morita, T. M. Engeman, S. Koga, E. M. Vapnek, M. G. Hobart,  and R. L. Fairchild. 2000. Early expression of interferon-g inducible protein 10  and monokine induced by interferon-g in cardiac allografts is mediated by CD81  T cells. Transplantation 69:1147.  	10762220
	43. Shanley, T. P., H. Schmal, H. P. Friedl, M. L. Jones, and P. A. Ward. 1995. Role  of macrophage inflammatory protein-1a (MIP-1a) in acute lung injury in rats.  J. Immunol. 154:4793.  	7722328
	44. Smith, R. E., R. M. Strieter, S. H. Phan, N. W. Lukacs, G. B. Huffnagle,  C. A. Wilke, M. D. Burdick, P. Lincoln, H. Evanhoff, and S. L. Kunkel. 1994.  Production and function of murine macrophage inflammatory protein-1a in bleo mycin-induced lung injury. J. Immunol. 153:4704.  	7525712
	45. Karpus, W. J., N. W. Lukas, B. L. McRae, R. M. Strieter, S. L. Kunkel, and  S. D. Miller. 1995. An important role for the chemokine macrophage inflamma tory protein-1a in the pathogenesis of the T cell-mediated autoimmune disease,  experimental autoimmune encephalomyelitis. J. Immunol. 155:5003.  	7594507
	46. Huffnagle, G. B., R. M. Strieter, T. J. Standiford, R. A. McDonald,  M. D. Burdick, S. L. Kunkel, and G. B. Toews. 1995. The role of monocyte  chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD41 T  cells during a pulmonary Cryptococcus neoformans infection. J. Immunol. 155:  4790.  	7594481
	47. Gong, J.-H., L. G. Ratkay, J. D. Waterfield, and I. Clark-Lewis. 1997. An an tagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the  MRL-lpr mouse model. J. Exp. Med. 186:131.  	9207007
	48. Lloyd, C. M., A. W. Minto, M. E. Dorf, A. Proudfoot, T. N. C. Wells,  D. J. Salant, and J.-C. Gutierrez-Ramos. 1997. RANTES and monocyte chemoat tractant protein-1 (MCP-1) play an important role in the inflammatory phase of  crescentic nephritis, but only MCP-1 is involved in crescent formation and in terstitial fibrosis. J. Exp. Med. 185:1371.  	9104823
	49. Sechler, J. M. G., J. C. Yip, and A. S. Rosenberg. 1997. Genetic variation among  129 substrains: practical consequences. J. Immunol. 159:5766.  	9550369
	50. Konieczny, B. T., Z. Dai, E. T. Elwood, S. Saleem, P. S. Linsley, F. K. Baddoura,  C. P. Larsen, T. C. Pearson, and F. G. Lakkis. 1998. IFN-g is critical for long term allograft survival induced by blocking the CD28 and CD40 ligand T cell  costimulation pathways. J. Immunol. 160:2059.  	9498741
1049.pdf
	1. Kalender WA, Sissler W, Klotz E, Vock P. Spiral  volumetric CT with single-breath-hold technique,  continuous transport, and continuous scanner ro tation.  Radiology 1990 ;176:181–183  	2353088
	2. Crawford CR, King K. Computed tomography  scanning with simultaneous patient translation.  Med Phys  1990 ;17:967–982  	2280740
	3. Remy-Jardin M, Remy J, Giraud F, Marquette  CH. Pulmonary nodules: detection with thick section spiral CT versus conventional CT.  Radiol ogy 1993 ;187:513–520  	8475300
	4. Buckley JA, Scott WW, Siegelman SS, et al. Pul monary nodules: effect of increased data sam pling on detection with spiral CT and confidence  in diagnosis.  Radiology 1995 ;196:395–400  	7617851
	5. Costello P. Thoracic helical CT.  RadioGraphics  1994 ;14:913–918   	7938778
	6. Costello P, Dupuy DE, Ecker CP, Tello R. Spiral CT  of the thorax with reduced volume of contrast  material: a comparative study.  Radiology 1992 ;183:  663–666  	1584915
	7. Cascade PN, Gross BH, Kazerooni EA, et al.  Variability in the detection of enlarged mediasti nal lymph nodes in staging lung cancer: a com parison of contrast-enhanced and unenhanced CT.  AJR 1998 ;170:927–931  	9530036
	8. Hopper KD. With helical CT, is nonionic contrast  a better choice than ionic contrast for rapid and  large IV bolus injections (answer to question)?  AJR 1996 ;166:715  	8623657
	9. Debatin J, Cohan RH, Leder RA, Zakrzewski CB,  Dunnick NR. Selective use of low-osmolar con trast media.  Invest Radiol  1991 ;26:17–21  	2022448
	10. Cohan RH, Dunnick NR, Leder RA, et al. Extrava sation of nonionic contrast media: efficacy of con servative treatment.  Radiology 1990 ;176:65–67  	2353113
	11. Hopper KD, Mosher TJ, Kasales CJ, TenHave TR,  Tully DA, Weaver JS. Thoracic spiral CT: delivery  of contrast material pushed with injectable saline so lution in a power injector.  Radiology 1997 ;205:  269–271  	9314997
	12. Rubin GD, Lane MJ, Bloch DA, Leung AN, Stark  P. Optimization of thoracic spiral CT: effects of  iodinated contrast medium concentration.  Radiol ogy 1996 ;201:785–791  	8939232
1033.pdf
	1. Shuman WP, Moss AA. The adrenal glands. In:  Moss AA, Gamsu G, Genant HK, eds.  Computed  tomography of the body , 2nd ed. Philadelphia:  Saunders,  1992 :1045–1056  	NO_MATCH
	2. Oliver TW Jr, Bernardino ME, Miller JI, Mansour  K, Greene D, Davis WA. Isolated adrenal masses  in nonsmall-cell bronchogenic carcinoma.  Radiol ogy 1984 ;153:217–218  	6473783
	3. Welch TJ, Sheedy PF II, Stephens DH, Johnson  CM, Swenson SJ. Percutaneous adrenal biopsy: re view of 10-year experience.  Radiology 1994 ;193:  341–344  	7972740
	4. Mody MK, Kazerooni EA, Korobkin M. Percuta neous CT-guided biopsy of adrenal masses: imme diate and delayed complications.  J Comput Assist  Tomogr  1995 ;19:434–439  	7790554
	5. Lee MJ, Hahn PF, Papanicolaou N, et al. Benign  and malignant adrenal masses: CT distinction with  attenuation coefficients, size, and observer analy sis.  Radiology 1991 ;179:415–418   	2014283
	6. van Erkel AR, van Gils APG, Lequin M, Kruit wagen C, Bloem JL, Falke THM. CT and MR dis tinction of adenomas and nonadenomas of the  adrenal glands.  J Comput Assist Tomogr  	8188912
	7. Singer AA, Obuchowski NA, Einstein DM, Paush ter DM. Metastasis or adenoma? Computed tomo graphic evaluation of the adrenal mass. J Med 1994 ;61:200–205 	8026063
	8. Korobkin M, Brodeur FJ, Yutzy GG, et al. Differen tiation of adrenal adenomas from nonadenomas us ing CT attenuation values.  AJR 1996 ;166:531–536   	8623622
	9. Mitchell DG, Crovello M, Matteucci T, Petersen  RO, Miettinen MM. Benign adrenocortical  masses: diagnosis with chemical shift MR imag ing.  Radiology 1992 ;185:345–351  	1410337
	10. Tsushima Y, Ishizaka H, Matsumoto M. Adrenal  masses: differentiation with chemical shift, fast  low-angle shot MR imaging.  Radiology  	8430178
	11. Mayo-Smith WW, Lee MJ, McNicholas MM,  Hahn PF, Boland GW, Saini S. Characterization of  adrenal masses (<5 cm) by use of chemical shift  MR imaging: observer performance versus quanti tative measures.  AJR 1995 ;165:91–95  	7785642
	12. Korobkin M, Lombardi TJ, Aisen AM, et al. Char acterization of adrenal masses with chemical shift  and gadolinium-enhanced MR imaging. 1995 ;197:411–418 	7480685
	13. McNicholas MMJ, Lee MJ, Mayo-Smith WW,  Hahn PF, Boland GW, Mueller PR. An imaging al gorithm for the differential diagnosis of adrenal ad enomas and metastases.  AJR 1995 ;165:1453–1459  	7484585
	14. Schwartz LH, Panicek DM, Doyle MV, et al. Com parison of two algorithms and their associated  charges when evaluating adrenal masses in patients  with malignancies.  AJR 1997 ;168:1575–1578  	9168729
	15. Dwamena BA, Kloos RT, Fendrick AM, et al. Di agnostic evaluation of the adrenal incidentaloma:  decision and cost-effectiveness analyses. 1998 ;39:707–712  	9544685
	16. Smith TJ, Hillner BE, Neighbors DM, McSorley  PA, Le Chevalier T. Economic evaluation of a ran domized clinical trial comparing vinorelbine, vi norelbine plus cisplatin, and vindesine plus  cisplatin for non-small-cell lung cancer. col 1995 ;13:2166–2173  	7666075
	17. Sandler MA, Pearlberg JL, Madrazo BL, Gitschlag  KF, Gross SC. Computed tomographic evaluation  of the adrenal gland in the preoperative assessment  of bronchogenic carcinoma.  Radiology  	7146405
	18. Pagani JJ. Non-small cell lung carcinoma adrenal  metastases: computed tomography and percutane ous needle biopsy in their diagnosis.  Cancer 53:1058–60  	6692299
	19. Salvatierra A, Baamonde C, Llamas JM, Cruz F,  Lopez-Pujol J. Extrathoracic staging of bron chogenic carcinoma.  Chest 1990 ;97:1052–1058  	2184992
	20. Silverman SG, Mueller PR, Pinkney LP, Koenker  RM, Seltzer SE. Predictive value of image-guided  adrenal biopsy: analysis of results of 101 biopsies.  Radiology 1993 ;187:715–718  	8497619
	21. Malenka DJ, Colice GL, Jacobs C, Beck JR. Medi astinal staging in non-small-cell lung cancer.  Med  Decis Making 1989 ;9:231–242  	NO_MATCH
	22. Damhuis RA, Schutte PR. Resection rates and  postoperative mortality in 7,899 patients with lung  cancer.  Euro Respir J  1996 ;9:7–10  	8834326
	23. Vrdoljak E, Mise K, Sapunar D, Rozga A, Marusic  M. Survival analysis of untreated patients with non small-cell lung cancer.  Chest 1994 ;106:1797–1800  	7988203
	24. Bunn PA Jr. The treatment of non-small cell lung can cer: current perspectives and controversies, future di rections.  Semin Oncol 1994 ;21[suppl 6]:49–59  	8052874
	25. Ginsberg RJ, Kris MG, Armstrong JG. Cancer of the  Lung. In: DeVita VT, Hellman S, Rosenberg SA,  eds.  Cancer: principles & practice of oncology , 4th  ed. Philadelphia: Lippincott,  1993 :673–712  	NO_MATCH
	26. Eisenberg JM. Clinical economics: a guide to the  economic analysis of clinical practices.  JAMA  1989 ;262:2879–2886  	2509745
	27. Smith TJ, Hillner BE, Desch CE. Efficacy and  cost-effectiveness in oncology: rational allocation  of cancer care resources.  J Natl Cancer Inst 1993  85:1460–1474  	NO_MATCH
	28. Outwater EK, Siegelman ES, Huang AB, Birn baum BA. Adrenal masses: correlation between  CT attenuation value and chemical shift ratio at  MR imaging with in-phase and opposed-phase se quences.  Radiology 1996 ;200:749–752  	8756926
	29. Korobkin M, Giordano TJ, Brodeur FJ, et al. Adre nal adenomas: relationship between histologic  lipid and CT and MR findings.  Radiology 1996  200:743–747  	8756925
	30. Ries LA. Influence of extent of disease, histology,  and demographic factors on lung cancer survival in  the SEER population-based data.  Semin Surg On col 1994 ;10:21–30  	8115783
	31. Jaakkimainen L, Goodwin PJ, Pater J, Warde P,  Murray N, Rapp E. Counting the costs of chemo therapy in a National Cancer Institute of Canada  randomized trial in nonsmall-cell lung cancer.  J  Clin Oncol 1990 ;8:1301–1309  	2166142
	32. Korobkin M, Brodeur FJ, Francis IR, Quint LE,  Dunnick NR, Goodsitt M. Delayed enhanced CT  for differentiation of benign from malignant adre nal masses.  Radiology 1996 ;200:737–742   	8756924
	33. Boland GW, Hahn PF, Pena C, Mueller PR. Adre nal masses: characterization with delayed contrast enhanced CT.  Radiology 1997 ;202:693–696  	9051018
	34. Boland GW, Goldberg MA, Lee MJ, et al. Indeter minate adrenal mass in patients with cancer:  evaluation at PET with 2-[F-18]-fluoro-2-deoxy D-glucose.  Radiology 1995 ;194:131–134  	7997539
	35. Erasmus JJ, Patz EF Jr, McAdams HP, et al. Evalua tion of adrenal masses in patients with bronchogenic  carcinoma using 18F-fluorodeoxyglucose positron  emission tomography.  AJR 1997 ;168:1357–1360  	9129444
	36. Tengs TO, Adams ME, Pliskin JS, et al. Five-hun dred life-saving interventions and their cost-effec tiveness.  Risk Anal 1995 ;15:369–390  	7604170
1009.pdf
	1. Puri P, Blake N, O’Donnell B, Guiney EJ. De layed primary anastomosis following spontane ous growth of esophageal segments in esophageal  atresia.  J Pediatr Surg 1981 ;16:180–183  	7241321
	2. Tam PKH, Chan FL, Saing H. Diagnosis and  evaluation of esophageal atresia by direct sagittal  CT.  Pediatr Radiol 1987 ;17:68–70  	3822585
	3. Tam PKH, Chan FL, Saing H. Direct sagittal CT  scan: a new diagnostic approach for surgical neo nates.  J Pediatr Surg 1987 ;22:397–400  	3585662
	4. Higgins WE, Ramaswamy K, Swift RD, McLen nan G, Hoffman EA. Virtual bronchoscopy for  three-dimensional pulmonary image assessment:  state of the art and future needs.  RadioGraphics  1998 ;18:761–778  	9599397
	5. Ferretti GR, Vining DJ, Knoplioch J, Coulomb  M. Tracheobronchial tree: three-dimensional spi ral CT with bronchoscopic perspective.  J Comput  Assist Tomogr 1996 ;20:777–781  	8797912
	6. Summers RM, Shaw DJ, Shelhamer JH. CT virtual  bronchoscopy of simulated endobronchial lesions:  effect of scanning, reconstruction, and display set tings and potential pitfalls.  AJR 1998 ;170:947–950  	9530041
	7. Konen E, Katz M, Rozenman J, Ben-Shlush A,  Itzchak Y, Szeinberg A. Virtual bronchoscopy in  children: early clinical experience.  AJR 1998  171:1699–1702  	9843316
Cancer Res-2000-Paige-1690-7.pdf
	1. Lisitsyn, N., Lisitsyn, N., and Wigler, M. Cloning the differences between two  complex genomes. Science (Washington DC), 259: 946–951, 1993.  	8438152
	2. Friend, S., Bernards, R., Roggel, J., Weinberg, R., Rapaport, J., Albert, D., and Dryja,  T. A human DNA segment with properties of the gene that predisposes to retino blastoma and osteosarcoma. Nature (Lond.), 323: 643–646, 1986.  	2877398
	3. Call, K. M., Glaser, T., Ito, C. Y., Buckler, A. J., Pelletier, J., Haber, D. A., Rose,  E. A., Kral, A., Yeger, H., and Lewis, W. H. Isolation and characterization of a zinc  finger polypeptide gene at the human chromosome 11 Wilms’ tumor locus. Cell, 60:  509–520, 1990.  	2154335
	4. Schutte, M., da-Costa, L. T., Hahn, S. A., Moskaluk, C., Hoque, A. T., Rozenblum,  E., Weinstein, C. L., Bittner, M., Meltzer, P. S., Trent, J. M., Yeo, C. J., Hruban,  R. H., and Kern, S. E. Identification by representational difference analysis of a  homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region.  Proc. Natl. Acad. Sci. USA, 92: 5950–5954, 1995.  	7597059
	5. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V.,  Stockert, E., Day, R. R., Johnson, B. E., and Skolnick, M. H. A cell cycle regulator  potentially involved in genesis of many tumor types. Science (Washington DC), 264:  436–440, 1994.  	8153634
	6. Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili,  Z., Mori, M., McCue, P., Druck, T., Croce, C. M., and Huebner, K. The FHIT gene,  spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8)  breakpoint, is abnormal in digestive tract cancers. Cell, 84: 587–597, 1996.  	8598045
	7. Hannon, G. J., and Beach, D. p15INK4B is a potential effector of TGF-b-induced cell  cycle arrest. Nature (Lond.), 371: 257–261, 1994.  	8078588
	8. Quelle, D. E., Zindy, F., Ashmun, R. A., and Sherr, C. J. Alternative reading frames  of the INK4a tumor suppressor gene encode two unrelated proteins capable of  inducing cell cycle arrest. Cell, 83: 993–1000, 1995.  	8521522
	9. Watson, J. E. V., Gabra, H., Taylor, K. J., Rabiasz, G. J., Morrison, H., Perry, P.,  Smyth, J. F., and Porteous, D. J. Identification and characterization of a homozygous  deletion found in ovarian ascites by representational difference analysis. Genome  Res., 9: 226–233, 1999.  	10077528
	10. Li, C., Berx, G., Larsson, C., Auer, G., Aspenblad, U., Pan, Y., Sundelin, B., Ekman,  P., Nordenskjold, M., van Roy, F., and Bergerheim, U. S. R. Distinct deleted regions  on chromosome segment 16q23–24 associated with metastases in prostate cancer.  Genes Chromosomes Cancer, 24: 175–182, 1999.  	10451696
	11. Latil, A., Cussenot, O., Fournier, G., Driouch, K., and Lidereau, R. Loss of heterozy gosity at chromosome 16q in prostate adenocarcinoma: identification of three inde pendent regions. Cancer Res., 57: 1058–1062, 1997.  	9067271
	12. Driouch, K., Dorion-Bonnet, F., Briffod, M., Champeme, M. H., Longy, M., and  Lidereau, R. Loss of heterozygosity on chromosome arm 16q in breast cancer  metastases. Genes Chromosomes Cancer, 19: 185–191, 1997.  	9219000
	13. Iida, A., Isobe, R., Yoshimoto, M., Kasumi, F., Nakamura, Y., and Emi, M. Local ization of a breast cancer tumour-suppressor gene to a 3-cM interval within chromo somal region 16q22. Br. J. Cancer, 75: 264–267, 1997.  	9010036
	14. Chen, T., Sahin, A., and Aldaz, C. M. Deletion map of chromosome 16q in ductal  carcinoma in situ of the breast: refining a putative tumor suppressor gene region.  Cancer Res., 56: 5605–5609, 1996.  	8971163
	15. Roylance, R., Gorman, P., Harris, W., Liebmann, R., Barnes, D., Hanby, A., and  Sheer, D. Comparative genomic hybridization of breast tumors stratified by histo logical grade reveals new insights into the biological progression of breast cancer.  Cancer Res., 59: 1433–1436, 1999.  	10197608
	16. Chou, Y-H., Chung, K-C., Jeng, L-B., Chen, T-C, and Liaw, Y-F. Frequent allelic  loss on chromosomes 4q and 16q associated with human hepatocellular carcinoma in  Taiwan. Cancer Lett., 123: 1–6, 1998.  	9461010
	17. Iwabuchi, H., Sakamoto, M., Sakunaga, H., Ma, Y. Y., Carcangiu, M. L., Pinkel, D.,  Yang-Feng, T. L., and Gray, J. W. Genetic analysis of benign, low-grade, and  high-grade ovarian tumors. Cancer Res., 55: 6172–6180, 1995.  	8521410
	18. Doggett, N. A., Breuning, M. H., and Callen, D. F. Report of the fourth international  workshop on human chromosome 16 mapping 1995. Cytogenet. Cell Genet., 72:  271–293, 1996.  	8641131
	19. Smith, D. I., Huang, H., and Wang, L. Common fragile sites and cancer. Int. J. Oncol.,  12: 187–196, 1998.  	NO_MATCH
	20. Lisitsyn, N. A., Lisitsina, N. M., Dalbagni, G., Barker, P., Sanchez, C. A., Gnarra, J.,  Linehan, W. M., Reid, B. J., and Wigler, M. H. Comparative genomic analysis of  tumors: detection of DNA losses and amplification. Proc. Natl. Acad. Sci. USA, 92:  151–155, 1995.  	7816807
	21. Wolf, C., Hayward, I., Lawrie, S., Buckton, K., McIntyre, M., Adams, D., Lewis, A.,  Scott, A., and Smyth, J. Cellular heterogeneity and drug resistance in two ovarian  adenocarcinoma cell lines derived from a single patient. Int. J. Cancer, 39: 695–702,  1987.  	3583449
	22. Hay, F. G., Duncan, L. W., and Leonard, R. C. F. Establishment and characterisation  of two new small cell lung cancer cell lines–one from a patient with previous familial  retinoblastoma. Br. J. Cancer, 63: 43–45, 1991.  	1645570
	23. Brattain, M. G., Fine, W. D., Khaled, F. M., Thompson, J., and Brattain, D. E.  Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res., 41:  1751–1756, 1981.  	7214343
	24. Boyd, A. C. Turbo cloning: a fast, efficient method for cloning PCR products and  other blunt-ended DNA fragments into plasmids. Nucleic Acids Res., 21: 817–821,  1993.  	8451184
	25. Doggett, N. A., Goodwin, L. A., Tesmer, J. G., Meincke, L. J., Bruce, D. C., Clark,  L. M., Altherr, M. R., Ford, A. A., Chi, H. C., Marrone, B. L., Longmire, J. L., Lane,  S. A., Whitmore, S. A., Lowenstein, M. G., Sutherland, R. D., Mundt, M. O., Knill,  E. H., Bruno, W. J., Macken, C. A., Torney, D. C., Wu, J-R., Griffith, J., Sutherland,  G. R., Deaven, L. L., Callen, D. F., and Moyzis, R. K. An integrated physical map of  human chromosome 16. Nature (Lond.), 377: 335–365, 1995.  	7566100
	26. Chumakov, I., Rigault, P., Guillou, S., Ougen, P., Billaut, A., Guasconi, G., Gervy, P.,  LeGall, I., Soularue, P., and Grinas, L. Continuum of overlapping clones spanning the  entire human chromosome 21q. Nature (Lond.), 359: 380–387, 1992.  	1406950
	27. Wu, C., Zhu, S., Simpson, S., and de Jong, P. J. DOP-vector PCR: a method for rapid  isolation and sequencing of insert termini from PAC clones. Nucleic Acids Res., 24:  2614–2615, 1996.  	8692704
	28. Church, D. M., Stotler, C. J., Rutter, J. L., Murrell, J. R., Trofatter, J. A., and Buckler,  A. J. Isolation of genes from complex sources of mammalian genomic DNA using  exon amplification. Nat. Genet., 6: 98–105, 1994.  	8136842
	29. Nelson, D. L., Ledbetter, S. A., Corbo, L., Victoria, M. F., Ramirez-Solis, R.,  Webster, T. D., Ledbetter, D. H., and Caskey, C. T. Alu polymerase chain reaction:  a method for rapid isolation of human-specific sequences from complex DNA  sources. Proc. Natl. Acad. Sci. USA, 86: 6686–6690, 1989.  	2771952
	30. Staden, R. The Staden sequence analysis package. Mol. Biotechnol., 5: 233–241,  1996.  	8837029
	31. Glover, T. W., Berger, C., Coyle, J., and Echo, B. DNA polymerase a inhibition by  aphidicolin induces gaps and breaks at common fragile sites in human chromosomes.  Hum. Genet., 67: 136–142, 1984.  	6430783
	32. Lichter, P., and Cremer, T. Chromosome analysis by non-isotopic in situ hybridiza tion. In: D. E. Rooney and B. H. Czepulkowski (eds.), Human Cytogenetics: A  Practical Approach, Ed. 1, Vol. 1, pp. 157–192. Oxford, United Kingdom: Oxford  University Press, 1992.  	NO_MATCH
	33. Suzuki, S., Sano, K., and Tanihara, H. Diversity of the cadherin family: evidence for  eight new cadherins in nervous tissue. Cell Regul., 2: 261–270, 1991.  	2059658
	34. Bussemakers, M. J., van Bokhoven, A., Mees, S. G., Kemler, R., and Schalken, J. A.  Molecular cloning and characterization of the human E-cadherin cDNA. Mol. Biol.  Rep., 17: 123–128, 1993.  	8459805
	35. Kastury, K., Baffa, R., Druck, T., Ohta, M., Cotticelli, M. G., Inoue, H., Negrini, M.,  Rugge, M., Huang, D., Croce, C. M., Palazzo, J., and Huebner, K. Potential gastro intestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous  deletions in tumor cell lines. Cancer Res., 56: 978–983, 1996.  	8640789
	36. Mangelsdorf, M., Ried, K., Woollatt, E., Dayan, S., Eyre, H., Finnis, M., Hobson, L.,  Nancarrow, J., Venter, D., Baker, E., and Richards, R. I. Chromosomal fragile site  FRA16D and DNA instability in cancer. Cancer Res., 60: 1683–1689, 2000.  	10749140
	37. Bednarek, A. K., and Aldaz, C. M. Characterization of transcripts from a commonly  deleted area of chromosome 16 (q23.3–q24.1). Proc. Am. Assoc. Cancer Res., 39:  128, 1998.  	NO_MATCH
	38. Becker-Follmann, J., Gaa, A., Bausch, E., Natt, E., Scherer, G., and von Deimling, O.  High-resolution mapping of a linkage group on mouse chromosome 8 conserved on  human chromosome 16Q. Mamm. Genome, 8: 172–177, 1997.  	9069116
	39. Yoshida, M. C., Nishizawa, M., Kataoka, K., Goto, N., Fujiwara, K. T., and Kawai,  S. Localization of the human MAF protooncogene on chromosome 16 to bands  q22–q23. Cytogenet. Cell Genet., 58: 2003, 1991.  	NO_MATCH
	40. Mourelatos, Z., Gonatas, J. O., Cinato, E., and Gonatas, N. K. Cloning and sequence  analysis of the human MG160, a fibroblast growth factor and E-selectin binding  membrane sialoglycoprotein of the Golgi apparatus. DNA Cell Biol., 15: 1121–1128,  1996.  	8985126
	41. Peyrard, M., Parveneh, S., Lagercrantz, S., Ekman, M., Fransson, I., Sahlen, S., and  Dumanski, J. P. Cloning, expression pattern, and chromosomal assignment to 16q23  of the human g-adaptin gene (ADTG). Genomics, 50: 275–280, 1998.  	9653655
	42. Nomura, N., Nagase, T., Miyajima, N., Sazuka, T., Tanaka, A., Sato, S., Seki, N.,  Kawarabayasi, Y., Ishikawa, K., and Tabata, S. Prediction of the coding sequences of  unidentified human genes. II. The coding sequences of 40 new genes (KIAA0041–  KIAA0080) deduced by analysis of cDNA clones from human cell line KG-1. DNA  Res., 1: 223–229, 1994.  	7584044
	43. Pan, M. G., Xiong, J., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., and Goeddel,  D. V. Sequence, genomic organization, and chromosome localization of the mouse  TRADD gene. J. Inflamm., 46: 168–175, 1995.  	NO_MATCH
	44. Kremmidiotis, G., Baker, E., Crawford, J., Eyre, H. J., Nahmias, J., and Callen, D. F.  Localization of human cadherin genes to chromosome regions exhibiting cancer related loss of heterozygosity. Genomics, 49: 467–471, 1998.  	9615235
	45. Berx, G., Cleton-Jansen, A. M., Nollet, F., de Leeuw, W. J., van de Vijver, M.,  Cornelisse, C., and van Roy, F. E-cadherin is a tumour/invasion suppressor gene  mutated in human lobular breast cancers. EMBO J., 14: 6107–6115, 1995.  	8557030
	46. Yunis, J. J., Soreng, A. L., and Bowe, A. E. Fragile sites are targets of diverse  mutagens and carcinogens. Oncogene, 1: 59–69, 1987.  	3438083
	47. Chesi, M., Bergsagel, P. L., Shonukan, O. O., Martelli, M. L., Brents, L. A., Chen, T.,  Schrock, E., Ried, T., and Kuehl, W. M. Frequent dysregulation of the c-maf  proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma. Blood,  91: 4457–4463, 1998.  	9616139
	48. Boldog, F., Gemmill, R. M., West, J., Robinson, M., Robinson, L., Li, E., Roche, J.,  Todd, S., Waggoner, B., Lundstrom, R., Jacobson, J., Mullokandov, M. R., Klinger,  H., and Drabkin, H. A. Chromosome 3p14 homozygous deletions and sequence  analysis of FRA3B. Hum. Mol. Genet., 6: 193–203, 1997.  	9063739
	49. Mimori, K., Druck, T., Inoue, H., Alder, H., Berk, L., Mori, M., Huebner, K., and  Croce, C. M. Cancer-specific chromosome alterations in the constitutive fragile  region FRA3B. Proc. Natl. Acad. Sci. USA, 96: 7456–7461, 1999.  	10377436
	50. Huang, H., Qian, J., Proffit, J., Wilber, K., Jenkins, R., and Smith, D. I. FRA7G  extends over a broad region: coincidence of human endogenous retroviral sequences  (HERV-H) and small polydispersed circular DNAs (spcDNA) and fragile sites.  Oncogene, 16: 2311–2319, 1998.  	9620548
	51. Mishmar, D., Rahat, A., Scherer, S. W., Nyakatura, G., Hinzmann, B., Kohwi, Y.,  Mandel-Gutfroind, Y., Lee, J. R., Drescher, B., Sas, D. E., Margalit, H., Platzer, M.,  Weiss, A., Tsui, L. C., Rosenthal, A., and Kerem, B. Molecular characterization of a  common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian  virus 40 integration site. Proc. Natl. Acad. Sci. USA, 95: 8141–8146, 1998.  	9653154
	52. Wang, L., Darling, J., Zhang, J. S., Huang, H., Liu, W., and Smith, D. I. Allele specific late replication and fragility of the most active common fragile site, FRA3B.  Hum. Mol. Genet., 8: 431–437, 1999.  	9949202
	53. Le Beau, M. M., Rassool, F. V., Neilly, M. E., Espinosa, R., III, Glover, T. W., Smith,  D. I., and McKeithan, T. W. Replication of a common fragile site, FRA3B, occurs late  in S phase and is delayed further upon induction: implications for the mechanism of  fragile site induction. Hum. Mol. Genet., 7: 755–761, 1998.  	9499431
	54. Lengauer, C., Kinzler, K. W., and Vogelstein, B. Genetic instabilities in human  cancers. Nature (Lond.), 396: 643–649, 1998.  	9872311
	55. Lengauer, C., Kinzler, K. W., and Vogelstein, B. Genetic instability in colorectal  cancers. Nature (Lond.), 386: 623–627, 1997.  	9121588
Cancer Res-2000-Boucher-1631-6.pdf
	1. Moolten, F. L. Drug sensitivity (“suicide”) genes for selective cancer chemotherapy.  Cancer Gene Ther., 1: 279–287, 1994.  	7543006
	2. Bridgewater, J. A., Springer, C. J., Knox, R. J., Minton, N. P., Michael, N. P., and  Collins, M. K. Expression of the bacterial nitroreductase enzyme in mammalian cells  renders them selectively sensitive to killing by the prodrug CB1954. Eur. J. Cancer,  31A: 2362–2370, 1995.  	NO_MATCH
	3. Mullen, C. A., Kilstrup, M., and Blaese, R. M. Transfer of the bacterial gene for  cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine:  a negative selection system. Proc. Natl. Acad. Sci. USA, 89: 33–37, 1992.  	1729703
	4. Moolten, F. L. Tumor chemosensitivity conferred by inserted herpes thymidine kinase  genes: paradigm for a prospective cancer control strategy. Cancer Res., 46: 5276–  5281, 1986.  	3019523
	5. Balzarini, J., Bohman, C., and DeClercq, E. Differential metabolism of cytostatic of  (E)-5-(2-bromovinyl)-29-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine,  and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene  of herpes simplex virus type 1 or type 2. J. Biol. Chem., 269: 6332–6337, 1993.  	8384209
	6. Ilsley, D. D., Lee, S-H., Miller, W. H., and Kuchta, R. D. Acyclic guanosine analogs  inhibit DNA polymerases a, d, and Iˆ with very different potencies and have unique  mechanisms of action. Biochemistry, 34: 2504–2510, 1995.  	7873530
	7. Freeman, S. M., Abboud, C. N., Whartenby, K. A., Packman, C. H., Koeplin, D. S.,  Moolten, F. L., and Abraham, G. N. The “bystander effect”: tumor regression when  a fraction of the tumor mass is genetically modified. Cancer Res., 53: 5274–5283,  1993.  	8221662
	8. DiMaio, J. M., Clary, B. M., Via, D. F., Coveney, E., Pappas, T. N., and Lyerly, H. K.  Directed enzyme pro-drug gene therapy for pancreatic cancer in vivo. Surgery, 116:  205–213, 1994.  	8047987
	9. Ezzeddine, Z. D., Martuza, R. L., Platika, D., Short, M. P., Malick, A., Choi, B., and  Breakefield, X. O. Selective killing of glioma cells in culture and in vivo by retrovirus  transfer of the herpes simplex virus thymidine kinase gene. New Biol., 3: 608–614,  1991.  	1655012
	10. Caruso, M., Panis, Y., Gagandeep, S., Houssin, D., Salzmann, J-L., and Klatzmann,  D. Regression of established macroscopic liver metastases after in situ transduction of  a suicide gene. Proc. Natl. Acad. Sci. USA, 90: 7024–7028, 1993.  	8346212
	11. Ram, Z., Culver, K. W., Walbridge, S., Blaese, R. M., and Oldfield, E. H. In situ  retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer  Res., 53: 83–88, 1993.  	8380127
	12. Vile, R. G., and Hart, I. R. Use of tissue-specific expression of the herpes simplex  virus thymidine kinase gene to inhibit growth of established murine melanomas  following direct intratumoral injection of DNA. Cancer Res., 53: 3860–3864, 1993.  	8395331
	13. Ido, A., Nakata, K., Kato, Y., Nakao, K., Murata, K., Fujita, M., Ishii, N., Tamaoki,  T., Shiku, H., and Nagataki, S. Gene therapy for hepatoma cells using a retrovirus  vector carrying herpes simplex virus thymidine kinase gene under the control of  human a-fetoprotein gene promoter. Cancer Res., 55: 3105–3109, 1995.  	7541712
	14. O’Malley, B. W., Jr., Chen, S-H., Schwartz, M. R., and Woo, S. L. C. Adenovirus mediated gene therapy for human head and neck squamous cell cancer in a nude  mouse model. Cancer Res., 55: 1080–1085, 1995.  	7866992
	15. Yoshida, K., Kawami, H., Yamaguchi, Y., Kuniyasu, H., Nishiyama, M., Hirai, T.,  Yanagihara, K., Tahara, E., and Toge, T. Retrovirally transmitted gene therapy for  gastric carcinoma using herpes simplex virus thymidine kinase gene. Cancer (Phila.),  75: 1467–1471, 1995.  	7889476
	16. Roth, J. A., and Cristiano, R. J. Gene therapy for cancer: what have we done and  where are we going? J. Natl. Cancer Inst., 89: 21–39, 1997.  	NO_MATCH
	17. Denning, C., and Pitts, J. D. Bystander effects of different enzyme-prodrug systems  for cancer gene therapy depend on different pathways for intercellular transfer of  toxic metabolites, a factor that will govern clinical choice of appropriate regimes.  Hum. Gene Ther., 8: 1825–1835, 1997.  	9358032
	18. Rubsam, L. Z., Boucher, P. D., Murphy, P. J., KuKuruga, M., and Shewach, D. S.  Cytotoxicity and accumulation of ganciclovir triphosphate in bystander cells cocul tured with herpes simplex virus type 1 thymidine kinase-expressing human glioblas toma cells. Cancer Res., 59: 669–675, 1999.  	9973216
	19. Bi, W. L., Parysek, L. M., Warnick, R., and Stambrook, P. J. In vitro evidence that  metabolic cooperation is responsible for the bystander effect observed with HSVtk  retroviral gene therapy. Hum. Gene Ther., 4: 725–731, 1993.  	8186287
	20. Boucher, P. D., Ruch, R. J., and Shewach, D. S. Differential ganciclovir-mediated  cytotoxicity and bystander killing in human colon carcinoma cell lines expressing  herpes simplex virus thymidine kinase. Hum. Gene Ther., 9: 801–814, 1998.  	9581903
	21. Machado, S. G., and Robinson, G. A. A direct, general approach based on isobolo grams for assessing the joint action of drugs in pre-clinical experiments. Stat. Med.,  13: 2289–2309, 1994.  	7855464
	22. Griffiths, G. M., Berek, C., Kaartinen, M., and Milstein, C. Somatic mutation and  maturation of immune response to 2-phenyl-oxazolone. Nature (Lond.), 312: 271–  275, 1984.  	6504141
	23. Hoogenboom, H. R., Griffiths, A. D., Johnson, K. S., Chriswell, D. J., Hudson, P., and  Winter, G. Multi-subunit proteins on the surface of filamentous phage: methodologies  for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res., 19:  4133–4137, 1991.  	1908075
	24. Coloma, M. J., Hastings, A., Wims, L. A., and Morrison, S. L. Novel vectors for the  expression of antibody molecules using variable regions generated by polymerase  chain reaction. J. Immunol. Methods, 152: 89–104, 1992.  	1640112
	25. Samejima, Y., and Meruelo, D. ‘Bystander killing’ induces apoptosis and is inhibited  by forskolin. Gene Ther., 2: 50–58, 1995.  	7712332
	26. Mesnil, M., Piccoli, C., Tiraby, G., Willecke, K., and Yamasaki, H. Bystander killing  of cancer cells by herpes simplex virus thymidine kinase gene is mediated by  connexins. Proc. Natl. Acad. Sci. USA, 93: 1831–1835, 1996.  	8700844
	27. Elshami, A. A., Saavedra, A., Zhang, H., Kucharczuk, J. C., Spray, D. C., Fishman,  G. I., Amin, K. M., Kaiser, L. R., and Albelda, S. M. Gap junctions play a role in the  “bystander effect” of the herpes simplex virus thymidine kinase/ganciclovir system in  vitro. Gene Ther., 3: 85–92, 1996.  	8929915
	28. Yeager, M., and Nicholson, B. J. Structure of gap junction intercellular channels.  Curr. Opin. Struct. Biol., 6: 183–192, 1996.  	8728651
	29. Fick, J., Barker, F. G. I., Dazin, P., Westphale, E. M., Beyer, E. C., and Israel, M. A.  The extent of heterocellular communication mediated by gap junctions is predictive  of bystander tumor cytotoxicity in vitro. Proc. Natl. Acad. Sci. USA, 92: 11071–  11075, 1995.  	7479939
	30. Yang, L., Chiang, Y., Lenz, H., Danenberg, K. D., Spears, C. P., Gordon, E. M.,  Anderson, W. F., and Parekh, D. Intercellular communication mediates the bystander  effect during herpes simplex thymidine kinase/ganciclovir-based gene therapy of  human gastrointestinal tumor cells. Hum. Gene Ther., 9: 719–728, 1998.  	9551619
	31. Rogulski, K. R., Kim, J. H., Kim, S. H., and Freytag, S. O. Glioma cells transduced  with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic  suicide and radiosensitivity. Hum. Gene Ther., 8: 73–85, 1997.  	8989997
	32. Aghi, M., Kramm, C. M., Chou, T., Breakefield, X. O., and Chiocca, E. A. Syner gistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cyto sine deaminase gene therapies. J. Natl. Cancer Inst., 90: 370–380, 1998.  	9498487
	33. Gwilt, P. R., and Tracewell, W. G. Pharmacokinetics and pharmacodynamics of  hydroxyurea. Clin. Pharmacokinet., 34: 347–358, 1998.  	9592619
	34. Donehower, R. C. Hydroxyurea. In: B. A. Chabner, and D. L. Longo (eds.), Cancer  Chemotherapy and Biotherapy, pp. 253–261. Philadelphia: Lippincott-Raven Pub lishers, 1996.  	NO_MATCH
	35. Bianchi, V., Pontis, E., and Reichard, P. Changes of deoxyribonucleoside triphos phate pools induced by hydroxyurea and their relation to DNA synthesis. J. Biol.  Chem., 261: 16037–16042, 1986.  	3536919
	36. Rubsam, L. Z., Davidson, B. L., and Shewach, D. S. Superior cytotoxicity with  ganciclovir compared with acyclovir and 1-b-D-arabinofuranosylthymine in herpes  simplex virus-thymidine kinase-expressing cells: a novel paradigm for cell killing.  Cancer Res., 58: 3873–3882, 1998.  	9731497
	37. Yoshioka, A., Tanaka, S., Osamu, H., Koyama, Y., Hirota, Y., Ayusawa, D., Seno, T.,  Garrett, C., and Wataya, Y. Deoxyribonucleoside triphosphate imbalance. J. Biol.  Chem., 262: 8235–8241, 1987.  	NO_MATCH
	38. Wadler, S., Horowitz, R., Zhang, H., and Schwartz, E. L. Effects of perturbations of  pools of deoxyribonucleoside triphosphates on expression of ribonucleotide reduc tase, a G1/S transition state enzyme, in p53-mutated cells. Biochem. Pharmacol., 55:  1353–1360, 1998.  	10076525
	39. Collins, A., and Oates, D. J. Hydroxyurea: effects on deoxyribonucleotide pool sizes  correlated with effects on DNA repair in mammalian cells. Eur. J. Biochem., 169:  299–305, 1987.  	3691495
992266.pdf
	1. Cotran, R.S. 1999. Inflammation: historical perspectives. In  Inflammation: Basic Principles and Clinical Correlates, 3rd  ed. J.I. Gallin, R. Snyderman, D.T. Fearon, B.F. Haynes,  and C. Nathan, editors. Lippincott Williams & Wilkins, Phil adelphia. 5–10.  	NO_MATCH
	2. Weissmann, G., J.E. Smolen, and H.M. Korchak. 1980. Re lease of inflammatory mediators from stimulated neutrophils.  N. Engl. J. Med. 303:27–34.  	6246431
	3. Samuelsson, B. 1982. From studies of biochemical mecha nisms to novel biological mediators: prostaglandin endoper oxides, thromboxanes and leukotrienes. In Les Prix Nobel:  Nobel Prizes, Presentations, Biographies and Lectures. T.  Frängsmyr, editor. Almqvist & Wiksell, Stockholm. 153–174.  	NO_MATCH
	4. Yokomizo, T., T. Izumi, K. Chang, Y. Takuwa, and T.  Shimizu. 1997. A G-protein-coupled receptor for leuko triene B4 that mediates chemotaxis. Nature. 387:620–624.  	9177352
	5. Perez, H.D. 1994. Chemoattractant receptors. Curr. Opin.  Hematol. 1:40–44.  	NO_MATCH
	6. Pillinger, M.H., and S.B. Abramson. 1995. The neutrophil  in rheumatoid arthritis. Rheum. Dis. Clin. North Am. 21:691–  714.  	8619095
	7. Serhan, C.N., J.Z. Haeggstrom, and C.C. Leslie. 1996. Lipid  mediator networks in cell signaling: update and impact of cy tokines. FASEB J. 10:1147–1158.  	8751717
	8. Diamond, P., A. McGinty, D. Sugrue, H.R. Brady, and C.  Godson. 1999. Regulation of leukocyte trafficking by li poxins. Clin. Chem. Lab. Med. 37:293–297.  	10353475
	9. Node, K., Y. Huo, X. Ruan, B. Yang, M. Spiecker, K. Ley,  D.C. Zeldin, and J.K. Liao. 1999. Anti-inflammatory prop erties of cytochrome P450 epoxygenase-derived eicosanoids.  Science. 285:1276–1279.  	10455056
	10. Munger, K.A., A. Montero, M. Fukunaga, S. Uda, T. Yura,  E. Imai, Y. Kaneda, J.M. Valdivielso, and K.F. Badr. 1999.  Transfection of rat kidney with human 15-lipoxygenase sup presses inflammation and preserves function in experimental  glomerulonephritis. Proc. Natl. Acad. Sci. USA. 96:13375–  13380.  	10557328
	11. Weissmann, G. 1991. Aspirin. Sci. Am. 264:84–90.  	NO_MATCH
	12. Marcus, A.J. 1995. Aspirin as prophylaxis against colorectal  cancer. N. Eng. J. Med. 333:656–658.  	7637730
	13. Takano, T., S. Fiore, J.F. Maddox, H.R. Brady, N.A. Peta sis, and C.N. Serhan. 1997. Aspirin-triggered 15-epi-lipoxin  A4 (LXA4) and LXA4 stable analogs are potent inhibitors of  acute inflammation: evidence for anti-inflammatory recep tors. J. Exp. Med. 185:1693–1704.  	9151906
	14. Clish, C.B., J.A. O’Brien, K. Gronert, G.L. Stahl, N.A. Peta sis, and C.N. Serhan. 1999. Local and systemic delivery of a  stable aspirin-triggered lipoxin prevents neutrophil recruit ment in vivo. Proc. Natl. Acad. Sci. USA. 96:8247–8252.  	10393980
	15. Chiang, N., K. Gronert, C.B. Clish, J.A. O’Brien, M.W.  Freeman, and C.N. Serhan. 1999. Leukotriene B4 receptor  transgenic mice reveal novel protective roles for lipoxins and  aspirin-triggered lipoxins in reperfusion. J. Clin. Invest. 104:  309–316.  	10430612
	16. Hachicha, M., M. Pouliot, N.A. Petasis, and C.N. Serhan.  1999. Lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4  inhibit tumor necrosis factor a–initiated neutrophil responses  and trafficking: regulators of a cytokine–chemokine axis. J.  Exp. Med. 189:1923–1929.  	10377187
	17. Fiore, S., J.F. Maddox, H.D. Perez, and C.N. Serhan. 1994.  Identification of a human cDNA encoding a functional high  affinity lipoxin A4 receptor. J. Exp. Med. 180:253–260.  	8006586
	18. Fiore, S., and C.N. Serhan. 1995. Lipoxin A4 receptor acti vation is distinct from that of the formyl peptide receptor in  myeloid cells: inhibition of CD11/18 expression by lipoxin  A4-lipoxin A4 receptor interaction. Biochemistry. 34:16678–  16686.  	8527441
	19. Quehenberger, O., E.R. Prossnitz, S.L. Cavanagh, C.G. Coch rane, and R.D. Ye. 1993. Multiple domains of the N-formyl  peptide receptor are required for high-affinity ligand binding.  Construction and analysis of chimeric N-formyl peptide re ceptors. J. Biol. Chem. 268:18167–18175.  	8349692
	20. Castano, A.R., S. Tangri, J.E. Miller, H.R. Holcombe,  M.R. Jackson, W.D. Huse, M. Kronenberg, and P.A. Peter son. 1995. Peptide binding and presentation by mouse CD1.  Science. 269:223–226.  	7542403
	21. Beckman, E.M., S.A. Porcelli, C.T. Morita, S.M. Behar,  S.T. Furlong, and M.B. Brenner. 1994. Recognition of a  lipid antigen by CD1-restricted ab1 T cells. Nature. 372:  691–694.  	7527500
	22. Brezinski, D.A., and C.N. Serhan. 1991. Characterization of  lipoxins by combined gas chromatography and electron-cap ture negative ion chemical ionization mass spectrometry: for mation of lipoxin A4 by stimulated human whole blood. Biol.  Mass Spectrom. 20:45–52.  	1883860
	23. Falk, W., R.H. Goodwin, and E. Leonard. 1980. A 48-well  microchemotaxis assembly for rapid and accurate measure ment of leukocyte migration. J. Immunol. Methods. 33:239–  247.  	6989919
	24. Gronert, K., S.P. Colgan, and C.N. Serhan. 1998. Charac terization of human neutrophil and endothelial cell ligand operated extracellular acidification rate by microphysiometry:  impact of reoxygenation. J. Pharmacol. Exp. Ther. 285:252–  261.  	9536019
	25. Wang, C.R., A.R. Castano, P.A. Peterson, C. Slaughter,  K.F. Lindahl, and J. Deisenhofer. 1995. Nonclassical binding  of formylated peptide in crystal structure of the MHC class Ib  molecule H2-M3. Cell. 82:655–664.  	7664344
	26. Shawar, S.M., R.R. Rich, and E.L. Becker. 1995. Peptides  from the amino-terminus of mouse mitochondrially encoded  NADH dehydrogenase subunit 1 are potent chemoattracta nts. Biochem. Biophys. Res. Commun. 211:812–818.  	7598710
	27. Serhan, C.N., J.F. Maddox, N.A. Petasis, I. Akritopoulou Zanze, A. Papayianni, H.R. Brady, S.P. Colgan, and J.L.  Madara. 1995. Design of lipoxin A4 stable analogs that block  transmigration and adhesion of human neutrophils. Biochem istry. 34:14609–14615.  	7578068
	28. Klein, C., J.I. Paul, K. Sauve, M.M. Schmidt, L. Arcangeli, J.  Ransom, J. Trueheart, J.P. Manfredi, J.R. Broach, and A.J.  Murphy. 1998. Identification of surrogate agonists for the  human FPRL-1 receptor by autocrine selection in yeast. Nat.  Biotechnol. 16:1334–1337.  	9853614
	29. Tessier, P.A., P.H. Naccache, I. Clark-Lewis, R.P. Gladue,  K.S. Neote, and S.R. McColl. 1997. Chemokine networks  in vivo: involvement of C-X-C and C-C chemokines in  neutrophil extravasation in vivo in response to TNF-a. J.  Immunology. 159:3595–3602.  	9317159
	30. Gabay, C., and I. Kushner. 1999. Acute-phase proteins and  other systemic responses to inflammation. N. Engl. J. Med.  340:448–454.  	9971870
	31. Su, S.B., W. Gong, J.L. Gao, W. Shen, P.M. Murphy, J.J.  Oppenheim, and J.M. Wang. 1999. A seven-transmembrane,  G protein–coupled receptor, FPRL1, mediates the chemo tactic activity of serum amyloid A for human phagocytic  cells. J. Exp. Med. 189:395–402.  	9892621
	32. Miettinen, H.M., J.M. Gripentrog, and A.J. Jesaitis. 1998.  Chemotaxis of chinese hamster ovary cells expressing the hu man neutrophil formyl peptide receptor: role of signal trans duction molecules and a5b1 integrin. J. Cell Sci. 111:1921–  1928.  	9645940
	33. Maddox, J.F., M. Hachicha, T. Takano, N.A. Petasis, V.V.  Fokin, and C.N. Serhan. 1997. Lipoxin A4 stable analogs are  potent mimetics that stimulate human monocytes and THP-1  cells via a G-protein-linked lipoxin A4 receptor. J. Biol.  Chem. 272:6972–6978.  	9054386
	34. Villanueva, M.S., C.J. Becker, and E.G. Pamer. 1994. Infec tion with Listeria monocytogenes impairs sialic acid addition to  host cell glycoproteins. J. Exp. Med. 180:2137–2145.  	7964488
	35. Olofsson, S., B. Khanna, and E. Lycke. 1980. Altered kinetic  properties of sialyl and galactosyl transferases associated with  herpes simplex virus infection of GMK and BHK cells. J.  Gen. Virol. 47:1–9.  	6154121
	36. Kim, J.W., and J.M. Cunningham. 1993. N-linked glycosyl ation of the receptor for murine ecotropic retroviruses is al tered in virus-infected cells. J. Biol. Chem. 268:16316–16320.  	8393858
	37. Miettinen, H.M., J.S. Mills, J.M. Gripentrog, E.A. Dratz,  B.L. Granger, and A.J. Jesaitis. 1997. The ligand binding site  of the formyl peptide receptor maps in the transmembrane  region. J. Immunol. 159:4045–4054.  	9378994
	38. Quehenberger, O., Z.K. Pan, E.R. Prossnitz, S.L. Cavanagh,  C.G. Cochrane, and R.D. Ye. 1997. Identification of an  N-formyl peptide receptor ligand binding domain by a gain of-function approach. Biochem. Biophys. Res. Commun. 238:  377–381.  	9299516
	39. Tai, H.H., C. Huang, and N. Chiang. 1997. Structure and  function of prostanoid receptors as revealed by site-directed  mutagenesis. In Eicosanoids and Other Bioactive Lipids in  Cancer, Inflammation and Radiation Injury. K.V. Honn, L.J.  Marnett, R. Jones, and P.Y.-K. Wong, editors. Plenum  Press, New York. 205–209.  	9321954
	40. Fiore, S., S.W. Ryeom, P.F. Weller, and C.N. Serhan. 1992.  Lipoxin recognition sites. Specific binding of labeled lipoxin  A4 with human neutrophils. J. Biol. Chem. 267:16168–  16176.  	1322894
	41. Liang, J.S., and J.D. Sipe. 1995. Recombinant human serum  amyloid A (apoSAAp) binds cholesterol and modulates cho lesterol flux. J. Lipid Res. 36:37–46.  	7706946
	42. Linke, R.P., V. Bock, G. Valet, and G. Rothe. 1991. Inhibi tion of the oxidative burst response of N-formyl peptide stimulated neutrophils by serum amyloid-A protein. Biochem.  Biophys. Res. Commun. 176:1100–1105.  	2039494
	43. Deng, X., H. Ueda, S.B. Su, W. Gong, N.M. Dunlop, J.-L.  Gao, P.M. Murphy, and J.M. Wang. 1999. A synthetic pep tide derived from human immunodeficiency virus type 1  gp120 downregulates the expression and function of  chemokine receptors CCR5 and CXCR4 in monocytes by  activating the 7-transmembrane G-protein-coupled receptor  FPRL1/LXA4R. Blood. 94:1165–1173.  	10438703
	44. Pettit, E.J., and F.S. Fay. 1998. Cytosolic free calcium and  the cytoskeleton in the control of leukocyte chemotaxis.  Physiol. Rev. 28:949–960.  	9790567
	45. Serhan, C.N. 1994. Lipoxin biosynthesis and its impact in in flammatory and vascular events. Biochim. Biophys. Acta. 1212:  1–25.  	8155718
	46. Levy, B.D., V.V. Fokin, J.M. Clark, M.J.O. Wakelam, N.A.  Petasis, and C.N. Serhan. 1999. Polyisoprenyl phosphate  (PIPP) signaling regulates phospholipase D activity: a “stop”  signaling switch for aspirin-triggered lipoxin A4. FASEB J.  13:903–911.  	10224233
	47. Schaldach, C.M., J. Riby, and L.F. Bjeldanes. 1999. Lipoxin  A4: a new class of ligand for the Ah receptor. Biochemistry. 38:  7594–7600.  	10360957
	48. Fernandez-Salguero, P., T. Pineau, D.M. Hilbert, T.  McPhail, S.S.T. Lee, S. Kimura, D.W. Nebert, S. Rudikoff,  J.M. Ward, and F.J. Gonzalez. 1995. Immune system impair ment and hepatic fibrosis in mice lacking the dioxin-binding  Ah receptor. Science. 268:722–726.  	7732381
992200.pdf
	1. Janeway, C.A., Jr. 1992. The immune system evolved to dis tinguish infectious nonself from non-infectious self. Immunol.  Today. 13:11–16.  	1739426
	2. Takahashi, K., M.J. Donovan, R.A. Rogers, and R.A.B.  Ezekowitz. 1998. Distribution of murine mannose receptor  expression from early embryogenesis through to adulthood.  Cell Tissue Res. 292:311–323.  	9560474
	3. Linehan, S.A., L. Martínez-Pomares, P.D. Stahl, and S. Gor don. 1999. Mannose receptor and its putative ligands in nor mal murine lymphoid and nonlymphoid organs: in situ ex pression of mannose receptor by selected macrophages,  endothelial cell, perivascular microglia, and mesangial cells,  but not dendritic cells. J. Exp. Med. 189:1961–1972.  	10377192
	4. Stahl, P.D., and R.A.B. Ezekowitz. 1998. The mannose re ceptor is a pattern recognition receptor involved in host de fense. Curr. Opin. Immunol. 10:50–55.  	9523111
	5. Sallusto, F., M.I. Cella, C. Danieli, and A. Lanzavecchia.  1995. Dendritic cells use macropinocytosis and the mannose  receptor to concentrate macromolecules in the major histo compatibility complex class II compartment: downregulation  by cytokines and bacterial products. J. Exp. Med. 182:389–  400.  	7629501
	6. Prigozy, T.I., P.A. Sieling, D. Clemens, P.L. Stewart, S.M.  Behar, S.A. Porcelli, M.B. Brenner, R.L. Modlin, and M.  Kronenberg. 1997. The mannose receptor delivers lipoglycan  antigens to endosomes for presentation to T cells by CD1b  molecules. Immunity. 6:187–197.  	9047240
	7. Ishizaki, J., K. Hanasaki, K. Higashino, J. Kishimo, N. Kiku chi, O. Ohara, and H. Arita. 1994. Molecular cloning of pan creatic group I phospholipase A2 receptor. J. Biol. Chem.  269:12156–12162.  	7509792
	8. Lambeau, G., P. Ancian, J. Barhanin, and M. Lazdunski.  1994. Cloning and expression of a membrane receptor for  secretory phospholipases A2. J. Biol. Chem. 269:1575–1578.  	8294398
	9. Ancian, P., G. Lambeau, M.-G. Madei, and M. Lazdunski.  1995. The human 180 kDa receptor for secretory phospholi pases A2. J. Biol. Chem. 270:8963–8970.  	NO_MATCH
	10. Jiang, W.P., W.J. Swiggard, C. Heufler, M. Peng, A. Mirza,  R.M. Steinman, and M.C. Nussenzweig. 1995. The receptor  DEC-205 expressed by dendritic cells and thymic epithelial  cells is involved in antigen processing. Nature. 375:151–155.  	7753172
	11. Wu, K., J. Yuan, and L.A. Lasky. 1996. Characterization of a  novel member of the macrophage mannose receptor type C  lectin family. J. Biol. Chem. 271:21323–21330.  	8702911
	12. Taylor, M.E., K. Bezouska, and K. Drickamer. 1992. Contri bution to ligand binding by multiple carbohydrate recogni tion domains in the macrophage mannose receptor. J. Biol.  Chem. 267:1719–1726.  	1730714
	13. Taylor, M.E., and K. Drickamer. 1993. Structural require ments for high affinity binding of complex ligands by the  mannose receptor. J. Biol. Chem. 268:399–404.  	8416946
	14. Weis, W.I., M.E. Taylor, and K. Drickamer. 1998. The  C-type lectin superfamily in the immune system. Immunol.  Rev. 163:19–34.  	9700499
	15. Mullin, N.P., P.G. Hitchen, and M.E. Taylor. 1997. Mecha nism of Ca21 and monosaccharide binding to a C-type car bohydrate-recognition domain of the macrophage mannose  receptor. J. Biol. Chem. 272:5668–5681.  	9038177
	16. Fiete, D., and J.U. Baenziger. 1997. Isolation of the SO4 4-GalNAcb1, 4GlcNAcb1, 2Mana-specific receptor from  rat liver. J. Biol. Chem. 272:14629–14637.  	9169424
	17. Fiete, D., M.C. Beranek, and J.U. Baenziger. 1997. The  macrophage endothelial cell mannose receptor cDNA en codes a protein that binds oligosaccharides terminating with  SO4-4-GalNAcb1,4GlcNAcb or Man at independent sites.  Proc. Natl. Acad. Sci. USA. 94:11256–11261.  	9326596
	18. Fiete, D.J., M.C. Beranek, and J.U. Baenziger. 1998. A cys teine-rich domain of the “mannose” receptor mediates Gal NAc-4-SO4 binding. Proc. Natl. Acad. Sci. USA. 95:2089–  2093.  	9482843
	19. Leteux, C., W. Chai, R.W. Loveless, C.-T. Yuen, L. Uhlin Hansen, Y. Combarnous, M. Jankovic, S.C. Maric, Z. Misu lovin, M.C. Nussenzweig, and T. Feizi. 2000. The cysteine-rich  domain of the macrophage mannose receptor is a multispe cific lectin which recognizes chondroitin sulfates A and B and  sulfated oligosaccharides of blood-group Lewisa and Lewisx  types in addition to the sulfated N-glycans of luteinizing hor mone. J. Exp. Med. 191:1117–1126.  	10748230
	20. Baenziger, J.U., S. Kumar, R.M. Brodbeck, P.L. Smith, and  M.C. Beranek. 1992. Circulatory half-life but not interaction  with the lutropin chorionic-gonadotropin receptor is modu lated by sulfation of bovine lutropin oligosaccharides. Proc.  Natl. Acad. Sci. USA. 89:334–338.  	1729704
	21. Smith, P.L., G.R. Bousfield, S. Kuman, D. Fiete, and J.U.  Baenziger. 1993. Equine lutropin and chorionic gonadotro pin bear oligosaccharides terminating with SO4-4-GalNAc  and Sia-a-2,3Gal, respectively. J. Biol. Chem. 268:795–802.  	8419356
	22. Martínez-Pomares, L., M. Kosco-Vilbois, E. Darley, P. Tree,  S. Herren, J.-Y. Bonnefoy, and S. Gordon. 1996. Fc chi meric protein containing the cysteine-rich domain of the  murine mannose receptor binds to macrophages from splenic  marginal zone and lymph node subcapsular sinus and to ger minal centers. J. Exp. Med. 184:1927–1937.  	8920880
	23. Taylor, M.E., J.T. Conary, M.R. Lennartz, P.D. Stahl, and  K. Drickmer. 1990. Primary structure of the mannose recep tor contains multiple motifs resembling carbohydrate-recog nition domains. J. Biol. Chem. 265:12156–12162.  	2373685
	24. Otwinowski, Z., and W. Minor. 1997. Processing of X-ray  diffraction data collected in oscillation mode. Methods Enzy mol. 276:307–326.  	NO_MATCH
	25. De La Fortelle, E., and G. Bricogne. 1997. Maximum-likeli hood heavy-atom parameter refinement for multiple isomor phous replacement and multiwavelength anomalous diffrac tion methods. Methods Enzymol. 276:472–494.  	NO_MATCH
	26. Abrahams, J.P., and A.G.W. Leslie. 1996. Methods used in  the structure determination of bovine mitochondrial F1 ATP ase. Acta Crystallogr. D. 52:30–42.  	NO_MATCH
	27. Kleywegt, G.J., and T.A. Jones. 1997. Template convolution  to enhance or detect structural features in macromolecular  electron density maps. Acta Crystallogr. D. 53:179–185.  	NO_MATCH
	28. Jones, T.A., and M. Kjeldgaard. 1997. Electron density map  interpretation. Methods Enzymol. 277:173–208.  	NO_MATCH
	29. Brünger, A.T., P.D. Adams, G.M. Clore, P. Gros, R.W.  Grosse-Kunstleve, J.-S. Jiang, J. Kuszewski, M. Nilges, N.S.  Pannu, R.J. Read, et al. 1998. Crystallography and NMR  system: a new software system for macromolecular structure  determination. Acta Crystallogr. D. 54:905–921.  	9757107
	30. Brünger, A.T. 1992. Free R value: a novel statistical quantity  for assessing the accuracy of crystal structures. Nature. 355:  472–475.  	NO_MATCH
	31. Kraulis, P.J. 1991. MOLSCRIPT: a program to produce  both detailed and schematic plots of protein structures. J.  Appl. Crystallogr. 24:946–950.  	NO_MATCH
	32. Merritt, E.A., and M.E.P. Murphy. 1994. Raster3D version  2.0, a program for photorealistic molecular graphics. Acta  Crystallogr. D. 50:869-873.  	NO_MATCH
	33. Nicholls, A., R. Bharadwaj, and B. Honig. 1993. GRASP:  graphical representation and analysis of surface properties.  Biophys. J. 64:A166.  	NO_MATCH
	34. Murzin, A.G., A.M. Lesk, and C. Chothia. 1992. Beta-trefoil  fold patterns of structure and sequence in the Kunitz inhibi tors, interleukins-1b and 1a and fibroblast growth factors. J.  Mol. Biol. 223:531–543.  	1738162
	35. McLachlan, A.D. 1979. Three-fold structural pattern in the  soybean trypsin inhibitory (Kunitz). J. Mol. Biol. 133:557–  563.  	537058
	36. Rutenber, E., and J.D. Robertus. 1991. Structure of ricin  B-chain at 2.5 Å resolution. Proteins. 10:260–269.  	1881882
	37. Zhu, X., H. Komiya, A. Chirino, S. Faham, G.M. Fox, T.  Arakawa, B.T. Hsu, and D.C. Rees. 1991. Three-dimen sional structures of acidic and basic fibroblast growth factors.  Science. 251:90–93.  	1702556
	38. Finzel, B.C., L.L. Clancy, D.R. Holland, S.W. Muchmore,  K.D. Watenpaugh, and H.M. Einspahr. 1989. Crystal struc ture of recombinant human interleukin-1b at 2.0 Å resolu tion. J. Mol. Biol. 209:779–791.  	NO_MATCH
	39. Graves, B.J., M.H. Hatada, W.A. Hendrickson, J.K. Miller,  V.S. Madison, and Y. Satow. 1990. Structure of interleukin 1a at 2.7 Å resolution. Biochemistry. 29:2679–2684.  	2346741
	40. Habazetti, J., D. Gondol, R. Wiltscheck, J. Otlewski, M.  Schleicher, and T.A. Holak. 1992. Structure of hisactophilin  is similar to interleukin-1b and fibroblast growth factor. Na ture. 359:855–858.  	1436061
	41. Harris, N., L.L. Peters, E.M. Eicher, M. Rits, D. Raspberry,  Q.G. Eichbaum, M. Super, and R.A. Ezekowitz. 1994. The  exon-intron structure and chromosomal localization of the  mouse macrophage mannose receptor gene Mrc1: identifica tion of a ricin-like domain at the N-terminus of the receptor.  Biochem. Biophys. Res. Commun. 198:682–692.  	8297379
	42. Weis, W.I., and K. Drickamer. 1996. Structural basis of lec tin-carbohydrate recognition. Annu. Rev. Biochem. 65:441–  473.  	8811186
	43. Pflugrath, J.W., and F.A. Quiocho. 1988. The 2 Å resolution  structure of the sulfate-binding protein involved in active  transport in Salmonella typhimurium. J. Mol. Biol. 200:163–  180.  	3288756
	44. Quiocho, F.A., J.S. Sack, and N.K. Vyas. 1987. Stabilization  of charges on isolated ionic groups sequestered in proteins by  polarized peptide units. Nature. 329:561–564.  	3657977
	45. DiGabriele, A.D., I. Lax, D.I. Chen, C.M. Svahn, M. Jaye, J.  Schlessinger, and W.A. Hendrickson. 1998. Structure of a  heparin-linked biologically active dimer of fibroblast growth  factor. Nature. 393:812–817.  	9655399
	46. Perez, S., N. Mouhous-Riou, N.E. Nifant’ev, Y.E. Tsvet kov, B. Bachet, and A. Imberty. 1996. Crystal and molecular  structure of a histo-blood group antigen involved in cell ad hesion: the Lewisx trisaccharide. Glycobiology. 6:537–542.  	8877374
	47. Ng, K.K.-S., and W.I. Weis. 1997. Structure of a selectin like mutant of mannose binding protein complexed with sial ylated and sulfated Lewisx oligosaccharides. Biochemistry. 36:  979–988.  	9033386
	48. Kogelberg, H., T.A. Frenkiel, S.W. Homans, A. Lubineau,  and T. Feizi. 1996. Conformational studies on the selectin  and natural killer cell receptor ligands sulfo- and sialyl-lacto N-fucopentaoses (SuLNFPII and SLNFPII) using NMR  spectroscopy and molecular dynamics simulations. Compari sons with the nonacidic parent molecule LNFPII. Biochemis try. 35:1954–1964.  	8639679
	49. Simpson, D.Z., P.G. Hitchen, E.L. Elmhirst, and M.E. Tay lor. 1999. Multiple interactions between pituitary hormones  and the mannose receptor. Biochem. J. 343:403–411.  	10510307
	50. Martínez-Pomares, L., J.A. Mahoney, R. Káposzta, S.A.  Linehan, P.D. Stahl, and S. Gordon. 1998. A functional solu ble form of the murine mannose receptor is produced by  macrophages in vitro and is present in mouse serum. J. Biol.  Chem. 273:23376–23380.  	9722572
	51. Hodel, A., S.-H. Kim, and A.T. Brünger. 1992. Model bias  in macromolecular crystal structures. Acta Crystallogr. A. 48:  851–858.  	NO_MATCH
	52. Kolatkar, A.R., and W.I. Weis. 1996. Structural basis of ga lactose recognition by C-type animal lectins. J. Biol. Chem.  271:6679–6685.  	8636086
J Pharmacol Exp Ther-2000-Cousins-104-13.pdf
	Anderson IM and Cowen PJ (1992) Effect of pindolol on endocrine and temperature  responses to buspirone in healthy volunteers. Psychopharmacol Ser (Berl) 106:  428–432.  	1570392
	Anderson IM, Cowen PJ and Grahame-Smith DG (1990) The effects of gepirone on  neuroendocrine function and temperature in humans. Psychopharmacol Ser (Berl)  100:498–503.  	2157231
	Azmitia EC (1981) Bilateral serotonergic projections to the dorsal hippocampus of  the rat: Simultaneous localization of 3H–5HT and HRP after retrograde transport.  J Comp Neurol 203:737–743.  	6173402
	Balcells-Olivero M, Cousins MS and Seiden LS (1998) Holtzman and Harlan  Sprague-Dawley rats: Differences in 72-sec performance and 8-hydroxy-di propylamino-tetralin-induced hypothermia. J Pharmacol Exp Ther 286:742–752.  	9694929
	Chen NH and Reith ME (1994) Effects of locally applied cocaine, lidocaine, and  various uptake blockers on monoamine transmission in the ventral tegmental area  of freely moving rats: A microdialysis study on monoamine interrelationships.  J Neurochem 63:1701–1713.  	7931325
	Cousins MS and Salamone JD (1996) Involvement of ventrolateral striatal dopamine  in movement initiation and execution: A microdialysis and behavioral investiga tion. Neuroscience 70:849–859.  	8848171
	Cowen PJ, Power AC, Ware CJ and Anderson IM (1994) 5-HT1A receptor sensitivity  in major depression. A neuroendocrine study with buspirone. Br J Psychiatry  164:372–379.  	8199791
	De Vry J (1995) 5-HT1A receptor agonists: Recent developments and controversial  issues. Psychopharmacol Ser (Berl) 121:1–26.  	8539333
	Fletcher PJ (1994) Effects of 8-OH-DPAT, 5-CT and muscimol on behaviour main tained by a DRL 20 schedule of reinforcement, following microinjection into the  dorsal or median raphe nuclei. Behav Pharmacol 5:326–336.  	NO_MATCH
	Fletcher PJ (1995) Effects of combined or separate 5,7-dihydroxytryptamine lesions  of the dorsal and median raphe nuclei on responding maintained by a DRL 20s  schedule of food reinforcement. Brain Res 675:45–54.  	7540930
	Forster EA, Cliffe IA, Bill DJ, Dover GM, Jones D, Reilly Y and Fletcher A (1995) A  pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY 100635. Eur J Pharmacol 281:81–88.  	8566121
	Fowler SC and Liou JR (1994) Microcatalepsy and disruption of forelimb usage  during operant behavior: Differences between dopamine D1 (SCH-23390) and D2  (raclopride) antagonists. Psychopharmacology 115:24–30.  	7862901
	Gershon ES, Badner JA, Goldin LR, Sanders AR, Cravchik A and Detera-Wadleigh  SD (1998) Closing in on genes for manic-depressive illness and schizophrenia.  Neuropsychopharmacology 18:233–242.  	9509491
	Gonzalez LE, File SE and Overstreet DH (1998) Selectively bred lines of rats differ  in social interaction and hippocampal 5-HT1A receptor function: A link between  anxiety and depression? Pharmacol Biochem Behav 59:787–792.  	9586832
	Gudelsky GA, Koenig JI and Meltzer HY (1986) Thermoregulatory responses to  serotonin (5-HT) receptor stimulation in the rat: Evidence for opposing roles of  5-HT2 and 5-HT1A receptors. Neuropharmacology 25:1307–1313.  	2951611
	Gupta ML, Gupta TK and Bhargava KP (1967) Central anticholinergic activity of  imipramine and allied drugs. Can J Physiol Pharmacol 45:353–355.  	6040438
	Heffner TG, Hartman JA and Seiden LS (1980) A rapid method for the regional  dissection of the rat brain. Pharmacol Biochem Behav 13:453–456.  	7422701
	Jolly DC, Richards JB and Seiden LS (1999) Serotonergic mediation of DRL 72-s  behavior: Receptor subtype involvement in a behavioral screen for antidepressant  drugs. Biol Psychiatry 45:1151–1162.  	10331107
	Jordan S, Kramer GL, Zukas PK, Moeller M and Petty F (1994) In vivo biogenic  amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvox amine. Synapse (NY) 18:294–297.  	7886621
	Keppel G (1991) Design and Analysis: A Researcher’s Handbook, Prentice-Hall, Inc.,  Upper Saddle River, NJ.  	NO_MATCH
	Knapp DJ, Overstreet DH and Crews FT (1998) Brain 5-HT1A receptor autoradiog raphy and hypothermic responses in rats bred for differences in 8-OH-DPAT  sensitivity. Brain Res 782:1–10.  	9519243
	Koenig JI, Meltzer HY and Gudelsky GA (1988) 5-Hydroxytryptamine1A receptor mediated effects of buspirone, gepirone and ipsapirone. Pharmacol Biochem Behav  29:711–715.  	2901112
	Kostowski W, Dyr W, Krzascik P, Jarbe T and Archer T (1992) 5-Hydroxytrypt amine1A receptor agonists in animal models of depression and anxiety. Pharmacol  Toxicol 71:24–30.  	1387935
	Lesch KP, Mayer S, Disselkamp-Tietze J, Hoh A, Schoellnhammer G and Schulte  HM (1990) Subsensitivity of the 5-hydroxytryptamine1A (5-HT1A) receptor mediated hypothermic response to ipsapirone in unipolar depression. Life Sci  46:1271–1277.  	1971701
	Lin MT, Wu JJ and Tsay BL (1983) Serotonergic mechanisms in the hypothalamus  mediate thermoregulatory responses in rats. Naunyn-Schmiedeberg’s Arch Phar macol 322:271–278.  	6866135
	Lucki I (1998) The spectrum of behaviors influenced by serotonin. Biol Psychiatry  44:151–162.  	9693387
	Marek GJ, Li AA and Seiden LS (1989) Evidence for involvement of 5-hydroxy tryptamine1 receptors in antidepressant-like drug effects on differential reinforcement-of-low-rate 72-second behavior. J Pharmacol Exp Ther 250:60 –  71.  	2746511
	McGuire PS and Seiden LS (1980) The effects of tricyclic antidepressants on perfor mance under a differential-reinforcement-of-low-rates schedule in rats. J Phar macol Exp Ther 214:635–641.  	7400965
	Meltzer HY and Maes M (1995) Effects of ipsapirone on plasma cortisol and body  temperature in major depression. Biol Psychiatry 38:450–457.  	8672605
	Overstreet DH, Daws LC, Schiller GD, Orbach J and Janowsky DS (1998) Cholin ergic/serotonergic interactions in hypothermia: Implications for rat models of  depression. Pharmacol Biochem Behav 59:777–785.  	9586831
	Overstreet DH, Rezvani AH, Knapp DJ, Crews FT and Janowsky DS (1996) Further  selection of rat lines differing in 5-HT1A receptor sensitivity: Behavioral and  functional correlates. Psychiatr Genet 6:107–117.  	8902886
	Overstreet DH, Rezvani AH, Pucilowski O, Gause L and Janowsky DS (1994) Rapid  selection for serotonin-1A sensitivity in rats. Psychiatr Genet 4:57–62.  	8049904
	Pollard GT and Howard JL (1986) Similar effects of antidepressant and non antidepressant drugs on behavior under an interresponse-time greater than 72-s  schedule. Psychopharmacol Ser (Berl) 89:253–258.  	3088646
	Porsolt RD, Anton G, Blavet N and Jalfre M (1978) Behavioural despair in rats: A  new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379–391.  	204499
	Richards JB, Sabol KE and Seiden LS (1993a) DRL interresponse-time distributions:  Quantification by peak deviation analysis. J Exp Anal Behav 60:361–385.  	8409824
	Richards JB, Sabol KE and Seiden LS (1993b) Fluoxetine prevents the disruptive  effects of fenfluramine on differential-reinforcement-of-low-rate 72-second sched ule performance. J Pharmacol Exp Ther 267:1256–1263.  	8263788
	Richards JB and Seiden LS (1991) A quantitative interresponse-time analysis of  DRL performance differentiates similar effects of the antidepressant desipramine  and the novel anxiolytic gepirone. J Exp Anal Behav 56:173–192.  	1683359
	Schreiber R and De Vry J (1993) Neuroanatomical basis for the antidepressant-like  effects of the 5-HT1A receptor agonists 8-OH-DPAT and ipsapirone in the rat  forced swimming test. Behav Pharmacol 4:625–636.  	NO_MATCH
	Tatarczynska E and Chojnacka-Wojcik E (1989) Effects of 8-OH-DPAT and ipsapi rone in the tests used for evaluation of the antidepressant action. Pol J Pharmacol  Pharm 41:321–330.  	2534521
	Wogar MA, Bradshaw CM and Szabadi E (1993) Does the effect of central 5-hydroxy tryptamine depletion on timing depend on motivational change? Psychopharma cology 112:86–92.  	NO_MATCH
76.full.pdf
	Aghajanian GK and Marek GJ (1997) Serotonin induces excitatory postsynaptic  potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology  36:589–599.  	9225284
	Aghajanian GK and Marek GJ (1999a) Serotonin, via 5-HT2A receptors, increases  EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of  glutamate release. Brain Res 825:161–171.  	10216183
	Aghajanian GK and Marek GJ (1999b) Serotonin-glutamate interactions: A new  target for antipsychotic drugs. Neuropsychopharmacology, in press.  	NO_MATCH
	Aghajanian GK and Rasmussen K (1989) Intracellular studies in the facial nucleus  illustrating a simple new method for obtaining viable motoneurons in adult rat  brain slices. Synapse 3:331–338.  	2740992
	Arunlakshana O and Schild HO (1959) Some quantitative uses of drug antagonists.  Br J Pharmacol 14:48–58.  	13651579
	Berendse HW and Groenewegen HJ (1991) Restricted cortical termination fields of  the midline and intralaminar thalamic nuclei in the rat. Neuroscience 42:73–102.  	1713657
	Blue ME, Yagaloff KA, Mamounas LA, Hartig PR and Molliver ME (1988) Corre spondence between 5-HT2 receptors and serotonergic axons in rat neocortex. Brain  Res 453:315–328.  	3401769
	Conn PJ and Pin J-P (1997) Pharmacology and functions of metabotropic glutamate  receptors. Annu Rev Pharmacol Toxicol 37:205–237.  	9131252
	Connors BW and Gutnick MJ (1990) Intrinsic firing patterns of diverse neocortical  neurons. Trends Neurosci 13:99–104.  	1691879
	de Boer T (1996) The pharmacologic profile of mirtazepine. J Clin Psychiatry 57:19–  25.  	8636062
	Eison AS, Eison MS, Torrente JR, Wright RN and Yocca FD (1990) Nefazodone:  Preclinical pharmacology of a new antidepressant. Psychopharmacol Bull 26:311–  315.  	2274630
	Fitzjohn SM, Bortolotto ZA, Palmer MJ, Doherty AJ, Ornstein PL, Schoepp DD,  Kingston AE, Lodge D and Collingridge GL (1998) The potent mGlu receptor  antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in  hippocampal synaptic plasticity. Neuropharmacology 37:1445–1458.  	9886667
	Goda Y and Stevens CF (1994) Two components of transmitter release at a central  synapse. Proc Natl Acad Sci USA 91:12942–12946.  	7809151
	Helton DR, Tizzano JP, Monn JA, Schoepp DD and Kallman MJ (1997) LY354740: A  metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine  withdrawal in rats. Neuropharmacology 36:1511–1516.  	9517421
	Helton DR, Tizzano JP, Monn JA, Schoepp DD and Kallman MJ (1998) Anxiolytic  and side-effect profile of LY354740: A potent, highly selective, orally active agonist  for Group II metabotropic glutamate receptors. J Pharmacol Exp Ther 284:651–  660.  	9454811
	Johnson BG, Wright RA, Arnold MB, Wheeler WJ, Ornstein PL and Schoepp DD  (1999) [3H]-LY341495 as a novel antagonist radioligand for group II metabotropic  glutamate (mGlu) receptors: Characterization of binding to membranes of mGlu  receptor subtype expressing cells. Neuropharmacology, 38:1519–1529.  	10530814
	Kingston AE, Ornstein PL, Wright RA, Johnson BG, Mayne NG, Burnett JP, Bel agaje R, Wu S and Schoepp DD (1998) LY341495 is a nanomolar potent and  selective antagonist of group II metabotropic glutamate receptors. Neuropharma cology 37:1–12.  	9680254
	Kroeze WK and Roth BL (1998) The molecular biology of serotonin receptors: Ther apeutic implications for the interface of mood and psychosis. Biol Psychiatry  44:1128–1142.  	9836016
	Li H, Weiss SRB, Chuang D-M, Post RM and Rogawski MA (1998) Bidirectional  synaptic plasticity in the rat basolateral amygdala: Characterization of an activ ity-dependent switch sensitive to the presynaptic metabotropic glutamate receptor  antagonist 2S-a-ethylglutamic acid. J Neurosci 18:1662–1670.  	9464991
	Lovinger DM and McCool BA (1995) Metabotropic glutamate receptor-mediated  presynaptic depression at corticostriatal synapses involves mGlu2 or 3. J Neuro physiol 73:1076–1083.  	7608756
	Marek GJ and Aghajanian GK (1998a) 5-HT-induced EPSCs in neocortical layer V  pyramidal cells: Suppression by m-opiate receptor activation. Neuroscience 86:485–  497.  	NO_MATCH
	Marek GJ and Aghajanian GK (1998b) The electrophysiology of prefrontal 5-HT  systems: Therapeutic implications for mood and psychosis. Biol Psychiatry 44:  1118–1127.  	9836015
	Marek GJ and Aghajanian GK (1999) 5-HT2A receptor or a1-adrenoceptor activation  induces excitatory postsynaptic currents in layer V pyramidal cells of the medial  prefrontal cortex. Eur J Pharmacol 367:197–206.  	10078993
	Marek GJ and Gewirtz JC (1999) Serotonin2A receptor-induced EPSCs in layer V  pyramidal cells of prefrontal cortex: Block by lesions of medial thalamus. Soc  Neurosci Abstr 25:449.  	NO_MATCH
	Marek GJ, McDougle CJ, Price LH and Seiden LS (1992) A comparison of trazodone  and fluoxetine: Implications for a serotonergic mechanism of antidepressant ac tion. Psychopharmacology 109:2–11.  	NO_MATCH
	McCormick DA, Connors BW, Lighthall JW and Prince DA (1985) Comparative  electrophysiology of pyramidal and sparsely spiny neurons of the neocortex. J Neu rophysiol 54:782–806.  	2999347
	Moghaddam B and Adams BW (1998) Reversal of phencyclidine effects by a group II  metabotropic glutamate receptor agonists in rats. Science (Wash DC) 281:1349–  1352.  	9721099
	Monn JA, Valli MJ, Massey SM, Hansen MM, Kress TJ, Wepsiec JP, Harkness AR,  Grutsch JL, Wright RA, Johnson BG, Andis SL, Kingston A, Tomlinson R, Lewis  R, Griffey KR, Tizzano JP and Schoepp DD (1999) Synthesis, pharmacological  characterization, and molecular modeling of heterobicyclic amino acids related to  (1)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): Identification  of two new potent, selective and systemically active agonists for group II metabo tropic glutamate receptors. J Med Chem 42:1027–1040.  	10090786
	Monn JA, Valli MJ, Massey SM, Wright RA, Salhoff CR, Johnson BG, Howe T, Alt  CA, Rhodes GA, Robey RL, Griffey KR, Tizzano JP, Kallman MJ, Helton DR and  Schoepp DD (1997) Design, synthesis, and pharmacological characterization of  (1)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): A potent, selec tive, and orally active group 2 metabotropic glutamate receptor agonist possessing  anticonvulsant and anxiolytic properties. J Med Chem 40:528–537.  	9046344
	Ohishi H, Akazawa C, Shigemoto R, Nakanishi S and Mizuno N (1995) Distributions  of the mRNAs for L-2-amino-4-phosphonobutyrate-sensitive metabotropic gluta mate receptors, mGluR4 and mGluR7, in the rat brain. J Comp Neurol 360:555–  570.  	8801249
	Ohishi H, Neki A and Mizuno N (1997) Distribution of a metabotropic glutamate  receptor, mGluR2, in the central nervous system of the rat and mouse: An immu nohistochemical study with a monoclonal antibody. Neurosci Res 30:65–82.  	9572581
	Ohishi H, Shigemoto R, Nakanishi S and Mizuno N (1993a) Distribution of the  messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central  nervous system of the rat. Neuroscience 53:1009–1018.  	8389425
	Ohishi H, Shigemoto R, Nakanishi S and Mizuno N (1993b) Distribution of the  mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: An in situ  hybridization study. J Comp Neurol 335:252–266.  	8227517
	Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates, 2nd ed.,  plates 9 and 10, Academic Press, New York.  	NO_MATCH
	Petralia RS, Wang Y-X, Niedzielski AS and Wenthold RJ (1996) The metabotropic  glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynap tic and glial localizations. Neuroscience 71:949–976.  	8684625
	Richelson E and Nelson A (1984) Antagonism by antidepressants of neurotransmit ter receptors of normal human brain in vitro. J Pharmacol Exp Ther 230:94–102.  	6086881
	Saugstad JA, Kinzie JM, Shinohara MM, Segerson TP and Westbrook GL (1997)  Cloning and expression of rat metabotropic glutamate receptor 8 reveals a distinct  pharmacological profile. J Pharmacol Exp Ther 51:119–125.  	9016353
	Scanziani M, Salin PA, Vogt KE, Malenka RC and Nicoll RA (1997) Use-dependent  increases in glutamate concentration activate presynaptic metabotropic glutamate  receptors. Nature (Lond) 385:630–634.  	9024660
	Schiller J, Schiller Y, Stuart G and Sakman B (1997) Calcium action potentials  restricted to distal apical dendrites of rat neocortical pyramidal cells. J Physiol  505:605–616.  	9457639
	Schoepp DD, Jane DE and Monn JA (1999) Pharmacological agents acting at sub types of metabotropic glutamate receptors. Neuropharmacology 38:1431–1476.  	10530808
	Schoepp DD, Johnson BG, Wright RA, Salhoff CR, Mayne NG, Wu S, Cockerham SL,  Burnett JP, Belagaje R, Bleakman D and Monn JA (1997) LY354740 is a potent  and highly selective group II metabotropic glutamate receptor agonist in cells  expressing human glutamate receptors. Neuropharmacology 36:1–11.  	9144636
	Schoepp DD, Johnson BG, Wright RA, Salhoff CR and Monn JA (1998) Potent,  stereoselective, and brain region selective modulation of second messengers in the  rat brain by (1)LY354740, a novel group II metabotropic glutamate receptor  agonist. Naunyn-Schmiedeberg’s Arch Pharmacol 358:175–180.  	9750002
	Schwindt PC and Crill WE (1997) Local and propagated dendritic action potentials  evoked by glutamate iontophoresis on rat neocortical pyramidal neurons. J Neu rophysiol 77:2466–2483.  	9163370
	Van der Kloot W (1991) The regulation of quantal size. Prog Neurobiol (NY) 36:93–  130.  	1847748
	Vollenweider FX, Vollenweider-Scherpenhuyzen MFI, Babler A, Vogel H and Hell D  (1998) Psilocybin induces schizophrenia-like psychosis in humans via a seroto nin-2 agonist action. Neuroreport 9:3897–3902.  	9875725
	Wander TJ, Nelson A, Okazaki H and Richelson E (1986) Antagonism by antide pressants of serotonin S1 and S2 receptors of normal human brain in vitro. Eur  J Pharmacol 132:115–121.  	3816971
	Wright RA, McDonald JW and Schoepp DD (1994) Distribution and ontogeny of  1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid sensitive and quisqualate insen sitive [3H]glutamate binding sites in the rat brain. J Neurochem 63:938–945.  	7914226
J Pharmacol Exp Ther-2000-Bauer-31-7.pdf
	Berlin J, Tutsch KD, Hutson P, Cleary J, Rago RP, Arzoomanian RZ, Alberti D,  Feierabend C and Wilding G (1997) Phase I clinical and pharmacokinetic study of  oral carboxyamidotriazole, a signal transduction inhibitor. J Clin Oncol 15:781–  789.  	9053505
	Berridge MJ and Irvine RF (1989) Inositol phosphates and cell signaling. Nature  (Lond) 341:197–205.  	2550825
	Figg WD, Cole KA, Reed E, Steinberg SM, Piscitelli SC, Davis PA, Soltis MJ, Jacob  J, Boudoilas S, Goldspiel B, Sarosy G, Liotta LA and Kohn EC (1995) Pharmaco kinetics of orally administered carboxyamido-triazole, an inhibitor of calcium  mediated signal transduction. Clin Cancer Res 1:797–803.  	NO_MATCH
	Folkman J (1966) Tumor behavior in isolated perfuse organs: In vitro growth and  metastases of biopsy material in rabbit thyroid and canine intestinal segments.  Ann Surg 164:493–502.  	5951515
	Folkman J (1971) Tumor angiogenesis: Therapeutic implications. N Engl J Med  285:1182–1186.  	4938153
	Frank S, Kolb N, Werner ER and Pfeilschifter J (1998) Coordinated induction of  inducible nitric oxide synthase and GTP-cyclohydrolase I is dependent on inflam matory cytokines and interferon-gamma in HaCaT keratinocytes: Implications for  the model of cutaneous wound repair. J Invest Dermatol 111:1065–1071.  	9856818
	Gimrone MA Jr, Aster RH and Cotran RS (1969) Preservation of vascular integrity  in organs perfused in vitro with a platelet-rich medium. Nature (Lond) 221:33–36.  	5775827
	Gusovsky F, Lueders JE, Kohn EC and Felder CC (1993) Muscarinic receptor mediated tyrosine phosphorylation of phospholipase C-gamma. J Biol Chem 268:  7768–7772.  	NO_MATCH
	Horti J, Dixon SC, Logothetis CJ, Guo Y, Reed E and Figg WD (1999) Increased  transcriptional activity of prostate-specific antigen in the presence of TNP-470, an  angiogenesis inhibitor. Br J Cancer 79:1588–1593.  	10188911
	Hupe DJ, Behrens ND and Boltz R (1990) Anti-proliferative activity of L-651,582  correlates with calcium-mediated regulation of nucleotide metabolism at phospho ribosyl pyrophosphate synthetase. J Cell Physiol 144:457–466.  	2167901
	Hupe DJ, Boltz R, Cohen CJ, Felix J, Ham E, Miller D, Soderman D and Van Skiver  D (1991) The inhibition of receptor-mediated and voltage-dependent calcium entry  by the antiproliferative L-651,582. J Biol Chem 266:10136–10142.  	1645340
	Jacobs W, Mikkelsen T, Smith R, Nelson K, Rosenblum ML and Kohn EC (1997)  Inhibitory effects of CAI in glioblastoma growth and invasion. J Neuro-Oncol  32:93–101.  	9120549
	Kobayashi S, Somlyo AP and Somlyo AV (1988) Guanine nucleotide- and inositol  1,4,5-trisphosphate-induced calcium release in rabbit main pulmonary artery.  J Physiol 403:601–619.  	3150985
	Kohn EC, Alessandro R, Spoonster J, Wersto RP and Liotta LA (1995) Angiogenesis:  Role of calcium-mediated signal transduction. Proc Natl Acad Sci USA 92:1307–1311.  	7533291
	Kohn EC, Figg WD, Sarosy GA, Bauer KS, Davis PA, Soltis MJ, Thompkins A, Liotta  LA and Reed E (1997). Phase I trial of micronized formulation carboxyamidotria zole in patients with refractory solid tumors: Pharmacokinetics, clinical outcome,  and comparison of formulations. J Clin Oncol 15:1985–1993.  	9164210
	Kohn EC, Jacobs W, Kim YS, Alessandro R, Stetler-Stevenson WG and Liotta LA  (1994) Calcium influx modulates expression of matrix metalloproteinase-2 (72 kDa type IV collagenase, gelatinase A). J Biol Chem 269:21505–21511.  	8063786
	Kohn EC and Liotta LA (1990) L651582: A novel antiproliferative and antimetasta sis agent. J Natl Cancer Inst 82:54–60.  	2152805
	Kroll J and Waltenberger J (1998) VEGF-A induces expression of eNOS and iNOS in  endothelial cells via VEGF receptor-2 (KDR). 252:716–743.  	9837777
	Lambert PA, Somers KD, Kohn EC and Perry RR (1997) Antiproliferative and  anti-invasive effects of carboxyamido-triazole on breast cancer cell lines. Surgery  122:372–379.  	9288143
	Miyazaki S (1988). Inositol 1,4,5-trisphosphate-induced calcium release and guanine  nucleotide-binding protein-mediated periodic calcium rises in golden hamster  eggs. J Cell Biol 106:345–353.  	3123497
	Morbidelli L, Chang C-H, Douglas JG, Granger HJ, Ledda F and Ziche M (1996)  Nitric oxide mediates mitogenic effect of VEGF on coronary endothelium. Am  Physiol Soc 363:H411–H415.  	8769777
	Park YC, Jun CD, Kang HS, Kim HD, Kim HM and Chung HT (1996) Role of  intracellular calcium as a priming signal for the induction of nitric oxide synthesis  in murine peritoneal macrophages. Immunology 87:296–302.  	8698394
	Pinkus GS, Etheridge CL and O’Connor EM (1986) Are keratin proteins a better  tumor marker than epithelial membrane antigen? A comparative immunohisto chemical study of various paraffin-embedded neoplasms using monoclonal and  polyclonal antibodies. Am J Clin Pathol 85:269–277.  	2428237
	Sunyer T, Rothe L, Kirsch D, Jiang X, Anderson F, Osdoby P and Collin-Osdoby P  (1997) Ca21 or phorbol ester but not inflammatory stimuli elevate inducible nitric  oxide synthase messenger ribonucleic acid and nitric oxide (NO) release in avian  osteoclasts: Autocrine NO mediates Ca21-inhibited bone resorption. Endocrinol ogy 138:2148–2162.  	9112415
	Trachtman H, Futterweit S, Franki N and Singhal PC (1998) Effect of vascular  endothelial growth factor on nitric oxide production by cultured rat mesangial  cells. Biochem Biophys Res Commun 245:443–446.  	9571172
	Wasilenko WJ, Palad AJ, Somers KD, Blackmore PF, Kohn EC, Rhim JS, Wright GL  and Schellhammer PF (1996) Effects of the calcium influx inhibitor carboxyamido triazole on the proliferation and invasiveness of human prostate tumor cell lines.  Intl J Cancer 68:259–264.  	8900438
	Weidner N, Carroll PR, Flax J, Blumenfeld W and Folkman J (1993) Tumor angio genesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol  143:401–409.  	7688183
	Weidner N, Semple JP, Welch WR and Folkman J (1991) Tumor angiogenesis and  metastasis correlation in invasive breast carcinoma. N Engl J Med 324:1–8.  	1701519
	Weikert S, Freyer D, Weih M, Isaev N, Busch C, Schultze J, Megow D and Dirnagl  U (1997) Rapid Ca21-dependent NO-production from central nervous system cells  in culture measured by NO-nitrite/ozone chemoluminescence. Brain Res 748:1–11.  	9067439
	Send reprint requests to: Dr. William D. Figg, Medicine Branch, Division of  Clinical Sciences, National Cancer Institute, NIH, Bldg. 10, Room 5A01, 10  Center Dr., Bethesda, MD 20892. E-mail: wdfigg@helix.nih.gov  	NO_MATCH
spp-01-1-38.pdf
spp-01-1-21.pdf
nihms226142.pdf
nihms59621.pdf
nihms38938.pdf
	1. Bairey Merz C, Dwyer J, Nordstrom C, Walton K, Salerno J, Schneider R. Psychosocial stress and  cardiovascular disease: Pathophysiological links. Behav Med 2002;27:141–146. [PubMed: 12165968]  	12165968
	2. Tennant CC. Life stress and hypertension. J Cardiovasc Risk 2001;8:51–56. [PubMed: 11234726]  	11234726
	3. Penninx BW, Beekman AT, Honig A, et al. Depression and cardiac mortality: Results from a  community based longitudinal study. Arch Gen Psychiatry 2001;58:221–227. [PubMed: 11231827]  	11231827
	4. Tennant CC, Mclean L. Mood disturbances and coronary heart disease: Progress in the past decade.  Med J Aust 2000;172:151–152. [PubMed: 10772583]  	10772583
	5. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of  cardiovascular disease and implications for therapy. Circulation 1999;99:2192–2217. [PubMed:  10217662]  	10217662
	6. Bairey Merz C, Subramanian R. Efficacy of psychosocial interventions and stress management for  reduction of coronary artery disease events. Preventive Cardiology 1999;1:1–6.  	NO_MATCH
	7. Linden W, Stossel C, Maurice J. Psychosocial interventions for patients with coronary artery disease.  Arch Intern Med 1996;156:745–752. [PubMed: 8615707]  	8615707
	8. Nunes E, Frank K, Kornfeld D. Psychologic treatment for Type A behavior pattern and for coronary  artery disease: A meta-analysis of the literature. Psychosom Med 1987;49:159–173. [PubMed:  3554294]  	3554294
	9. Polk, DM.; Nordstrom, CK.; Dwyer, J.; Kop, WJ.; Krantz, DS.; Bairey Merz, CN. Novel psychosocial  factors and cardiovascular disease. In: Shah, PK., editor. Risk Factors in Coronary Disease. New York:  Marcel Dekker; 2003.  	NO_MATCH
	10. Frasure-Smith N, Lesperance F, Prince RH, et al. Randomized trial of home-based psychosocial  nursing intervention for patients recovering from myocardial infarction. Lancet 1997;350:473–479.  [PubMed: 9274583]  	9274583
	11. Jones DA, West RR. Psychological rehabilitation after myocardial infarction: Multicentre randomised  controlled trial. BMJ 1996;313:1517–1521. [PubMed: 8978226]  	8978226
	12. Orme-Johnson DW, Walton KG. All approaches to preventing or reversing effects of stress are not  the same. American Journal of Health Promotion 1998;12:297–299. [PubMed: 10181138]  	10181138
	13. Murphy LR. Stress management in work settings: A critical review of the health effects. American  Journal of Health Promotion 1996;11:112–135. [PubMed: 10163598]  	10163598
	14. Murphy, M.; Donovan, S.; Taylor, E. The Physical and Psychological Effects of Meditation: A Review  of Contemporary Research with a Comprehensive Bibliography. Sausalito, California: Institute of  Noetic Sciences; 1997. p. 1931-1996.  	NO_MATCH
	15. Alexander, CN.; Davies, JL.; Dixon, CA., et al. Growth of higher stages of consciousness: Maharishi’s  Vedic psychology of human development. In: Alexander, CN.; Langer, EJ., editors. Higher Stages  of Human Development: Perspectives on Adult Growth. New York: Oxford University Press; 1990.  p. 286-341.  	NO_MATCH
	16. Schneider RH, Alexander CN, Salerno J, Robinson D, Fields J, Nidich S. Disease prevention and  health promotion in the aging with a traditional system of natural medicine: Maharishi Vedic  Medicine (MVM). The Journal of Aging and Health 2002;14:57–78.  	11892761
	17. Nader T, Rothenberg S, Averbach R, Charles B, Fields J, Schneider R. Improvements in chronic  diseases with a comprehensive natural medicine approach: A review and case studies. Behav Med  2000;26:34–46. [PubMed: 10971882]  	10971882
	18. Walton K, Pugh N. Stress, steroids, and “ojas”: Neuroendocrine mechanisms and current promise of  ancient approaches to disease prevention. Indian J Physiol Pharmacol 1995;39:3–36. [PubMed:  7705867]  	7705867
	19. Orme-Johnson, DW.; Farrow, J. Scientific Research on the Transcendental Meditation Program:  Collected Papers. Vol. 1. Rheinweiler, West Germany: MERU Press; 1977. p. 722  	776380
	20. Chalmers, R.; Clements, G.; Schenkluhn, H.; Weinless, M. Scientific Research on the Transcendental  Meditation Program: Collected Papers. Vol. 2–4. Vlodrop, The Netherlands: MVU Press; 1990.  	NO_MATCH
	21. Wallace, RK.; Orme-Johnson, DW.; Dillbeck, MC. Scientific Research on the Transcendental  Meditation Program: Collected Papers. Vol. 5. Fairfield, Iowa: MIU Press; 1990.  	NO_MATCH
	22. Jevning R, Wallace RK, Biedebach M. The physiology of meditation: A review. A wakeful  hypometabolic integrated response. Neurosci Biobehav Rev 1992;16:415–424. [PubMed: 1528528]  	1528528
	23. Hawkins MA. Effectiveness of the Transcendental Meditation program in criminal rehabilitation and  substance abuse recovery: A review of the research. Journal of Offender Rehabilitation 2002;36:47–  65.  	11681142
	24. Roth, R. Maharishi Mahesh Yogi’s Transcendental Meditation. Washington, DC: Primus; 1994. p.  90-102.  	NO_MATCH
	25. Williams R, Barefoot J, Califf R. Prognostic importance of social and economic resources among  medically treated patients with angiographically documented coronary artery disease. JAMA  1992:267.  	1729574
	26. Julkunen J, Salonen R, Kaplan G, Chesney M, Salonen J. Hostility and the progression of carotid  atherosclerosis. Psychosom Med 1994;56:519–525. [PubMed: 7871107]  	7871107
	27. Reed DM, LaCroix AZ, Karasek RA, Miller D, MacLean CA. Occupational strain and the incidence  of coronary heart disease. Am J Epidemiol 1989;129:495–502. [PubMed: 2916542]  	2916542
	28. Hlatky MA, Lam LC, Lee KL, et al. Job strain and the prevalence and outcome of coronary artery  disease. Circulation 1995;92:327–333. [PubMed: 7634445]  	7634445
	29. Grundy SM, Pasternak R, Greenland P, Smith SJ, Fuster V. AHA/ACC scientific statement:  Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement  for healthcare professionals from the American Heart Association and the American College of  Cardiology. J Am Coll Cardiol 1999;34:1348–1359. [PubMed: 10520820]  	10520820
	30. Schneider RH, Staggers F, Alexander C, et al. A randomized controlled trial of stress reduction for  hypertension in older African Americans. Hypertension 1995;26:820–827. [PubMed: 7591024]  	7591024
	31. Alexander C, Schneider R, Staggers F, et al. A trial of stress reduction for hypertension in older  African Americans (Part II): Sex and risk factor subgroup analysis. Hypertension 1996;28:228–237.  [PubMed: 8707387]  	8707387
	32. Alexander CN, Langer EJ, Newman RI, Chandler HM, Davies JL. Transcendental Meditation,  mindfulness, and longevity: an experimental study with the elderly. J Person Soc Psychol  1989;57:950–964.  	2693686
	33. Wenneberg S, Schneider R, Walton K, et al. A controlled study of the effects of the Transcendental  Meditation program on cardiovascular reactivity and ambulatory blood pressure. Int J Neurosci  1997;89:15–28. [PubMed: 9134445]  	9134445
	34. Barnes VA, Treiber FA, Davis H. Impact of Transcendental Meditation on cardiovascular function  at rest and during acute stress in adolescents with high normal blood pressure. J Psychosom Res  2001;51:597–605. [PubMed: 11595248]  	11595248
	35. De Armond, DL. Effects of the Transcendental Meditation program on psychological, physiological,  behavioral and organizational consequences of stress in managers and executives in management.  Fairfield, Iowa: Maharishi University of Management; 1996. p. 161  	NO_MATCH
	36. Schneider R, Nidich S, Salerno J, et al. Lower lipid peroxide levels in practitioners of the  Transcendental Meditation program. Psychosom Med 1998;60:38–41. [PubMed: 9492237]  	9492237
	37. Calderon, R. Effects of Nonpharmacological Approaches on Cholesterol Levels in Mild Hypertensive  African Americans: A Pilot Study of the Transcendental Meditation Program and a Health Education  Program dissertation. Fairfield, Iowa: Maharishi University of Management; 2000. p. 122  	NO_MATCH
	38. Alexander, CN.; Robinson, P.; Rainforth, M. Treating and preventing alcohol, nicotine and drug abuse  through Transcendental Meditation Technique: A review and statistical analysis. In: O’Connell, DF.;  Alexander, CN., editors. Self Recovery—Treating Addictions Using Transcendental Meditation and  Maharishi Ayur-Veda. New York: Haworth Press; 1994. p. 13-88.  	NO_MATCH
	39. Collins R, Petro R, MacMahone S, et al. Blood pressure, stroke, and coronary heart disease, part 2,  Short-term reductions in blood pressure: Overview of randomized drug trials in their epidemiological  context. Lancet 1990;335:827–838. [PubMed: 1969567]  	1969567
	40. Collins P, Fox K. Pathophysiology of angina. Lancet 1990;335:94–96. [PubMed: 1967428]  	1967428
	41. Cooper MJ, Aygen MM. Transcendental Meditation in the management of hypercholesterolemia.  Journal of Human Stress 1979;5:24–27. [PubMed: 392003]  	420081
	42. Salonen JT, Yla-Herttuala S, Yamamoto R, et al. Autoantibody against oxidized LDL and progression  of carotid atherosclerosis. Lancet 1992;339:883–887. [PubMed: 1348295]  	1348295
	43. Naito C, Kawamura M, Yamamoto Y. Lipid peroxides as the initiating factor of atherosclerosis. Ann  N Y Academ Sci 1990:27–45.  	NO_MATCH
	44. Berliner J, Navab M, Fogelman A, et al. Atherosclerosis: Basic mechanisms. Oxidation, inflammation  and genetics. Circulation 1995;91:2488–2496. [PubMed: 7729036]  	7729036
	45. Matthews KA, Woodall KL, Allen MT. Cardiovascular reactivity to stress predicts future blood  pressure status. Hypertension 1993;22:479–485. [PubMed: 8406652]  	8406652
	46. Kamarck TW, Jennings JR, Pogue-Geile M, Manuck SB. A multidimensional measurement model  for cardiovascular reactivity: Stability and cross-validation in two adult samples. Health Psychol  1994;13:471–478. [PubMed: 7889901]  	7889901
	47. Eppley K, Abrams AI, Shear J. Differential effects of relaxation techniques on trait anxiety: A meta analysis. J Clin Psychol 1989;45:957–974. [PubMed: 2693491]  	2693491
	48. Gaylord C, Orme-Johnson D, Travis F. The effects of the Transcendental Meditation technique and  progressive muscle relaxation on EEG coherence, stress reactivity, and mental health in black adults.  Intern J Neurosci 1989;46:77–86.  	2670798
	49. Alexander CN, Rainforth MV, Gelderloos P. Transcendental Meditation, self actualization, and  psychological health: A conceptual overview and statistical meta-analysis. Journal of Social Behavior  and Personality 1991;6:189–247.  	NO_MATCH
	50. Ferguson, PC. An integrative meta-analysis of psychological studies investigating the treatment  outcomes of meditation techniques. In: Chalmers, R.; Clements, G.; Schenkluhn, H.; Weinless, M.,  editors. Scientific Research on Maharishi’s Transcendental Meditation and TM-Sidhi Programme:  Collected Papers. Vol. 4. Vlodrop, Holland: Maharishi European Research University, MVU Press;  1991. p. 2039-2048.  	NO_MATCH
	51. Jevning R, Wilson AF, Smith WR. Adrenocortical activity during meditation. Hormones and Behavior  1978;10:54–60. [PubMed: 350747]  	350747
	52. Dillbeck MC, Orme-Johnson DW. Physiological differences between Transcendental Meditation and  rest. American Psychologist 1987;42:879–881.  	NO_MATCH
	53. Michaels RR, Huber MJ, McCann DS. Evaluation of Transcendental Meditation as a method of  reducing stress. Science 1976;192:1242–1244. [PubMed: 775639]  	775639
	54. Mills PJ, Schneider RH, Hill D, Walton KG, Wallace RK. Beta-adrenergic receptor sensitivity in  subjects practicing transcendental meditation. J Psychosom Res 1990;34:29–33. [PubMed: 2156071]  	2156071
	55. Alexander CN, Swanson GC, Rainforth MV, Carlisle TW, Todd CC, Oates RM. Effects of the  Transcendental Meditation program on stress reduction, health, and employee development: A  prospective study in two occupational settings. Anxiety, Stress and Coping: An International Journal  1993;6:245–262.  	NO_MATCH
	56. Walton KG, Pugh N, Gelderloos P, Macrae P. Stress reduction and preventing hypertension:  Preliminary support for a psychoneuroendocrine mechanism. Journal of Alternative and  Complementary Medicine 1995;1:263–283.  	NO_MATCH
	57. Levitsky, DK. Effects of the Transcendental Meditation program on neuroendocrine indicators of  chronic stress dissertation. Fairfield, Iowa: Maharishi University of Management; 1997. p. 298  	NO_MATCH
	58. MacLean C, Walton K, Wenneberg S, et al. Effects of the Transcendental Meditation program on  adaptive mechanisms: Changes in hormone levels and responses to stress after 4 months of practice.  Psychoneuroendocrinology 1997;22:277–295. [PubMed: 9226731]  	9226731
	59. Infante JR, Peran F, Martinez M, et al. ACTH and beta-endorphin in Transcendental Meditation.  Physiol Behav 1998;64:311–315. [PubMed: 9748098]  	9748098
	60. Infante JR, Torres-Avisbal M, Pinel P, et al. Catecholamines in practitioners of the Transcendental  Meditation technique. Physio Behav 2001;72:141–146.  	11239991
	61. Barnes VA, Treiber FA, Turner JR, Davis H, Strong WB. Acute effects of Transcendental Meditation  on hemodynamic functioning in middle-aged adults. Psychosom Med 1999;61:525–531. [PubMed:  10443761]  	10443761
	62. Alexander C, Walton K, Goodman R. Walpole study of the TM program in maximum security  prisoners I: Cross-sectional differences in development and psychopathology. Journal of Offender  Rehabilitation 2002;36:97–125.  	NO_MATCH
	63. Castillo-Richmond A, Schneider R, Alexander C, et al. Effects of stress reduction on carotid  atherosclerosis in hypertensive African Americans. Stroke 2000;31:568–573. [PubMed: 10700487]  	10700487
	64. Fields JZ, Walton KG, Schneider RH, et al. Effect of a multimodality natural medicine program on  carotid atherosclerosis in older subjects: A pilot trial of Maharishi Vedic Medicine. Am J Cardiol  	2002;89:952–958. [PubMed: 11950434]	11950434
	65. Blankenhorn DH, Hodis HN. Arterial imaging and atherosclerosis reversal. George Lyman Duff  Memorial Lecture. Arteriosclerosis & Thrombosis 1994;14:177–192. [PubMed: 8305407]  	NO_MATCH
	66. Kondwani, KA. Psychology. Fairfield, Iowa: Maharishi University of Management; 1998.  Nonpharmacologic treatment of hypertension and hypertensive heart disease in African Americans:  A trial of the Transcendental Meditation program and a health education program; p. 130  	NO_MATCH
	67. Zamarra JW, Schneider RH, Besseghini I, Robinson DK, Salerno JW. Usefulness of the  Transcendental Meditation program in the treatment of patients with coronary artery disease. Am J  Cardio 1996;78:77–80.  	8623742
	68. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic  progression. Circulation 1993;87(Suppl 2):56–65.  	8443925
	69. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and  geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med  1991;114:345–352. [PubMed: 1825164]  	1825164
	70. Kondwani K, Schneider RH, Alexander CN, et al. Left ventricular mass regression with the  Transcendental Meditation technique and a health education program in hypertensive African  Americans. Journal of Social Behavior and Personality. In press  	NO_MATCH
	71. Devereux RB, Okin PM, Roman MJ. Pre-clinical cardiovascular disease and surrogate end-points in  hypertension: Does race influence target organ damage independent of blood pressure? Ethnicity and  Disease 1998;8:138–148. [PubMed: 9681280]  	9681280
	72. Devereux RB, Roman MJ, Ganau A, de Simone G, Okin PM, Kligfield P. Cardiac and arterial  hypertrophy and atherosclerosis in hypertension. Hypertension 1994;23:802–809. [PubMed:  8206580]  	8206580
	73. Devereux R, Roman M. Hypertensive left ventricular hypertrophy: Pathogenesis, prognostic  importance and treatment. CVR & R 1992 August;:24–33.  	NO_MATCH
	74. Alexander CN, Barnes VA, Schneider RH, et al. A randomized controlled trial of stress reduction on  cardiovascular and all-cause mortality in the elderly: Results of 8 and 15 year follow-ups. Circulation  1996;93:629.[abstract]  	NO_MATCH